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Abstract 
 
Glucocorticoid receptor (GR) levels, which modulate the response to glucocorticoids (GCs), vary 
between tissues and individuals and are altered by physiological and pharmacological effectors.  In 
this study we set out to investigate the effects and implications of differences in GR concentration. 
Firstly, we established conditions that resulted in three statistically different GR populations in 
transiently transfected COS-1 cells. We demonstrated, using whole cell saturation ligand binding 
experiments, that high levels of wild type GR, but not of dimerization deficient GR, exhibited positive 
cooperative ligand binding with a concomitant increased ligand binding affinity. Furthermore, we 
established, through co-immunoprecipitation and fluorescent resonance energy transfer, that ligand 
independent dimerization correlates with positive cooperative ligand binding. This is the first time that 
positive cooperative ligand binding and increased ligand binding affinity have been explicitly correlated 
and linked to increased ligand independent dimerization of the GR. The downstream consequences of 
variation in GR concentration and dimerization included modulation of GR import and export rates, as 
investigated through live cell as well as immunofluorescent analysis. Furthermore, the nuclear 
distribution of GR was also influenced by GR dimerization. The major function of the GR is as a 
transcription factor, which mediates the response to GCs via activation or repression of genes. We 
have revealed direct influences of GR concentration and dimerization in a number of promoter reporter 
assays as well as in the transactivation of an endogenous gene. Specifically, cooperative ligand 
binding was found to be responsible for the GR level dependent potency shift in transrepression of an 
NFĸB containing promoter reporter construct via dexamethasone and the shift in the bio-character of 
Compound A, a dissociative GR agonist. Transactivation potency of dexamethasone as well as the 
partial agonist bio-character of medroxyprogesterone and mifepristone via a multiple GRE containing 
promoter reporter construct were influenced directly by cooperative ligand binding. Dimerization of the 
GR was shown to be crucial for ligand dependent transactivation of a single GRE containing promoter 
reporter construct, while ligand independent transactivation of both single and multiple GRE containing 
constructs was significantly increased due to an increase in GR concentration. The endogenous GC 
responsive glucocorticoid induced leucine zipper (GILZ) gene demonstrated significant ligand 
independent transactivation at GR levels, which displayed ligand independent dimerization. An 
increase in GR concentration resulted in an increase in efficacy through all promoter reporter 
constructs as well as the endogenous GILZ gene. Positive cooperative binding and the concomitant 
increase in ligand binding affinity to the GR at high levels may be a crucial factor in determining both 
the efficacy and potency of the GC response. Considering the significant differences in GR 
concentrations expressed by different tissues and by individuals within the same tissue, our findings 
may explain the interindividual as well as tissue specific responses to GC treatment and suggest an 
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important mechanism of action through which the GR is primed to responsed to subsaturating GC 
concentrations and displays a significant level of ligand independent activity.   
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Opsomming 
 
Glukokortikoïed reseptor (GR) vlakke, wat die gedrag van glukokortikoïede (GCs) moduleer, wissel 
tussen weefsels en onder individue en word verander deur fisiologiese en farmakologiese effektore. In 
hierdie studie ondersoek ons die gevolge en implikasies van verskille in GR konsentrasie. Eerstens 
het ons die kondisies vasgestel wat benodig word om drie statisties verskillende GR populasies te 
vestig in kortstondige getransfekteerde COS-1 selle. Ons het getoon, met behulp van die heel sel 
versadigings ligand bindings eksperimente, dat hoë vlakke van wilde-tipe GR, maar nie van 
dimeriserings gebrekkige GR, positiewe koöperatiewe ligand binding, met 'n gepaardgaande toename 
in ligand bindings affiniteit, toon. Verder het ons bevestig, deur ko-immunopresipitasie en fluoressente 
resonansie energie-oordrag, dat ligand onafhanklike dimerisering korreleer met positiewe 
koöperatiewe ligand binding. Dit is die eerste keer dat positiewe koöperatiewe ligand binding en 
verhoogde ligand bindings affiniteit uitdruklik gekorreleer en gekoppel word aan verhoogde ligand 
onafhanklike dimerisering van die GR. Die daarop nagevolge van variasie in GR konsentrasie en 
dimerisering sluit in modulasie van die invoer en uitvoer tempo van die GR, soos ondersoek deur 
lewendige sel sowel as immunofluorescente analise. Verder is die verspreiding van die GR in die kern 
ook beïnvloed deur GR dimerisering. Die belangrikste funksie van die GR is as 'n transkripsie faktor, 
wat die respons van GCS bemiddel via aktivering of onderdrukking van gene. Ons het die direkte 
invloed van GR konsentrasie en dimerisering in 'n aantal promotor verslaggewer essais sowel as in 
die transaktivering van ŉ endogene gene onthul. Spesifiek, is gevind dat koöperatiewe ligand binding 
verantwoordelik is vir die GR vlak afhanklike verskuiwing in transrepressie potensie van 'n NFĸB 
bevattende promotor verslaggewer konstruk via deksametasoon en die verskuiwing van die bio- 
karakter van verbinding A,' ŉ dissosiatiewe GR agonis. Transaktiverings potensie van 
deksametasoon, asook die gedeeltelike agonis bio-karakter van medroksie-progesteroon en 
mifepristoon, via 'n veelvoudige GRE bevattende promotor verslaggewer konstruk is direk beïnvloed 
deur koöperatiewe ligand binding. Dimerisering van die GR is getoon om deurslaggewend vir ligand 
afhanklike transaktivering van 'n enkele GRE bevattende promotor verslaggewer konstruk te wees, 
terwyl ligand onafhanklike transaktivering van beide enkel-en veelvoudige GRE bevattende konstrukte 
aansienlik toegeneem het as gevolg van ŉ toename in GR konsentrasie. Die endogene GC 
responsiewe glukokortikoïed geïnduseerde leusien rits (GILZ) gene het beduidende ligand 
onafhanklike transaktivering gedemonstreer op GR vlakke wat ligand onafhanklike dimerisering toon. 
'n toename in GR konsentrasie het gelei tot ŉ toename in die effektiwiteit van al die promotor 
verslaggewer konstrukte, sowel as die endogene GILZ gene. Positiewe koöperatiewe ligand binding 
en die gepaardgaande toename in ligand bindings affiniteit van die GR by hoë vlakke kan 'n 
belangrike faktor wees in die bepaling van sowel die effektiwiteit as die potensie van die GC respons. 
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As die aansienlike verskille in GR konsentrasies van verskillende weefsels en tussen verskillende 
individue in dieselfde weefsel in ag geneem word, kan ons bevindings die inter-individuele sowel as 
weefsel spesifieke response op GC behandeling verduidelik en stel dit 'n belangrike meganisme van 
aksie voor waardeur die GR voorberei word om op sub-versadigings konsentrasies van GC te reageer 
deur 'n beduidende vlak van ligand onafhanklike aktiwiteit te toon. 
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Introduction 
 
We aim to introduce the reader to the relevance of glucocorticoid receptor (GR) concentration and 
homodimerization at a physiological and cellular level. This is preceded by a brief discussion of the 
regulation and secretion of endogenous glucocorticoids (GCs) and the pharmacological administration 
and uses of exogenous GCs. An overview of the mechanism of GR action will then be presented 
followed by an overview of the major factors which modulate the response to GCs. Having set the 
scene, we will analyze the two focal topics of this literature review, namely the effects of GR 
concentration and homodimerization. Finally we will conclude with our hypothesis and aims.  
 
1.1 Glucocorticoids  
 
In a practical demonstration of nomenclature the name glucocorticoid is derived from a few key 
features of this class of steroid hormone. Namely, the role they play in the regulation of glucose 
metabolism, the fact that they are synthesized endogenously in the adrenal cortex and their steroidal 
structure. GCs are pleiotropic and affect diverse cellular processes including homeostasis, cell growth, 
development, metabolism, stress response and inflammation. Physiological trauma including 
inflammation, pain, infection or even mental stress, leads to the activation of the hypothalamic-
pituitary-adrenal (HPA) axis. This excitation of the hypothalamus causes it to secrete corticotrophin-
releasing hormone (CRH), which acts on the anterior pituitary inducing the synthesis and release of 
adrenocorticotropic hormone (ACTH). ACTH in turn stimulates the adrenal cortex to release GC’s, 
such as cortisol in humans, which is synthesized in a stepwise fashion from cholesterol by cytochrome 
P450-catalyzed reactions.  
 
The HPA axis tightly regulates the synthesis and secretion of GCs by the adrenal cortex and is 
sensitive to negative feedback by circulating hormones and exogenous GCs (1). The majority of 
secreted cortisol, 90 percent, is bound to corticosteroid-binding globulin (CBG), a high affinity plasma 
transport glycoprotein in the blood (2-5). Either free or bound GCs are transported in the blood to the 
target organs. At target organs, free GCs, due to their highly lipophylic nature, readily diffuse across 
the cell membrane where they elicit their effects, primarily through the GR (6).  
 
Generally, a GR agonist is defined as a compound which mimics the endogenous ligand and is 
capable of transcriptional regulation, both transactivation as well as transrepression of genes. In 
contrast a GR antagonist binds to the GR but is transcriptionally inactive, essentially blocking the GR 
from activation by agonists (7). The majority of GCs, whether endogenous or exogenous, synthetic or 
natural, share a similar steroidal structure (Fig.1.1A,B). The structure of synthetic GCs such as 
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dexamethasone (DEX) mimic that of cortisol, the endogenous GC in humans (Fig.1.1A,B). However, 
exceptions do exist such as the dissotiative GC, Compound A (CpdA) (8) (Fig1.1C). There is 
considerable variation in the behaviour of GCs, their ability to bind the GR, their capacity to induce 
dimerization of the GR (Addendum B) (9), the degree of nuclear import, export and nuclear distribution 
they induce (10, 11) and the degree to which they transactivate or transrepress genes (7). 
 
 
A B
C
 
 
Figure 1.1. Molecular structure of GCs. (A) The steroidal synthetic GR agonist, dexamethasone, (B) 
the endogenous GC agonist, cortisol, and (C) the non-steroidal dissociative synthetic GC, Compound 
A. 
 
1.1.1 Endogenous glucocorticoids are secreted in a circadian and ultradian pattern 
 
The average non-stressed individual secretes 10 to 20 mg of cortisol daily (1). Cortisol is released in a 
circadian cycle which is governed by the secretion of ACTH (12) (Fig.1.2).  Levels of free serum 
cortisol, not bound to the high affinity plasma transport glycoprotein, CBG, or the low affinity plasma 
transport protein, albumin, average 11.0nM daily, peaking at ~18.7nM in the morning and dropping to 
~3.3nM at night (13).   
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Figure 1.2. Circadian pattern of total serum cortisol concentration in humans. Mean total serum 
cortisol levels (µg/dL) in non-stressed male and female humans. (from Charmandari et al. (13)). 
 
Although ACTH secretion follows a circadian pattern, which induces a concomitant circadian secretion 
of cortisol (Fig.1.2), the release of ACTH is not gradual but pulsatile resulting in an ultradian (hourly) 
pattern of hormone release into the blood stream in both humans and rodents (14),(15, 16) (Fig.1.3). 
The majority of studies conducted on the pulsatile nature of endogenous GC secretion have been 
conducted on laboratory rats and mice. We have redrawn a figure from Windle et al. (15), which 
demonstrates this behaviour (Fig.1.3). It is important to note that corticosterone is the primary 
endogenous GC secreted by rodents, the anolog of cortisol in humans. Further more these rodents 
are nocturnal and their circadian cycle of corticosterone secretion is therefore the inverse of that 
displayed by humans, peaking at night and dropping to its minimum during the day (Fig.1.3). 
 
Stavreva et al. (17) demonstrated that the ultradian cycle of corticosterone release in freely moving 
rats results in waves of GR activation and transcription followed by GR recycling through the 
transcription machinery and priming for future reactivation. This form of hormone stimulation is 
referred to as gene pulsing and is the primary mechanism through which GC exert their basal function 
endogenously (18).  
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Figure 1.3. Total plasma corticosterone concentrations of three non-stressed Sprague-Dawley 
rats. Blood samples were taken every 10 minutes over a 24 hour period and analyzed for total 
corticosterone concentration. The 10 hour dark phase of the 24 hour cycle is indicated by the filled bar 
(from Windle et al. (15)). 
 
The transient stress of a 114 decibel noise for 10 minutes caused a significant increase in total 
corticosterone plasma concentration from 29ng per ml corticosterone in non-stressed rats to a peak of 
377ng per ml in stressed rats (Fig.1.4) (15). The maximal response to noise stress was 20 minutes 
after the initiation of the stress and corticosterone levels decreased to basal levels with in 40 to 50 
minutes. This stress response, reflected in the post stress corticosterone peak, resulted in a 
significantly extended interpeak period from 51 minutes in non-stressed rats to 95 minutes in post 
stressed rats. 
Stellenbosch University  https://scholar.sun.ac.za
 6
 
  
 
 
Figure 1.4. Total plasma corticosterone concentrations of stressed Sprague-Dawley rats. Noise 
stress of 114 decibels was administered at 08:20h for 10 minutes and is indicated by the horizontal 
dashed line bar. Blood samples were taken every 10 minutes before and after the noise stress and 
analyzed for total corticosterone concentration (±SEM, n=6) (from Windle et al. (15)). 
 
Prolonged stress results in continuously elevated cortisol levels (19, 20). Sarabadjitsingh et al. (21) 
elucidated the effects of prolonged GC exposure on rats implanted with corticosterone releasing 
pellets. They demonstrated that prolonged exposure to GCs results in significantly decreased levels of 
GR protein expression in the hippocampal area of the brain. As rats implanted with the corticosterone 
releasing pellets showed an inability to respond to chronic stress, it was concluded that the pulsatile 
nature of endogenous GC secretion in non-stressed animals was necessary for the maintenance of 
the stress response. 
 
1.1.2 Synthetic glucocorticoids are administered at a single dosage 
 
Unlike the daily circadian and hourly pulsatile nature of endogenous GC secretion, synthetic GCs are 
generally administered once or twice daily, typically in 1 to 2mg daily dosages (22). Following an oral 
dosage of 1.5mg of DEX, the plasma concentration of the exogenous GC drops from 38nM to 1nM 
within 24 hours (23). Chriguet et al. (24) demonstrated a similar result where subjects exposed to a 1 
mg oral dosage of DEX showed plasma DEX levels from 1 to 10 nM, 24 hours after administration. 
Although the levels of exogenous GC are often lower than those of the endogenous hormones, they 
are generally more potent due to greater ligand binding affinity (7) and the fact that they display 
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greater bioavailability. Synthetic GCs, unlike endogenous GCs, are preferentially bound to low affinity 
albumin and not high affinity CBG in plasma (1), thus increasing their bioavailable component.  
 
As discussed previously, the ultradian cycles of endogenous GC secretion result in the hourly 
withdrawal of GC stimulation, which leads to the rapid dissociation of GR from DNA, occurring within 
10 minutes (18). However, rapid response to ligand withdrawal is only possible through the relatively 
low affinity endogenous ligands. In the system used by McNally et al. (18), the potent synthetic agonist 
DEX leads to GR association with glucocorticoid response element (GRE) containing promoter arrays, 
which did not dissociate even after ligand withdrawal, leading to sustained target gene expression 
(18). Thus, the high affinity of synthetic GCs leads to continuous stimulation of the GR and has been 
linked to numerous side effects (18). For example, the administration of 0.5mg of the exogenous GC, 
DEX, leads to negative feed back on the HPA axis, essentially shutting down the secretion of 
endogenous cortisol secretion within 8 hours of ingestion (25).  Thus the long term effects of GC 
treatment are insidious, leading to, amongst other effects, GR down regulation which in turn may 
result in GC resistance (26).  
 
1.1.3 Pharmacological uses of glucocorticoids 
 
The ability of GCs to suppress the immune system is of primary interest pharmacologically and has 
led to GCs becoming the most widely used anti-inflammatory drugs world wide (27). Numerous 
synthetic GCs are in use, for example, betamethasone, cortisone, DEX, fluprednisone, hydrocortisone, 
meprednisone, paramethasone and prednisolone. Most of these anti-inflammatory drugs have a 
chemical structure, which is based on that of the endogenous GC, cortisol (Fig.1.1A,B). Their clinical 
efficacy stems from their ability to mimic natural GCs in suppressing inflammation and as a result they 
are administered for the treatment of inflammation and autoimmune diseases such as asthma, 
inflammatory bowel diseases, systemic lupus erythematosus, sarcoidosis, nephritic syndrome and 
rheumatoid arthritis (27). GCs also play a role in apoptosis and have as a result found a role in 
chemotherapeutic regimens (28), while their ability to suppress the immune system means they are 
commonly administered to transplant patients to reduce the risk of rejection (29).  
 
The secretion of endogenous GCs during times of stress facilitates the ‘fight or flight’ response, where 
glucose is mobilized as a readily available source of energy and non-essential functions such as 
growth are shut down. These influences of GCs are the primary cause of their side effects, notably 
endogenous or pharmacologically administered GCs lead to an increase in blood glucose levels, 
stimulate gluconeogenesis in the liver and mobilise amino acids and fatty acids. Furthermore, the 
effect of GCs in suppressing non-essential functions of the body, promotes bone metabolism. As a 
Stellenbosch University  https://scholar.sun.ac.za
 8
consequence, prolonged high dosages of GCs result in side effects which include HPA-axis 
depression, diabetes mellitus, adrenal atrophy, growth retardation, muscle atrophy, osteoporosis and 
hypertension (6). Due to these side effects, which result from high dosage and long-term use of GCs, 
their usefulness is limited. The prevalence for developing these side effects varies immensely between 
individuals. One of the great mysteries of GC research is why some patients develop severe side 
effects following low dose therapy over a short period while others may experience no side effects 
what so ever, even after prolonged use of GCs at high concentrations (30). 
 
Since the major anti-inflammatory effects of GCs are elicited by transrepression of pro-inflammatory 
genes (31), while the majority of side-effects are elicited by transactivation of genes involved in 
metabolism (32), there is much interest in dissociated GCs that selectively transrepress without 
significant transactivation of GC responsive genes (33). Dissociative GCs may be steroidal or non-
steroidal compounds, which display only partial GC effects and are dissociated in their clinical profile. 
Thus they display a separation between anti-inflammatory effects and certain side effects. Because of 
this they may be considered as improved therapeutic compounds, exerting many of the anti-
inflammatory and immunosuppressive effects of standard GCs, while inducing fewer side effects (34). 
For example, mifepristone (RU486) better known as a GR antagonist (35), achieves a degree of 
functional separation in Hela cells transiently transfected with promoter reporters where it shows little 
ability to transactivate GR dependent transcription, but represses activator protein-1 (AP-1) dependent 
transcription by 50 to 70 percent of that of DEX (36). However, the behaviour of RU486 has been 
demonstrated to be cell type specific, achieving a high degree of transactivation of an MMTV promoter 
in osteosarcoma cells but none in breast cancer cells (37). Intriguingly Zhao et al. (35) have shown a 
GR concentration dependent shift in RU486’s ability to repress transcription of an NF-ĸB-driven 
promoter reporter from that of an antagonist at low GR levels to that of a full agonist at high GR levels. 
Other dissociative GCs include the steroids ZK 216348 (38), RU24782, RU24858, RU40066 (36) and 
AL-438 (39). Compound A (CpdA), a novel dissociative GC first synthesised by the University of 
Stellenbosch Biochemistry Department, is an analogue of a compound from the indigenous Southern 
African shrub Salsola tuberculatiformis Botsch. (40). CpdA behaves as a fully dissociative GC in 
transrepressing, but not transactivating, select GC-responsive genes. As a result it may have potential 
for pharmacological use in the design of anti-inflammatory drugs with fewer side effects. The 
dissociative nature of CpdA has recently been linked to its ability to abrogate GR dimerization (9, 41), 
which we will discuss in more detail in section 1.6.4. However it should be noted that transactivation 
versus transrepression characteristics are highly cell type and gene specific and that an increasing 
number of antiinflammatory genes have been characterised which are up-regulated by the GR (42). 
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1.2 The glucocorticoid receptor 
 
As mentioned above the GR mediates the effects of both endogenous GCs in diverse cellular 
processes ((43),(44),(45),(46),(47),(48)) as well as natural or synthetic GCs used to treat  
inflammatory diseases ((49),(42),(1),(27)). The GR is a steroid hormone receptor (SR), a group which 
comprises the structurally similar progesterone receptor (PR), mineralocorticoid receptor (MR), 
androgen receptor (AR) and estrogen receptor (ER), which fall under the nuclear receptor (NR) 
superfamily (50). The GR is a ubiquitous ligand dependent transcription factor and essential for life. 
Transgenic mice, which express a truncated GR protein because of a disruption in exon 2, were born 
with severe abnormalities and died a few hours after birth (51, 52).  
 
There are two major isoforms of the GR, namely GRα and GRβ. Both originate from the same gene 
located on chromosome 5 (53) by alternative splicing (Fig.1.5). While the GRα actively binds ligand 
and is capable of transcription, the GRβ is generally inactive (54, 55).  
 
Figure 1.5. The gemonic localization of the GR gene, its structure and major isoforms. The GR 
gene is found in chromosome 5 and consists of 9 exons, the numbered boxes. Transcription and 
translation of the complete 9 exons gives rise to the GRα protein. Splicing of exon 9 results in the 
truncated GRβ. Insertion of an arginine codon between exons 3 and 4 (arrow) results in the GRγ while 
skipping exons 5 to 7 result in GR-A and deletion of exons 8 and 9 result in GR-P (from Duma et al. 
(56)). 
 
The expression of GRα at both the mRNA, as well as protein, level has been shown to be much higher 
than that of GRβ (54, 55, 57, 58). In fact, although GRβ mRNA was found within a number of healthy 
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tissues, the levels were 400-fold lower than that of GRα and unlike GRα protein, whose presence was 
ubiquitous, GRβ protein was not detected by Pujols et al. (59) in any of the ten tissues they examined. 
Clearly GRα is the predominant isoform of the receptor in healthy tissues having been detected at high 
concentrations in human brain, liver, nasal mucosa, kidney, lung, muscle, heart, colon, neutrophils and 
peripheral blood mononuclear cells (PBMC) (59). In addition GRα mRNA was found to be present in 
all 39 tissues tested in the mouse (60). We will discuss the other 3 GR isoforms as well as GR 
polymorphisms in greater detail later. 
 
1.2.1 Overview of the mechanism of glucocorticoid receptor action 
   
1.2.1.1 Ligand binding and nuclear import 
 
In the absence of ligand the GR occurs primarily in the cytoplasm in the form of a heteromeric 
complex consisting of a heat shock protein (Hsp) 90 dimer, Hsp70, the small acidic protein, p23, and 
one of the tertratricopeptide repeat (TPR)-domain proteins (53). Binding of a GC to the GR produces a 
conformational change in the GR resulting in a change in the proteins making up the heteromeric 
complex (61), GR dimerization (62) and active import into the nucleus. Nuclear import of the GR 
occurs quickly and relies on the association with Hsp90 (63-65), the TPR FK506-binding protein 52 
(FKBP52) (66) and importin-α (67). This complex is actively shuttled into the nucleus by dynein (66, 
68) along the cytoskeleton (69) through the nuclear pore complex (65, 70, 71). Nuclear import of the 
GR has been shown to have a half-time (t½) of 4 to 5 minutes following 10-6M DEX stimulation (10, 
63). The unliganded GR, although mostly cytoplasmic, does exist in a dynamic equillibrium where a 
small proportion of the population is actively shuttled into the nucleus and allowed to diffuse back into 
the cytoplasm. Upon ligand activation this equillibrium shifts toward a predominantly import driven 
state, which results in primarily nuclear GR localization (72, 73). 
 
1.2.1.2 Ligand induced dimerization 
 
The ligand bound GR may exist in equilibrium as either a monomer or dimer, although ligand binding 
shifts the equilibrium toward more dimer (74, 75). Two areas of the GR have been identified as 
influential in GR dimerization, the dimerization loop (D-loop) of the DNA binding domain (DBD) (76) 
and the LBD (77). Dimerization of the GR has been demonstrated in the cytoplasm following ligand 
binding in live cells (62) and through glycerol gradient centrifugation of purified GR (78). Other studies 
have, however, also indicated that dimerization of the GR occurs via the cooperative association of 
two GR monomers to the half-sites of the GRE (79).  We will discuss this disparity and the influences 
of GR dimerization in greater detail in section 1.6.  
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1.2.1.3 How the glucocorticoid receptor functions as a transcription factor 
 
As a ligand activated transcription factor, the primary function of the GR is the transactivation or 
transrepression of GC responsive genes. In the human U2OS osteosarcoma bone cell line the GRα is 
directly responsible for the expression of 2978 out of a total of 41079 genes (43), of these, 51 percent 
were shown to be repressed by the GR, while 49 percent were activated. 
 
In a chromatin immunoprecipitation-microarray study conducted in A549 human lung cancer cells, 68 
percent of GC responsive genes demonstrated direct association of the GR with their promoter DNA, 
which suggests that 32 percent were regulated through tethering of the GR to secondary transcription 
factors (80). Thus the GR interacts directly with DNA or via other transcription factors and various 
mechanisms of direct or indirect associations have been demonstrated (31, 81, 82). We present the 
most common forms of transactivation (via GREs) and transrepression (via negative GREs (nGREs)) 
in Figure 1.6. To illustrate, the activated GR may bind directly as a dimer to GREs in the promoter 
regions of GC-responsive genes or alternatively two GR monomers may bind cooperatively to each of 
the GRE half-sites which constitute a complete GRE (Fig.1.6A), stimulating transcription. Alternatively, 
in the case of transrepression, the ligand bound GR binds directly to nGREs (Fig.1.6D) or to other 
transcription factors, such as nuclear factor-ĸB (NFĸB) or AP-1 (Fig.1.6F), as either a monomer or a 
dimer, resulting in repression of gene transcription (80). 
 
Once ligand binding to the GR has occurred, the process of GR nuclear import, dimerization and 
interaction with GREs occurs rapidly, within 10min (83), while the removal of stimulating ligands 
results in dissociation of the GR from DNA and reattachment to Hsp90 (84) in the nucleus within 
30min (85) (Fig1.7). The interaction of ligand bound GR with GREs has been shown to be a transitory 
process (86), with the GR binding and dissociating from the DNA within seconds as opposed to 
remaining attached to the GRE during the course of transcription (83). This dynamic behaviour of the 
GR was first demonstrated by McNally et al. (18) who showed that ligand induced interactions 
between a green fluorescent protein tagged GR (GFP-GR) and the mouse mammary tumour virus 
(MMTV) promoter lasted for 10 to 20 seconds at a time before dissociating (18). This transitory 
association is referred to as the ‘hit and run’ theory of transcription where transient binding of the GR 
recruits a secondary set of transcription factors that form a stable complex, which initiates transcription 
(86-88). Furthermore, it has been shown that the ligand dependent exchange of the GR with its 
regulatory sites is an active process requiring ATP (83, 86).  
 
Following activation of transcription and before a new round of GRE association can be initiated (89), 
the GR must first be primed for re-association with the ligand. This is done through the chaperone 
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cycle which occurs in the nucleus and involves re-chaperoning of the GR with Hsp90 (17) (Fig1.7). 
Where Hsp90 association with the GR is blocked by the addition of geldanamycin (an Hsp90 inhibitor), 
GR association with response elements ceases within 5 to 10 minutes even in the continued presence 
of GC (17). Interaction with Hsp90 has also been demonstrated to be necessary for nuclear retention 
of the GR (90).  
 
Figure 1.6. Models of transcriptional regulation by the glucocorticoid receptor. Transactivation of 
genes may be initiated by (A) direct binding of a GR dimer to a simple GRE, (B) binding of a GR dimer 
or monomer as well as a secondary transcription factor to a composite GRE or (C) tethering of the GR 
to a GRE bound transcription factor. Repression of transcription may be brought about by (D) direct 
binding of a GR dimer to a nGRE, (E) GR competition for binding to a promoter which blocks its 
activation by another transcription factor or (F) tethering of the GR to a secondary transcription factor 
(modified from Newton et al. (6)). 
 
The ultradian manner through which the body secretes GCs leads to gene pulsing or cyclic rounds of 
GR mediated transcriptional regulation (17) (Fig.1.7). The rapid exchange of the activated GR on 
response elements is followed by reassociation of the receptor with its ligand through the chaperone 
cycle (17) (Fig1.7), which occurs in the nucleus and does not require transit of the GR through the 
cytoplasm for the GR to regain functionality (91). The sustained nuclear localization of the GR allows 
for a dynamic response to the hourly fluctuations in endogenous GC concentration which produces a 
wave of GR activation that decreases to baseline within 60 minutes of each hormone pulse. In 
contrast, the pharmacological administration of GCs at a single high dose leads to continuously high 
levels of GR response (17) as detected by continuous GR induced mRNA production. This behaviour 
is exacerbated by the fact that potent synthetic GCs, such as DEX, which has a higher affinity for the 
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GR than the endogenous GC, cortisol (7) take longer to disengage from the GR and have a much 
longer t½ in the plasma than endogenous GCs (17) leading to decidedly non-physiological behaviour 
which increases the risk of side effects. 
 
Figure 1.7. A simplified model of the mechanism of GR action, focusing on the chaperone 
cycle. (a) Endogenous GCs vary in concentration due to ultradian hormone pulsing. (b) The GR is 
chaperoned in the cytoplasm to Hsp90/p23 (green crescent) and Hsp70 (blue half-ring). GC binding 
induces active nuclear import while nuclear export in the absence of GC is primarily through diffusion. 
(c) The chaperone cycle in the nucleus, GR re-association with chaperones is necessary for ligand 
binding. (d) GC activated GR associates with DNA and in so doing dissociates from its chaperones, 
initiating transcription through the recruitment of cofactors (light blue boxes) and RNA polymerase II 
(dark blue box) (from Desvergne et al. (14)). 
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1.2.1.4 Degradation or nuclear export 
 
Ligand binding to and the subsequent activation of the GR is the primary cause for its homologous 
down regulation in most cells types (92, 93), but not all (94). For example, GC treatment has been 
shown to result in a decrease in GR mRNA levels by 50 to 80 percent (95, 96). While at the protein 
level, ligand dependent phosphorylation of the GR is responsible for recognition by the ubiquitin and 
proteosome pathways for degradation of the GR (97). Phosphorylation of the GR allows for 
recognition by E2 ubiquitin-congugating enzymes and E3 ubiquitin-ligase enzymes that covalently add 
the 76-amino acid protein ubiquitin to lysine 426 of the GR (98). Tagging with ubiquitin targets the GR 
for degradation by the proteosome, a multisubunit protein complex which breaks down proteins into 
small peptides and amino acids (99, 100)  
 
Ligand dependent phosphorylation of the GR has been shown to occur mainly at serine residues 
S203, S211 and S226 (101). Furthermore, recent research has demonstrated a correlation between 
extent of ligand selective phosphorylation at S226 and S211 and the efficacy and potency of 
transactivation as well as the t½ of GR degradation. However, the influence of GR phosphorylation on 
transrepression was inconclusive (102). The same paper revealed a correlation between ligand 
selective GR t½ and ligand efficacy in transrepression and transactivation assays (102) and that 
transcription is not required for DEX mediated GR degradation. Degradation of the GR can occur in 
both the nucleus and the cytoplasm (103), displaying a t½ of 44 hours for the unstimulated GR which 
drops to 10 hours following 10-6M DEX stimulation (102). 
 
After ligand withdrawal the unliganded GR remains nuclear for a considerable amount of time (91), 
typically 8 to 9 hours following the washout of 10-6M cortisol (63). The retention of the GR in the 
nucleus is linked to GR association with Hsp90 in the nucleus (90). GR dissociation from DNA 
following ligand withdrawal occurs rapidly (85) and is followed by the subsequent localization of the 
GR to transcriptionaly inactive areas of the nucleus (91), prior to export of the GR from the nucleus or 
degradation of the GR by the proteosome. It has been demonstrated that nuclear export of the GR is 
independent of the exportin 1/CRM1-directed nuclear export pathway (103) and is an inactive process 
which occurs independently of ATP (91). Considering the slow rate of nuclear export and its inactive 
nature it is most likely that nuclear export of the GR occurs through passive diffusion. 
 
1.2.2 Glucocorticoid receptor functional domains 
 
The GR protein may be divided into three functional domains, the amino-terminal activation domain, a 
central DNA binding domain (DBD) and a carboxyl-terminal ligand binding domain (LBD) (Fig.1.8) 
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(104). The amino or N-terminus contains the hormone-independent activation function 1 (AF1) 
domain, which is associated with transcriptional activity. The carboxy or C-terminus contains the AF2 
domain, which is responsible for hormone binding and hormone-dependent activation. Inactive GR is 
bound by the C-terminus to Hsp90. Upon hormone binding the receptor undergoes a conformational 
change and the composition of the Hsp90 tethering complex is altered (105) (Fig.1.8).  
 
 
 
Figure 1.8. Major functional domains of the GR and positions where post translational 
modification occurs. (A) Structural domains of the GR, the N-terminal domain (NTD), DNA binding 
domain (DBD), hinge region (HR) and ligand binding domain (LBD). Points where post translational 
modification occur are indicated: phosphorylation sites (P), sumoylation sites (SUMO) and the 
ubiquitination site (UB). (B) The major functional domains of the GR displaying areas responsible for 
subnuclear mobility, dimerization, nuclear localization and cofactor/chaperone binding. Transcriptional 
activation function (AF1), transcriptional activation function 2 (AF2) and an area of additional 
transcription activity (TA2) are also displayed (redrawn from Duma et al. (56)). 
 
Nuclear import of the liganded GR is carried out through the nuclear localization 1 (NL1) sequence, 
which is situated in the hinge-region of the GR that separates the DBD and the LBD (Fig.1.8). The 
NL1 is a nuclear localization signal (NLS) that allows for nuclear import of GR through interaction with 
importin-α and importin 7 (72, 106, 107) (Fig.1.8). A second ligand dependent nuclear localization 2 
(NL2) domain that overlaps with the LBD and also plays a role in GR nuclear import (72, 106) has 
been identified. Comparison with the predominantly nuclear PR has revealed that helices 1 to 5 within 
the N-terminal of the LBD of the GR are responsible for its cytoplasmic localization when uninduced 
A 
 
 
B 
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(108). Furthermore, a nuclear retention signal (NRS) has been shown to exist in the hinge region of 
the GR, which actively opposes the nuclear export of GR (109). Homodimerization sequences exist at 
the C-terminal domain and in the D-loop of the DBD. Both of these are necessary for optimum GR 
dimer formation (75), however, evidence suggests that the D-loop dimerization signal is more 
important (75),(110) and we will discuss this in detail in section 1.6. 
 
1.3 Overview of factors that modulate glucocorticoid response 
 
At a specific time point, the concentration of GCs are basically constant throughout the body as they 
are transported to all cells in the blood plasma and gain entry into the cell by free diffusion across the 
cellular membrane due to their lipophilic nature. Equally ubiquitous is the GR, which is expressed in all 
tissues of the human body tested (111). Despite the fact that GC concentration is equal throughout the 
body at a specific time point and that GR is present in every major tissue there are considerable tissue 
specific (25), interindividual (25, 112, 113) and diseased compared to healthy tissue (114) differences 
in GC response. The same can be said for tissue culture experiments where it is common knowledge 
that GC responses in different cell lines are not always directly comparable (7, 101).  
 
The most widely encountered and clear mechanisms through which GC response is modulated, and 
which will be discussed in this section, are through availability of the ligand itself (section 1.3.1), 
concentration of the GR (section 1.3.2), the occurrence of GR isoforms, polymorphisms and post 
translational modifications (section 1.3.3) and availability of corepressors, coactivators and 
comodulators (section 1.3.4). In a recent review article De Bosscher et al. (49) describe the five most 
widely accepted modulatory factors of GC response (Fig.1.9), of which our four factors form part. 
However, the fifth set of factors, which are known to influence the response to GCs, involve interaction 
with other transcription factors, regulation at RNA level by RNA cofactors and the basal transcription 
machinery. These influences are more generalized and therefore their effects are not limited to the 
response to GCs specifically. Thus we will focus on the four more direct mechanisms thought to 
modulate specificity of GCs. 
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Figure 1.9. Factors which modulate GR function. Numbers refer to the subsections under which we 
discuss the respective modulating factors (from De Bosscher et al. (49)). 
 
1.3.1 Ligand availability 
 
The availability of GCs may be influenced at a tissue specific level by the presence of 11β-
hydroxysteroid dehydrogenase type 2 (11β-HSD2), which catalyzes the conversion of active cortisol to 
the inactive GC metabolite, cortisone, or 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), 
which is responsible for the inverse reaction, namely, the conversion of cortisone to cortisol (48, 115, 
116). These enzymes are differentially expressed in order to fine tune tissue specific responses to 
GCs. For example, 11β-HSD1 is found in the GC responsive metabolic tissues of the liver, fat, lung 
and central nervous system (117), while 11β-HSD2 is predominantly expressed in the 
mineralocorticoid responsive cells of the kidney (117). In addition, 11β-HSD1 is highly expressed in 
the hippocampus of the brain and other tissues of the central nervous system (CNS) and has been 
shown to amplify the action of GCs in these tissues (118). In contrast, 11β-HSD2 is expressed most 
frequently in tissues which are required to display a high level of aldosterone specificity as the primary 
steroid receptor for aldosterone, the MR, has a high affinity for cortisol and 11β-HSD2 thus effectively 
1.3.1 
1.3.4 
1.3.3 
1.3.2 
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removes the competing ligand (119, 120). The levels of 11β-HSD1 and 11β-HSD2 enzymes in tissues 
may thus directly influence the intracellular availability of GCs in a tissue specific manner (115). 
Another factor that is responsible for limiting the availability of GCs to specific tissues is the efflux 
transporter P-glycoprotein (Pgp), which is a member of the ABC-transporter protein family (121). The 
Pgp is a transmembrane protein, which has been shown to export the synthetic GCs, DEX and 
prednisolone, as well as endogenous cortisol, from the intracellular compartment to the extracellular 
space (122). As Pgp is expressed in the capillary endothelial cells of the blood-brain barrier (123) it 
has been linked to the 6-fold lower levels of cortisol found in the brain as compared to in the blood 
(124).  
 
Finally, the concentration of CBG, the high affinity plasma transport glycoprotein in the blood, that is 
primarily produced by the liver may influence the interindividual and tissue specific availability of GCs 
(4, 5). Intriguingly, the enzyme elatase expressed by neutrophils has been shown to cleave the CBG 
protein resulting in the localized release of GCs. As elastase is expressed on the surface of these cells 
it is suggested that interaction with CBG is a mechanism for the delivery of large amounts of GCs to 
the activated neutrophil and sites of inflammation (4).  
 
1.3.2 GR concentration 
 
Physiologically, the concentration of expressed GR varies considerably between tissues, ranging from 
4.1 fmol GR per mg protein in PBMCs (24) to as high as 893 fmol GR per mg protein in the skin (125) 
(Table.1.1). Considerable interindividual variation, within the same tissue type, has also been 
reported, primarily in cancerous tissues (Table.1.1,Table.1.2). In an extensive study, which 
characterized the mRNA expression of 49 NRs in 39 different mouse tissues, GR mRNA was detected 
in all the tissues tested (60), however, the levels of GR mRNA varied by at least 20-fold (60). 
 
A useful model in which to appreciate the effects of interindividual differences in GR concentration are 
transgenic mice that contain two additional copies of the GR gene (126). Their expression of GR 
mRNA was shown to be elevated by 20 to 60 percent in various tissues, while in the one tissue 
analyzed for GR protein levels, the hippocampus, GR concentration was found to be 50 percent above 
that of wild-type mice (126). These GR knock-in mice are therefore a tool through which to study the 
physiological consequences of GR concentration. GR knock-in mice display significantly reduced 
basal levels of ACTH and consequently levels of corticosterone which are 4 times lower than in wild-
type mice. Their response to restraint stress was also reduced indicating a better capacity to handle 
psychological stress. This may be linked to studies that demonstrate a decrease in the capacity to 
handle psychological stress in mice, which display reduced hippocampal GR expression, due to 
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exposure to postnatal stress (127). GC treatment is known to induce thymocyte apoptosis, which the 
GR knock-in mice have an increased sensitivity to, in fact despite expressing only 1.5-fold more GR 
than wild type mice, the potency of GC induced thymocyte apoptosis is 10-fold greater in the knock-in 
mice. Finally, increased GR concentration enhances the ability of knock-in mice to resist inflammation 
as displayed by their heightened resistance to cytokine induced endotoxic shock (126). Thus, an 
increased expression of GR allows these mice to cope better with stress and inflammation.  
 
Table 1.1. GR concentrations of various human cell lines and tissue biopsies.  
Cell Line or tissue biopsy fmol GR/mg 
protein 
GR/cell Reference 
Cell lines: 
  
 
LMCAT (fibroblast) 151.8 - (128) 
MCF-7 (breast cancer) - 29995 (129) 
K562 (bone marrow cancer) - 32450 
SiHa (uterine cervical cancer) - 81000 (130) 
Hep3B (hepatoma) - 43000 
Healthy tissue biopsies: 
  
 
brain 30 - (131) 
bone marrow - 1106 to 27000 (112) 
lung 30.3 to 84.9 - (132) 
cytotrophoblasts (epithelial stem cells) 16200 - (133) 
lymphocyte (white blood cell) - 2248 to 79364 (28) 
monocyte (white blood cell) - 4834 to 17734 
PBMC 4.1 - (24) 
mononuclear leukocytes (white blood cell) 191 - (12) 
skin fibroblasts - 133400 
skin 893 - (125) 
AIDS patient biopsy: 
  
 
skin 2777 - (125) 
Cancerous tissue biopsies: 
  
 
skin (AIDS patient Kaposi's sarcoma tumour) 4663 - (125) 
skin - 52000 (113) 
brain 142 - (131) 
lung - 5230 to 36500 (134) 
lung 56.5 to 87.8 - (132) 
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Table 1.2 Interindividual variances in GR expression within the same tissue type. 
 
Tissue 
Variance [GR] 
(GR/cell) Fold difference Population Ref. 
Leukemia 1433 to 26858 19 18 (112) 
Leukemia 2248 to 79364 35 174 (28) 
PBMC 1391 to 15133 11 54 (135) 
Lung cancer 1100 to 314000 285 49 (136) 
Lung cancer 5230 to 36500 7 43 (134) 
 
The most widely encountered phenomena of GR concentration change is the down regulation of GR 
protein and mRNA brought about by prolonged GC treatment (26). A decrease in GR concentration 
has been directly linked to GC resistance in rheumatoid arthritis (137, 138), systemic lapus 
erythematosus (139), and bronchial asthma (140).  
 
GCs are capable of inducing apoptosis and are used in conjunction with chemotherapeutic regimes in 
the treatment of hematological cancers such as Hodgkin’s lymphoma, acute lymphoblastic leukemia 
and myelomas (141). The administration of GCs along with chemotherapeutic agents are an effective 
means of treating lymphoblastic leukemias as high doses of GCs promote the cytolysis of these cells. 
However, only 70 percent of patients respond to this therapy (141). A significant correlation has been 
demonstrated between the clinical responsiveness to the GC prednisone, with or without co-
administration of the chemotherapeutic agent vincristine, and GR levels (112). Of the patients studied, 
all 11 that demonstrated low levels of GR (< 5000 GR per cell) were resistant to the treatment. 
Conversely, 13 of the 20 patients with GR levels between 5000 and 15000 GRs per cell, responded 
readily to prednisone alone or to the combination of prednisone and vincristine (112). Another study of 
leukemia patients, demonstrated that those with GR levels below 16000 GR per cell were shown to 
have a higher risk of relapse following chemotherapeutic treatment (28). Furthermore, a direct 
correlation was found between GR concentration and survival rates of patients with advanced non-
small cell lung cancer (NSCLC), with increased GR expression in tumours resulting in a beneficial 
outcome to GC and chemotherapeutic treatment (134). In addition, primary cancer tissue cell lines 
treated with high dosages of DEX displayed inhibition of cell growth if expressing high levels of GR (> 
19400 GR per cell) (130). Unusually, human leukemia cells demonstrated increased GR expression 
as a result of prolonged GC treatment. This is one of the few cases of GC induced auto-induction of 
GR and facilitates GC induced apoptosis of this cancer (142). Thus increased GR concentration 
imparts heightened GC induced apoptosis in a variety of cancerous tissues.  
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The concentration of GR varies widely between individuals and tissues. Furthermore, within the same 
individual and the same tissue the concentration of GR may differ due to a diseased state such as 
cancer. A low GR concentration has been directly linked to decreased GC response while heightened 
GR concentrations may result in increased GC response. We will discuss the factors which influence 
GR concentration in more detail in section 1.4 and explain the influence of GR concentration at a 
cellular level. 
 
1.3.3 Varying glucocorticoid receptor isoforms, polymorphisms and post translational 
modification 
 
Multiple isoforms of the GR are generated from a single gene, through alternative RNA splicing and 
translation initiation, while mutations in the GR gene itself result in a number of GR polymorphisms. 
Additionally, each isoform may be modified post-translationally through phosphorylation, sumoylation 
and ubiquitination (56). 
 
As mentioned before, there are two major isoforms of the human GR namely, GRα and GRβ (Fig.1.5). 
They are identical up to amino acid 727 where their sequences diverge. The ligand binding GRα is 
made up of the full 777 amino acids coded for by the GR gene, while the 50 carboxy terminal amino 
acids of the GRα have been replaced by 15 non-homogenous amino acids to form the 724 amino acid 
GRβ (143). Pujols et al. (59) detected GRβ mRNA in healthy human tissue but found that it occured at 
a level that was 400 times lower than that of GRα mRNA, while their Western blots for GR protein 
detected GRα, but no GRβ protein was found in any of the 12 healthy human tissues tested due to its 
low level of expression.  
 
It has been suggested that the GRβ, which is largely incapable of binding GCs and displays a greatly 
reduced capacity for transcriptional activation (58), acts as a dominant negative inhibitor of GRα 
mediated transcription through heterodimerization with the GRα (144). Gougat et al. (145) have shown 
that the GRβ isoform, when overexpressed in A549 cells, is constitutively nuclear and that when 
tranfected at a 5-fold excess to GRα in COS-1 cells results in a 40 percent inhibition of DEX stimulated 
transactivation. As a result of the tendency of GRβ to repress the response of GRα it has been 
implicated in tissue specific GC resistance in several diseases (146, 147). Furthermore, exposure of 
human skeletal myoblasts to increasing concentrations of cortisol resulted in a dose dependent 
decrease in GRα expression and a dose dependent increase in GRβ expression (148). In similar 
studies, GC exposure has been demonstrated to increase the ratio of GRβ/GRα expression in PBMCs 
leading to generalized GC resistance (149) and in tuberculin induced inflammatory lesions resulting in 
steroid resistant asthma (146). In addition, studies in epithelial and lymphoid cells have demonstrated 
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that stimulation with the cytokine, tumour necrosis factor (TNF)-α, lead to the disproportionate 
increase in GRβ over GRα, which again may contribute to GC resistance in this cell line and possibly 
in other tissues that are exposed to high levels of TNFα (150). Apart from the more common GRα and 
GRβ isoforms, the rare splice variants GRP and GRA (Fig.1.5) have been identified in GC resistant 
myeloma patients (151, 152) and are thought to be the cause of their reduced response to GCs. 
Finally GRγ has been detected in childhood acute lymphoblastic leukemia (153). The GRα isoforms 
GRα, GRα-A, GRα-B, GRα-C and GRα-D have a unique capacity to transactivate and transrepress 
genes and as a result their varied expression levels in tissues may contribute to tissue specific 
responses, for example, only GRα influences the BCL10 gene, only GRα-A the BMF gene, only GRα-
B the BCL2L14 gene, only GRα-C the GADD45A gene and only GRα-D the EPO (43). 
 
Not much work has been done on the tissue specific levels of GR phosphorylation. However, it has 
been suggested that at a cellular level hyperphosphorylation of GR during the G2/M phase may 
account for GC resistance reported during this period of the cell cycle (154). Furthermore, an increase 
in the ligand dependent phosphorylation of the GR at serine residues S211 and S226 has been 
correlated with an increased ability to activate transcription (102) (Fig.1.8A). Although the 
phosphorylation status of the GR has been shown to be ligand dependent (102), results from 
investigations of tissue specific differences due to the phosphorylation status of the GR are 
inconclusive (155). 
 
Another form of post translational modification of the GR is the attachment of ubiquitin to lysine 426 of 
the GR (Fig.1.8A), which marks it for degradation by the proteasome (98). Finally, the process of 
sumoylation involves the covalent attachment of a small ubiquitin-related modifier-1 (SUMO-1) to 
lysine residues of the target protein (156). Sumoylation of the GR at K277, K293 and/or K703 is 
involved in the regulation of protein stability, localization and activity (Fig.1.8A). Over expression of 
SUMO-1 as well as GR in COS-1 cells has been demonstrated to result in a 5-fold increase in ligand 
induced transactivation through a promoter reporter (157) though once again no tissue specific 
responses have been described. 
 
GC hypersensitivity, as defined by the inability of a patient’s endogenous cortisol levels to recover 8 
hours after the administration of a potent synthetic GC, DEX (called the overnight DEX suppression 
test), has been linked to two single nucleotide polymorphisms of the GR gene (158). The N363S 
polymorphism, which occurs in ~4 percent of the population (159), has been linked to increased 
sensitivity to GCs with a physiological profile that closely resembles the side effects of prolonged GC 
exposure namely, lower bone mineral density and increased body mass index (160). BclI a restriction 
fragment length polymorphism, which results from a C/G substitution in intron 2, 646 nucleotides 
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downstream from exon 2, also displays increased sensitivity to GCs (161) and is associated with an 
increased risk of cardiovascular disease (162).  
 
A mouse model used to investigate GC hypersensitivity is based on an artificial mutant human GR that 
contains a leucine (L) substitution for methionine (M) at residue 604 in the LBD. The artificial human 
GR mutant does not correspond to any known human polymorphisms and is activated by 5 to 10-fold 
lower corticosterone concentrations than the GR wild type (163). The mouse analog has the same 
substitution at residue 610 and is termed GRM610L. GRM610L knock-in mice were created that express 
this gain in function GR as opposed to wild type GR and their response to GCs was studied (164). 
Similarly to the mice which over express GR (discussed in section 1.3.2), these gain in function GR 
mice displayed decreased corticosterone and ACTH levels, both basally as well as in response to 
psychological stress. A response which is linked to enhanced down-regulation of the HPA axis. In 
addition, these mutant mice responded to a 10-fold lower concentration of DEX as compared to the 
wild type mice, displaying a DEX induced rise in blood pressure following the administration of 1mg 
per litre DEX in their drinking water, while a similar effect was only seen at 10mg per litre DEX in the 
wild type population (164). This model demonstrates that an increase in GR sensitivity to GCs has an 
influence on the physiological response to endogenous as well as exogenous GCs.   
 
GR polymorphisms associated with GC insensitivity have also been found. An arginine (R) to lysine 
(K) amino acid mutation at position 23 (R23K) in the N terminus results in the ER22/23EK 
polymorphism, which has been detected in ~3 percent of the population (159). ER22/23EK displays 
reduced transcriptional activity in promoter reporter assays and of endogenous genes when compared 
to the wild type receptor (165). Carriers of this polymorphism display phenotypes which are associated 
with GC insensitivity such as lower total cholesterol levels, lower fasting insulin concentrations and 
increased insulin sensitivity (160). Furthermore, a polymorphism of the GRβ, A3669G, results in 
enhanced expression of the dominant negative GRβ protein (166) and homozygous carriers display 
reduced immunosuppression reflected by increased incidences of rheumatoid arthritis (167). 
 
1.3.4 Coregulating and comodulating factors 
 
Transactivation of GRE driven genes by the ligand activated GR is modulated by multiple proteins with 
coactivating or corepressing influences on transcription. They are generally referred to as coregulators 
and are subdivided into coactivators and corepressors (168). Furthermore, the behaviour of the GR is 
also influenced by factors which influence events upstream from transcription. These proteins are 
called comodulators. 
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1.3.4.1 Coactivators 
 
The over expression of coactivators results in nonspecific up regulation of promoter reporter 
transactivation by various SRs. Due to this tendency, the specificity of coactivators was initially 
unclear, however, it was subsequently demonstrated that the combination of coactivators interacting 
with the PR or GR on a single promoter varied (169). For example, the p160 steroid receptor 
coactivators (SRCs) interact differently with steroid receptors and have tissue specific expression 
patterns (170). It is therefore likely that the combination of coactivators which act on a given steroid 
receptor and their tissue specific expression confers tissue as well as steroid receptor specific 
activation (47, 171). The SRC family make up the most prominent group of coactivators that interact 
with the GR and consist of three genes that code for related proteins, namely, SRC-1 (protein: NCoA-
1), SRC-2 (proteins: NCoA-2, TIF2 or GRIP1) and SRC-3 (proteins: NCoA-3 or 
pCIP/ACTR/AIB1/RAC3/TRAM1) (172).  
 
The majority of coactivators bind to the LBD of the GR via nuclear receptor boxes such as LXXLL 
motifs (173, 174). They promote transactivation either through direct interaction with the basal 
transcription machinery or by the induction of local chromatin remodeling, which serves to activate 
promoters (47, 175, 176). The coactivators, transcription intermediary factor 2 (TIF2)/GR-interacting 
protein (GRIP), SRC-1 and AIB1/pCIP/ACTR/RAC3/TRAM1, have all been shown to increase 
transactivation potency and partial agonist activity of antagonists (177, 178). In addition, a recent 
paper by Ronacher et al. (7) demonstrated that GRIP-1 and SRC-1a interaction with the GR leads to 
an increase in both potency and efficacy of transactivation via GREs in a ligand specific manner. They 
found that in general, agonist bound GR has a higher affinity for these coactivators than antagonist 
bound GR. 
  
An example of tissue specific expression of coactivators comes from the SRC-1 gene, which has two 
splice variants SRC-1a and SRC-1e. These two variants interact differently with the LDB of the GR 
(179) and influence the behaviour of the GR differentially (171). SRC-1a mRNA was detected at much 
higher levels than SRC-1e mRNA in hypothalamic nuclei (180). Additionally, SRC-3 also demonstrates 
tissue specific expression in sub fields of the hippocampus, while knock-out of the SRC-3 gene in 
mice resulted in numerous detrimental phenotypes (181). 
 
1.3.4.2 Corepressors 
 
Corepressors, such as nuclear receptor corepressor (NCoR) and silencing mediator of the retinoid and 
thyroid hormone receptor (SMRT), have histone deacetyl transferase activity, which catalyzes the 
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deacetylation of chromatin and may recruit additional components of corepressor complexes. 
Traditionally, it was thought that corepressors only functioned in the absence of ligand or in the 
presence of antagonists, to repress transcription (47, 182). However, it is now accepted that 
corepressors are capable of interacting with agonist as well as partial agonist bound GR in 
transactivation as well as transrepression assays (7, 183).  
 
Their capacity to prevent access of the GR to GREs and nGREs results in a reduction in transcription 
(184) as has been demonstrated in experiments over expressing SMRT which result in a decrease in 
DEX induced potency and efficacy at subsaturating concentrations of ligand in transactivation assays 
(177). Szapary et al. (177) have shown that the coactivator TIF2 and the corepressor SMRT were 
mutually antagonistic and that SMRT over expression reversed the increase in potency and efficacy 
brought about by an increase in GR concentration (177). This implies that the level of corepressors 
influences the effect of increased GR concentrations on transactivation. Thus the ratio of corepressors 
versus coactivators affects the extent of GC induced gene expression (185) and therefore tissue 
specific differences in the expression of either of these coregulatory protein groups would result in 
differences in the response to GCs.  
  
1.3.4.3 Comodulators 
 
Whether bound to a ligand or unliganded, the cytoplasmic GR occurs in a complex consisting of an 
Hsp90 dimer, Hsp70, the cochaperone p23 and one of the TPR proteins, also called immunophilins 
(186). The four TPRs are FKBP52, FK506 binding protein 51 (FKBP51), cyclosporine A-binding 
protein (Cyp40) and protein phosphatase 5 (PP5). They are known to associate indirectly to the GR 
via binding to the C-terminal TPR acceptor site of the Hsp90 dimer (187-189), which can bind to any of 
the four TPR proteins. FKBP51, FKBP52 and PP5 have been shown to have profound influences on 
the ligand binding affinity of the GR, while FKBP51 and FKBP52 are known to influence the 
localization of the GR (66, 128).  
 
Ligand binding to the GR results in a shift from FKBP51 to FKBP52 association with Hsp90, which in 
turn stimulates nuclear import of the GR, Hsp90 and FKBP52 complex by dynein (66). Interestingly, 
WCL2 cells, which have a high concentration of FKBP52, display a high degree of ligand independent 
nuclear localization of the GR (190). Neither Cyp40 nor PP5 influence GR nuclear localization (61). 
 
Over expression of FKBP52 resulted in an increase in GR ligand binding affinity for [3H]-DEX, reflected 
in a decrease in the equilibrium dissociation constant (Kd) from 32.6nM to 10.1nM (128). Association 
of PP5 increased [3H]-DEX binding affinity from 32.6nM to 15.6nM, while Cyp40 had no effect on the 
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ligand binding affinity of the GR (128). FKBP51 over expression reduces the ligand binding affinity of 
the GR (191-193). Thus, it is possible that cells which over express FKBP52 would display enhanced 
GC responsiveness relative to cells over expressing FKBP51. 
 
TPR expression levels have also been demonstrated to vary between cell lines. For example, WCL2 
cells (a Chinese hamster ovary cell line) have more FKBP52 than L929 ( a murine fibrosarcoma cell 
line) and COS-1 (monkey kidney fibroblast cells), while L929 cells have the highest FKBP51 
expression amongst these three cell lines. COS-1 and WCL2 cell lines have similar Cyp40 and PP5 
expression levels, both of which are lower than L929 cells (61). The difference in expression levels of 
these comodulators between cell lines results in tissue specific behaviour, for example, GR in L929 
cells was found predominantly in the cytoplasm in a complex containing PP5 and FKBP51, while the 
GR of WCL2 cells was predominantly nuclear and complexed with PP5 and FKBP52 (61).  
 
Intriguingly, Cho et al. (194) have shown that GR concentration influences the behaviour of the 
comodulator, ubiquitin-conjugating enzyme 9 (Ubc9) in DEX stimulated promoter reporter 
transactivation assays. At low GR concentrations, increased Ubc9 expression raises efficacy 
significantly but has no influence on potency. However, at high GR concentrations, increased Ubc9 
has a reduced effect on efficacy, but increases potency significantly. As GR concentrations differ 
dramatically between tissues, the GR concentration dependent influence of Ubc9 may lead to further 
separation of tissue specific response above that which is already elicited by differences in GR 
concentration. 
 
Finally, it is not immediately clear from the literature whether each of the two Hsp90 dimers which is 
found in association with the dimerized cytoplasmic GR are associated with TPRs. However, recent 
research by Banerjee et al. (61) demonstrated association of both PP5 and FKBP52 in the nuclear 
unliganded GR complex and PP5 and FKBP51 in the cytoplasmic unliganded GR complex, which 
suggests that both Hsp90 chaperone complexes are capable of binding a TPR while in association 
with GR. Furthermore this evidence suggests ligand independent dimerization of the GR. 
 
1.4 Physiological glucocorticoid receptor concentrations 
 
We have established that GR concentration has a profound effect on the physiological response to 
GCs and have discussed the fact that GR concentrations vary between tissue types (12, 59, 60, 114, 
195, 196) (Table.1.1) and individuals (28, 112, 135) (Table.1.2). However, we have focused on only a 
few of the causes for differences in GR concentration, notably down regulation due to GC exposure 
(21, 148, 197-199). There are a wide variety of other influences that affect GR concentration and we 
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will now elaborate on these in terms of influences that increase or decrease physiological GR 
concentrations. 
 
1.4.1 Increased glucocorticoid receptor concentrations 
 
High levels of GR have been detected in a number of cancers (28, 130). For example, while the 
average concentration of GR in healthy human brain varies from 32 to 67 fmol GR per mg protein, 
depending on the specific tissue, the concentration of GR in brain tumours is significantly higher, 
ranging from 99 to 171 fmol GR per mg protein (131). Furthermore acquired immune deficiency 
syndrome (AIDS) exacerbates the phenomena of increased GR in cancerous cells. For example, 
although healthy skin has one of the highest GR concentrations of all tissues at 893 fmol GR per mg 
protein (Table.1.1), this rises 3-fold in the healthy skin of AIDS sufferers and peaks at a 5-fold increase 
in GR expression in Kaposi's sarcoma of AIDS sufferers (125).  
 
Following an extreme mechanical injury to skeletal muscle tissue, sepsis is known to develop. Sepsis 
involves the catabolic breakdown of damaged muscle through proteolysis (200). The level of GR 
expression increases 2-fold in septic muscle, despite dramatically increased plasma corticosterone 
levels in rats (114). It has been suggested that under septic conditions the up regulation of GR and 
GCs facilitate the catabolism of the damaged muscle tissue (201). 
 
Adrenalectomy involves the surgical removal of the adrenal glands and results in virtually undetectable 
plasma corticosterone levels 4 days after the operation in rats (202). This dramatic decrease in 
circulating GCs results in tissue specific up regulation of GR expression. GR concentration in the rat 
hippocampus increased 3-fold 4 days after adrenalectomy, while the increase was a less dramatic 2-
fold in the prefrontal cortex (202). 
 
Dietary restriction (DR) without malnutrition has been much lauded as a means of delaying aging and 
has been shown to protect rodents from diabetes, impaired tissue growth and reproductive 
senescence (203). It also results in a 37 percent increase in the GR expression of mouse liver. Mice 
subjected to DR demonstrated an increase in GR concentration from 122 to 167 fmol GR per mg 
protein compared to mice that were fed ad libitum (204). Although DR mice displayed a similar age 
dependent percentage decrease in GR concentration as the mice fed ad libitum, their GR levels in old 
age where statistically the same as young ad libitum fed mice. The relatively increased GR levels in 
old DR mice may allow them to maintain basal and stress-related homeostasis better than old ad 
libitum fed mice.  
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1.4.1 Decreased glucocorticoid receptor concentrations 
 
A ubiquitous cause of down regulation of GR expression is aging. For example, an inverse correlation 
has been demonstrated between GR concentration in PBMCs and age in human subjects (205), while 
cortisol levels remained unchanged. Levels of GR mRNA in the human prefrontal cortex have also 
been shown to decrease in subjects greater than 77 years of age (195).  Studies in rats indicated a 
similar trend, showing significant deceases in GR levels in the liver of older animals (> 20 months old) 
ranging from 19 to 25 percent decrease in GR expression, depending on the study (198, 204). The 
loss of GR in the liver of aging rats was associated with decreased GC responsiveness and may 
contribute to impaired metabolic function (198).  
 
Ironically exercise has also been linked to a significant decrease in GR expression levels of PBMCs in 
humans. The strenuous training of athletes is reflected in an increased plasma cortisol level compared 
to sedentary individuals, which in turn results in greater down regulation of GR expression (205). 
 
The body draws little distinction between its physiological response to physical or psychological stress. 
In animal studies, psychological stress results in a down regulation of GR in the muscle, liver and 
hippocampus and prefrontal cortex of the brain (196, 206, 207). These lowered GR levels, particularly 
in the hippocampus, are associated with heightened resting as well as stress induced GC levels (196, 
206, 207). For example, the psychological stress of maternal separation of rat pups within the first 3 
weeks of life results in permanently lowered hippocampal GR expression, which causes a lack of 
negative feedback of GCs to the HPA axis and therefore to massively elevated endogenous GC levels 
in response to stress. This is associated with depressive-like behaviour and a general inability to cope 
with psychological stress (206). Human depressives also display elevated cortisol levels in the brain 
and GC resistance consistent with the results found in rodents (208). 
 
To summarize, the concentration of GR in tissues can be upregulated following adrenalectomy, due to 
the environmental influence of DR and in diseased states such as cancers, AIDS and in muscle 
sepsis. Factors which have been shown to result in a decrease in tissue GR concentration, other than 
aging, are generally linked to an increase in the stress response for example, strenuous exercise and 
psychological stress.  
 
1.5 The cellular effects of glucocorticoid receptor concentration 
 
The influence of GR concentration on GC response has been explored in a number of tissue culture 
studies, which focus on the modulation of GC response at a cellular level. Where as clinical 
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observations of patients broadly reveal hypersensitivity to GCs brought about by increased GR levels 
or GC resistance at reduced GR levels, molecular biological investigation suggests the cause of these 
symptoms. We will focus on the effects of altered GR concentration on ligand binding and 
transcription. Additionally, as it has been revealed that the nuclear mobility of activated AR is receptor 
concentration dependent (209), we will discuss these findings as well. 
 
1.5.1 Ligand binding affinity and positive cooperative ligand binding   
 
Ligand binding affinity is quantified in terms of Kd (210-213). The Kd is calculated by dividing the 
dissociation constant by the association constant (211). In the case of receptor ligand binding, Kd is 
defined as the concentration of ligand required to bind to half of the available binding sites (213). 
Although counter intuitive an increase in ligand binding affinity is reflected in a decrease in Kd. 
Physiologically a 4.3-fold decrease in GR concentration brought about by the tumour promoter, 
phorbol 12-myristate 13-acetate (PMA), in mice resulted in a 5.2-fold decrease in DEX binding affinity 
(199). Furthermore, cytosolic fractions from human mononuclear leukocytes demonstrate a 2-fold 
increase in ligand binding affinity at high GR concentrations (12). However, 48 hour treatment of the 
human monocytic cell line, U937, with tumor necrosis factor α (TNFα), a pro-inflammatory cytokine, 
resulted in a 2.4-fold decrease in GR concentration (from 11709 to 4834 GR per cell) but no significant 
change in ligand binding affinity (214). There are only a handful of studies which explore the link 
between GR concentration and ligand binding affinity and their findings are not definitive. This is an 
issue which begs further analysis. 
 
Ligand binding behaviour may also be quantified in terms of the amount of ligand required to shift 
receptor occupancy from 10 to 90 percent (215). The slope of the ligand binding curve between 10 
and 90 percent receptor occupancy by ligand is termed the Hill slope (Fig.3.2). Where an 81-fold 
increase in ligand is required to shift receptor occupancy from 10 to 90 percent a Hill slope of 1 is 
generated and ligand binding is considered non-cooperative. When less than an 81-fold difference in 
ligand concentration is required to shift the receptor occupancy from 10 to 90 percent a Hill slope of 
greater than 1 is generated. A Hill slope greater than 1 is indicative of positive cooperative ligand 
binding, which implies an increase in the ligand binding affinity by the receptor. A Hill slope of 1 
reflects a single binding site on the receptor or receptor complex, while a Hill slope greater than 1 can 
only be achieved where more than one binding site exists. The Hill slope indicates the minimal number 
of binding sites possible. Therefore, a Hill slope between 1 and 2 suggests the existence of 2 binding 
sites. Changes in receptor concentration have been directly linked to shifts in Hill slope. Notides et al. 
(216) demonstrated a relationship between the concentration of the ER and Hill slope, where 
increasing ER levels brought about an increase in the Hill slope. A shift from non-cooperative ligand 
Stellenbosch University  https://scholar.sun.ac.za
 30
binding at low ER concentrations to positive cooperative ligand binding at high ER concentrations was 
ascribed to dimerization of the ER. At high concentrations of ER (above 2 nM ER in cytosolic 
preparations) the Hill slope of [3H]-estradiol binding to the ER was 1.68, however, preincubation with 
low levels of the enzyme trypsin decreased the Hill slope to ~1. The level of trypsin used over the 1 
hour co-incubation with [3H]-estradiol at 0OC was shown to result in ER monomers without affecting 
the number of binding sites significantly. Thus the authors concluded that the loss of positive 
cooperative ligand binding was not as a result of enzymatic degradation of the ER by trypsin but as a 
result of the loss in ER dimerization. 
 
In a recent paper, which explored the influence of GR concentration on [3H]-DEX binding, it was found 
that, similarly to the ER, an increase in GR concentration resulted in a shift from non-cooperative (Hill 
slope of 0.995) to positive cooperative ligand binding (Hill slope of 1.479) (194). Once again this 
phenomenon was ascribed to receptor dimerization, as a GR mutant, which displayed an enhanced 
capacity to homodimerize, retained the capacity for positive cooperative ligand binding at 
concentrations where the wild type receptor displayed non-cooperative ligand binding.  
 
The increase in ligand affinity at high GR concentrations, reflected by the shift to positive cooperative 
ligand binding and a decrease in the Kd, could explain the hypersensitivity to GCs displayed by tissues 
with high GR concentrations. Less ligand would be required to shift GR occupancy from 10 to 90 
percent, while 50 percent of receptor occupancy would occur at a lower ligand concentration, implying 
greater sensitivity to both endogenous as well as exogenous GCs.   
 
1.5.2 Nuclear mobility 
 
Although we have found no studies where the influence of GR concentration on GR nuclear mobility 
has been analysed, receptor concentration has been demonstrated to influence the nuclear mobility of 
ER and AR. Marcelli et al. (209) demonstrated, in fluorescent recovery after photobleaching (FRAP) 
studies, that the nuclear mobility of agonist bound GFP tagged AR is related to AR concentration. 
Increasing AR levels in transiently transfected HeLa cells lead to a 5-fold decrease in the rate of 
nuclear mobility. Over expression of GFP-ER has been shown to behave in a similar manner (217). 
The nuclear localization of agonist bound AR and ER results in discrete foci at areas of transcription. It 
is suggested that increased levels of these receptors allow for greater association with slow moving 
components of the transcription machinery and DNA resulting in a decrease in nuclear mobility (209, 
217). 
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1.5.3 Transcription by the glucocorticoid receptor 
 
The GR mediated transcriptional response to GCs is influenced by GR concentrations (46). It is an 
accepted fact that increasing the concentration of a transcription factor, like the GR, will enhance its 
maximal efficacy, however, this does not imply an increase in potency or the amount of partial agonist 
activity produced by antagonists (44). In order to affect the concentration of agonist required to elicit 
50 percent of the maximal gene expression or repression (potency) a mechanistic change must occur, 
which facilitates greater sensitivity to ligand. The shift towards greater ligand affinity reflected by a 
decrease in Kd or positive cooperative ligand binding at high GR concentrations is one such 
mechanism. Facilitating greater GR occupancy at lower ligand concentrations should result in an 
increase in transcription potency. Similarly a mechanistic change must also occur in order for an 
antagonist or weak agonist to display a shift to full agonist behaviour.  
 
Maximal GC dependent (218) as well as GC independent (145) transrepression, referred to as 
efficacy, increases as GR levels are increased. Furthermore, Zhoa et al. (35) demonstrated an 
increase in both the potency (log EC50) and efficacy (maximal response) of DEX induced 
transrepression by increasing the concentration of transfected GR in promoter reporter assays. They 
also revealed a biocharacter shift in the transrepression profile of RU486, which shifted from behaving 
as an antagonist of DEX at low GR concentrations to full agonist behaviour at high GR concentrations.  
 
Similarly, increased GR concentrations cause an increase in the potency and efficacy of GC induced 
transactivation of promoter reporters (177, 194, 219-221). An increase in the efficacy of ligand 
independent transactivation has also been reported (145). Furthermore, increased GR concentration 
also leads to a biocharacter shift from weak agonist to partial agonist behaviour by RU486 (222), 
dexamethasone-21-mesylate (Dex-Mes) (220) and progesterone (Prog) (219, 220) in transactivation 
assays. It has been observed that the effects of increased GR concentration on both potency and 
efficacy are saturatable. Voss et al. (223) have suggested that at increasingly high GR concentrations 
the cofactors required to facilitate GR action may become limiting.  
 
Although GR concentration changes have been shown to result in clear shifts in efficacy, potency and 
biocharacter of partial agonists, none of the above studies have defined the specific GR 
concentrations at which shifts occur nor have they compared or attempted to correlate the changes in 
GR induced transcription with a change in Kd or shift from non-cooperative ligand binding to positive 
cooperative ligand binding. 
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1.6 Dimerization of the glucocorticoid receptor 
 
1.6.1 Homodimerization and heterodimerization of the glucocorticoid receptor 
 
Upon ligand binding the GR is known to homodimerize (62, 75, 78, 110, 224), a characteristic shared 
with other members of the SR family, including the ER, PR, MR and AR (224).  
 
Savory et al. (62) demonstrated that DEX- as well as RU486-stimulated nuclear import of a nuclear 
import defective GR mutant was facilitated by over expression of the wild type GR. This cotransport 
from the cytoplasm into the nucleus of the nuclear import defective mutant GR through interaction with 
the wild type GR is strong evidence that homodimerization of the GR occurs in the cytoplasm. 
However, other studies suggest that NR dimerization occurs on the DNA following the sequential 
binding of two receptor monomers. Dahlman-Wright et al. (79) demonstrated using the DBD of the GR 
that occupancy of the low binding affinity half-site of the GRE is dependent on the initial binding of the 
GR to the high binding affinity half-site. Similarly, it has been shown that the binding of the DBD of the 
retinoid-X-receptor to DNA induces conformational changes in the receptor monomer which facilitate 
dimerization of the receptor at direct repeat recognition elements (225). In vitro evidence has also 
been brought to light which shows ER binding to DNA as either a monomer or a dimer (226). Tellingly, 
it has been shown that the GRE has a greater affinity for the GR dimer than for the GR monomer. 
Binding of the GR dimer to the imperfect palindromic GRE of the tyrosine amino transferase (TAT) 
gene (TGTACAggaTGTTCT) has a Kd of 2.56nM, while association of the GR monomer to one site of 
this GRE has a Kd of 62nM (75). Similarly, Drouin et al. (74) demonstrated a 5-fold decrease in GRE 
affinity through GR monomer binding than through dimer binding. Furthermore, they revealed that 
activated GR binds to DNA as a preformed dimer and not in a stepwise fashion. When increasing 
concentrations of purified GR were added to a fixed concentration of GRE probe and run in an electro-
mobility shift assay (EMSA) a single band representing GR dimers associated to the GRE was 
revealed (74). This result is consistent with the finding that the GR monomer displays a lower affinity 
for the GRE than the GR dimer (75),(74) as the GR dimer binds preferentially to the GRE. These 
studies present strong evidence that the activated GR is capable of DNA independent dimerization 
and that ligand induced DNA binding of the GR occurs primarily through the dimer.  
 
Dimerization of the GR to other SRs has also been observed. GR heterodimerization to the MR (227), 
as well as to the AR (228), occurs in the nucleus only and is believed to require monomeric receptor 
binding to the half-sites of hormone response elements (HRE) in order for dimerization to be achieved. 
To clarify the SRs, AR, MR, PR and GR display similar binding affinity for many promoters and the 
terms HRE and GRE are often used interchangeably, it is thus possible for the association of a GR as 
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well as either an MR or AR on the two half-sites of an HRE. Heterodimerization of the GR with MR or 
AR can result in heterodimer specific transactivation via HREs (227, 228), while GR 
heterodimerization with the MR leads to impaired transactivation via GREs (229). Thus, these 
interactions may play a part in tissue specific GC responses in tissues where these receptors are co-
expressed. However, dimerization of the GR favours homodimerization. Where as heterodimerization 
appears to be limited to the nucleus (62, 227), homodimerization occurs both independently of (78) 
and dependently on (79) DNA binding. Furthermore, although co-immunoprecipitation (Co-IP) as 
well as fluorescent resonance energy transfer (FRET) experiments have revealed a high degree of 
ligand independent homodimerization of the GR in transiently transfected cells over expressing the 
GR (9, 41), no ligand independent heterodimerization has been reportered. As GR homodimerization 
is the primary form of GR dimerization, we will refer to it as dimerization and refer to 
heterodimerization specifically when discussing GR dimerization to other SRs. 
 
1.6.2 The D-loop and ligand binding domain 
 
As mentioned earlier the GR has two dimerization domains, one within the LBD and one in the DBD. 
Both of these are necessary for optimal dimer formation (Fig.1.8) (75). Dahlman-Wright et al. (76) 
identified 5 amino acids (amino acids 458 to 462 in the human GR) within the second zinc finger of the 
DBD, which when mutated abolished high affinity GR binding to the DNA as defined by a significant 
increase in the Kd of GR binding to DNA. As GR dimerization is required to elicit high affinity DNA 
binding it was concluded that these 5 amino acids play a significant role in the dimerization of the GR. 
These 5 amino acids have subsequently been termed the D-loop (Fig.1.10).  
 
Although crystallographic studies of the GR LBD consisting of amino acids 521 to 777, which does not 
include the DBD, have shown that ligand dependent dimerization of the LBD alone is also possible, 
the interaction is relatively weak displaying a Kd for dimerization of 1.5 µM (110). In comparison 
Segard-Maurel et al. (75) determined the Kd of activated and non-truncated GR dimerization 
independent of DNA binding as 3.9nM in cell cytosol. The affinity for GR dimerization is therefore 385-
fold higher in the whole protein than for the LDB alone. Dimerization of a truncated GR mutant that 
does not contain the LBD has also been demonstrated, further supporting the importance of the D-
loop in dimerization (62). It is therefore likely that the activated GR exists in equilibrium as either a 
monomer or a dimer where increased GR concentrations shift the balance towards a higher 
concentration of dimerized receptor (194). 
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Figure 1.10.  The amino acid sequence of the two zinc fingers of the human GR. Zinc fingers one 
and two are labelled while the 5 amino acids which make up the D-loop are indicated in bold type. The 
A to T mutation that results in the dimerization defective mutation at position 458 is indicated.  
 
1.6.3 Dimerization deficient glucocorticoid receptor 
 
Based on work by Kaspar et al. (230) in the AR, which demonstrated inhibition of dimerization due to a 
single amino acid exchange in the D-loop, Heck et al. (231) created a dimerization deficient GR 
mutant, through the exchange of alanine to threonine at position 458, in the human GR. We will 
henceforth refer to GR which contains this amino acid substitution in the D-loop and which is 
characterized by impaired dimerization as the GRdim. It was demonstrated in gel mobility shift 
experiments on whole cell extracts of COS-7 cells expressing GRdim and exposed to DEX stimulation 
that unlike the GR wild type (GRwt), the GRdim did not associate with radio-labelled GRE, suggesting 
a reduced ability to bind directly to DNA. In DEX induced promoter reporter assays GRdim was also 
shown to have a greatly reduced capacity to transactivate via a single GRE (GRE-tk-CAT) as well as 
via a multiple GRE (MMTV-CAT). However, GRdim displayed the same capacity to repress an AP-1 
driven promoter reporter as the GRwt (231). This study concluded that GR dimerization is required for 
DNA binding, that transactivation occurs primarily through the GR dimer and that transrepression of 
the AP-1 transcription factor is as efficient through the GR monomer as the GR dimer. Dimerization of 
the GR has been linked to high affinity binding of the receptor to DNA (54), which is prevented through 
mutation of the D-loop (76). Although GRdim has been demonstrated to have a reduced affinity for 
DNA it does not prove that dimerization was abrogated by this mutation. Despite the ubiquitious use of 
this dimerization deficient mutant its ability to dimerize has never actually been reported. Numerous 
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other dimerization reduced GR mutants exist (232) but the GRdim is the most widely characterised 
and as a result it is the one we will focus on. 
 
Subsequent research supports the theory that GRdim can not transactivate through a single GRE, 
however, its capacity to transactivate via multiple GRE containing promoter reporters has been 
revealed to be greater that of the GRwt (232, 233). Specifically, Adams et al. (232) demonstrate that 
the GRdim can in fact bind to the promoter of the GR regulated phenylethanolamine N-
methyltransferase (PNMT) gene, which contains multiple GREs, although with a slightly reduced 
affinity than the GRwt, and that it is capable of inducing 3-fold higher levels of transcription via a 
PNMT promoter driven reporter. Work with endogenous genes reveals that differences in promoter 
architecture results in varied transcriptional response through both the GRwt as well as the GRdim 
(234). Of the 10 GR responsive genes studied by Rogatsky et al. (234), 3 were induced to at least 50 
percent of the GRwt levels by the GRdim, while 1 was more responsive to the GRdim. These findings 
were supported by the work of Meijsing et al. (235) who showed that the GRdim was capable of 30 
percent of the GRwt’s TAT transactivation capacity and enhanced transactivation through a number of 
GR responsive gene promoters such as glucocorticoid induced zipper (GILZ), Cgt, Sgk and Pal.  
 
Transgenic mice which express the GRdim as opposed to the wild type receptor display similar 
properties, namely, a lack of GR binding to DNA and greatly reduced transactivation of GRE 
containing promoter reporters (197). Furthermore, injection of these mice with DEX did not influence 
mRNA levels of the GRE containing TAT gene (236). In contrast, tissue from GRdim mice has an 
equal capacity as that of wild type mice for DEX stimulated down regulation of AP-1 induced 
collogenase-3 mRNA expression. Reichardt et al. (31) went on to prove that these mice retain the 
ability to repress the inflammatory response of locally irritated skin, the metabolic response to 
lipopolysaccharides and that repression of NFĸB driven transcription is also possible through the 
GRdim. A recent study which explored the influence of the synthetic GC, prednisolone, on the 
expression of liver genes in wild type and GRdim mice demonstrated a greatly reduced transcriptional 
response in the GRdim mice (237). Where as prednisolone treatment influenced the regulation of 518 
genes (347 upregulated and 171 down regulated) in GR wild type mice, only 34 genes (29 
upregulated and 5 down regulated) were influenced in the GRdim mice (237). Of the genes, which 
were regulated by both the GRwt and the GRdim, there was on average a two thirds reduction in the 
response through the GRdim. Clearly GR dimerization is a factor in the ability of the GR to regulate 
transcription, and that this influence is more pronounced in the physiological system of the transgenic 
mouse model than in promoter reporter assays. 
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1.6.4 CpdA abrogates dimerization 
 
A possible mechanism through which CpdA achieves its dissociative behaviour (238-240) has been 
revealed in two recent articles by Dewint et al. (41) and Robertson et al. (Addendum B (9)). Unlike 
DEX, which induces maximal dimerization of the GR, addition of CpdA results in abrogation of GR 
dimerization as displayed in Co-IP (41) as well as fluorescent resonance energy transfer (FRET) (9) 
and nuclear immunofluorescence studies of nuclear localization deficient GR (9) experiments. It was 
found that the action of DEX through the GRdim was similar to that of CpdA through the GRwt in 
nuclear import, nuclear export and transactivation as well as transrepression assays (9). This offers a 
strong argument that the loss of dimerization of GR brought about by CpdA results in the dissociated 
behaviour of the compound. Intriguingly, these studies utilized tissue culture cell lines over expressing 
GR and display a high degree of ligand independent dimerization of the GR. Ligand independent 
dimerization ranges from 40 percent to 90 percent of the maximal DEX induced dimerization in the 
FRET (9) and Co-IP (41) experiments, respectively.  
 
1.7 Summary, hypothesis and aims 
 
1.7.1 Summary 
 
Analysis of the literature has confirmed the influence of GR concentration on ligand binding affinity as 
well as the response to GCs at a physiological level as well as in tissue culture experiments. 
Increased GR concentrations result in GC hypersensitivity in individuals and in an increase in the 
efficacy, potency and biocharacter of partial agonists in promoter reporter assays. Low GR levels are 
associated with GC hyposensitivity in patients and reduced response in promoter reporter assays. It is 
clear that there is a vast difference in the level of GR expression between tissues as well as between 
individuals within the same tissue. Furthermore, GR concentration may differ in the same tissue type 
in the same individual due to diseases such as cancer or physiological trauma such as muscle sepsis. 
This variance in GR concentration has been directly linked to GC hypersensitivity in the case of GR 
over expression and GC resistance in the case of GR suppression.  
 
The increased ligand binding affinity and shift to positive cooperative ligand binding as well as 
increased potency and shift in biocharacter of partial agonists in both transactivation as well as 
transrepression due to increased GR concentrations suggest the involvement of a mechanistic 
alteration in GR conformation at heightened GR levels. A mechanistic alteration implies a change in 
the conformation of the receptor itself most probably the ligand binding site, which facilitates 
cooperative ligand binding and an increase in ligand binding affinity. A direct influence of a GR 
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concentration dependent mechanistic change in GR is illustrated by studies, which have shown an 
increase in ligand binding affinity and a shift from non-cooperative ligand binding to positive 
cooperative ligand binding at high GR concentrations. Dimerization of the GR has been implicated in 
the shift from non-cooperative to positive cooperative ligand binding at high GR concentrations, 
however, no attempt has been made to correlate this with ligand binding affinity.  
 
1.7.2 Hypothesis 
 
As reviewed in this Chapter, a number of studies have shown that GR concentration has a direct 
influence on the ligand binding behaviour of the GR, affecting both Kd and Hill slope. GR concentration 
has also been shown to affect the potency of agonists and the biocharacter of partial agonists. 
Unfortunately, none of the studies reviewed have quantified the concentrations of GR required to elicit 
these shifts in behaviour so inter experimental comparison is speculative. Nonetheless it is highly 
plausible that increases in GR concentration result in a GR dimerization dependent increase in ligand 
binding affinity that facilitates an increase in transcriptional potency.  
 
It has been reported that positive cooperative ligand binding to the GR at high GR concentrations 
demonstrates a Hill slope of ~1.5, which can only be achieved through ligand association to a receptor 
or receptor complex containing 2 binding sites, the GR dimer. Ligand independent dimerization of the 
GR could account for the shift from non-cooperative to positive cooperative ligand binding to the GR 
as this protein-protein interaction creates a GR complex containing two binding sites. 
 
The canonical model of ligand binding to the GR monomer is non-cooperative (Fig.1.11A). We 
propose that ligand independent dimerization of the GR occurs at high GR concentrations (Fig.1.11B), 
which allows for positive cooperative ligand binding to the two ligand binding sites on the GR dimer. If 
our assumption is correct high concentrations of GRdim will continue to display non-cooperative ligand 
binding due to this mutant’s impaired ability to dimerize (Fig.1.11C). Furthermore, the use of GRdim 
may provide insight into the influence of GR dimerization on the down stream behaviour of the GR. 
 
An increase in ligand binding affinity at high GR concentrations would allow for an increase in 
transcriptional potency and biocharacter shift in partial agonists. At a physiological level differences in 
biological response at differing GR concentrations may be due to cooperative ligand binding and an 
increase in ligand binding affinity at high GR concentrations. Therefore we hypothesize that: 
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Ligand independent dimerization of the GR at high concentrations facilitates positive 
cooperative ligand binding and a concomitant increase in ligand binding affinity, which may 
affect down stream signalling events such as nuclear localization and transcription. 
 
 
Figure 1.11. Theoretical models of ligand binding to the GRwt and GRdim. (A) At low GRwt levels 
non-cooperative ligand binding to GR monomers results in dimerization of the GR. (B) High GR levels 
result in ligand independent dimerization of the GR, which allows for positive cooperative ligand 
binding. (C) At high levels the GRdim remains monomeric resulting in non-cooperative ligand binding 
after which it does not dimerize. 
 
1.7.3 Aims 
 
Our four major aims are each investigated in a separate results chapter. In this section we will present 
an overview of the methodology and objectives which underpin each of these chapters. For ease of 
reference, we will present the over arching aim of each results chapter in a separate paragraph. 
    
Aim 1: Establish GR concentrations that display cooperative and non-cooperative ligand 
binding as well as a significant difference in Kd 
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Central to our hypothesis is the establishment of GR concentrations in transiently transfected COS-1 
cells which display either non-cooperative or positive cooperative ligand binding. Using whole cell 
saturation ligand binding assays, we will define three levels of GR concentration which we will term 
low, medium and high, respectively. Saturation ligand binding generates both a Hill slope as well as a 
Kd, which makes it possible for us to identify the shift from non-cooperative to positive cooperative 
ligand binding as well as to quantify a change in ligand binding affinity. In addition, we will include the 
GRdim mutant in our saturation ligand binding studies in order to investigate the influence of 
dimerization on the two ligand binding parameters investigated. Results are reported in Chapter 3. 
 
Aim 2: Confirm that ligand independent dimerization of the GR occurs at GR concentrations 
that display cooperative ligand binding and increased ligand binding affinity 
In order for cooperative ligand binding to occur we hypothesize that ligand independent dimerization of 
the GR must occur. In Chapter 4 we make use of Co-IP and FRET techniques in order to test whether 
ligand independent dimerization of the GR correlates with an increase in ligand binding affinity and 
cooperative ligand binding. Co-IP of low, medium and high GR concentrations will be employed to 
demonstrate the level of GFP-GRwt or GFP-GRdim dimerization to Flag-GRwt. We will examine the 
levels of ligand independent GR dimerization as well as the level of dimerization brought about by 
stimulation with DEX and by the dimerization abrogating compound, CpdA. While Co-IP will be carried 
out on cell lysates, FRET relies on live cells expressing low, medium and high levels of cyan 
fluorescent protein (CFP) tagged GR and yellow fluorescent protein (YFP) tagged GR. Dimerization of 
CFP-GR and YFP-GR will be quantified as an increase in the level of corrected FRET signal, which 
will be measured prior to DEX induction and for 30 minutes afterwards. Ligand independent 
dimerization of the GR will be quantified as either the fold ligand induced maximal FRET response or 
through mathematical modelling of the FRET results. 
 
Aim 3: Determine the influence of positive cooperative ligand binding and increased ligand 
binding affinity, GR concentration and GR dimerization on glucocorticoid receptor 
nuclear import, export and distribution 
In Chapter 5, live cell nuclear import and export studies will be conducted on cells expressing medium 
and high levels of GFP-GRwt or GFP-GRdim. The nuclear import rate will be measured following 
stimulation with a range of test compounds, while export will be measured following the washout of 
DEX. Cells expressing medium and high GFP-GRwt or GFP-GRdim will be stimulated with either DEX 
or CpdA prior to being permeabilized and fixed. Nuclear distribution of the GFP tagged receptors will 
be quantified and related directly to random or non-random nuclear distribution. An indirect method for 
fluorescence labelling of the GR, termed immunofluorescence, will also be employed to determine the 
nuclear import and export rates of low and medium GRwt or GRdim concentrations. The nuclear 
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import rate following DEX or CpdA stimulation will be tested in order to elucidate the effect of 
dimerization on nuclear import in the GRwt. The use of GFP-GRdim or GRdim in the live cell or 
immunofluorescence assays, respectively, will allow insight into the influence dimerization may have 
on the rate of nuclear import and export as well as the pattern of nuclear distribution. 
 
Aim 4: Establish the influence cooperative ligand binding and increased ligand binding affinity 
has on GR mediated transcription 
Finally, the major function of the GR, namely its ability to induce transcription both dependent and 
independent of ligand binding, will be put under the spot light in Chapter 6. We will examine the 
influence of GR concentration, the ability to dimerize and positive cooperative ligand binding on 
transrepression of a promoter reporter as well as transactivation through a single and multiple GRE 
containing promoter reporter and the endogenous GILZ gene. Potency (log EC50), efficacy (maximal 
induction or repression) and the biocharacter of a range of ligands relative to DEX will be determined 
in order to quantify transcription. Transrepression of an NFĸB promoter containing construct will be 
tested at varying GRwt and GRdim concentrations stimulated by DEX or CpdA in order to elucidate 
the influence of GR dimerization, cooperative ligand binding and an increase in ligand binding affinity. 
A similar methodology will be applied to the investigation of transactivation through a single as well as 
a multiple GRE containing promoter reporter construct and the endogenous GC responsive GILZ 
gene. Use of varying GRwt concentrations allows for the elucidation of cooperative ligand binding and 
an increase in ligand binding affinity on transcription, while the behaviour of the same concentrations 
of GRdim reveal the influence of dimerization.  
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2.1 Materials and methods 
 
2.1.1 Reagents 
Dexamethasone (11β,16α)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione), 
hydrocortisone (11β,17α,21-trihydroxypregn-4-ene-3,20-dione-17-hydroxycorticosterone), 
progesterone (4-pregnene-3,20-dione), medroxyprogesterone (6α-methyl-17αhydroxyprogesterone 
acetate), mifepristone (11β-(4-dimethyl amino)phenyl-17β-hydroxy-17-(1-propynyl)estra-4,9-dien-3-
one), cycloheximide, DEAE-Dextran, chloroquine diphosphate salt (chloroquine)  and phorbol 12-
myristate 13-acetate (PMA) were purchased from Sigma-Aldrich. Compound A (2(4-acetoxyphenyl)-2-
chloro-N-methyl-ethylammonium chloride) was synthesized as described previously (1). The [3H]-DEX 
(specific activity of 68-85Ci/mmol) was obtained from AEC Amersham Biosciences.  
 
2.1.2 Plasmids 
The pGL2-basic (empty vector) was obtained from Promega. The pRS-hGRα (GRwt) was a gift from 
R. M. Evans (2), pECFP-hGRα (CFP-GR) and pEYFP-hGRα (YFP-GR) were gifts from J. Cidlowski 
(3). pEFFlaghGRα (Flag-GR, molecular mass, 96 kDa) (4) and pHisGRA477T (GRdim) where gifts 
from K. De Bosscher (University of Ghent, Belgium). The pEGFP-C2-GR (GFP-GR, molecular mass, 
128.5 kDa) was provided by S. Okret (Karolinska Institute, Sweden) (5). The GRE-containing promoter 
reporter constructs, pTAT-GRE2-Elb-luc was a gift from G. Jenster (6) and p∆ODLO was a gift from D. 
Pearce (University of California), while the NFĸB containing IL6-luc promoter reporter construct, 
p(IL6Kβ)350hu.IL6P-luc was a gift from G. Haegeman (University of Ghent, Belgium) (7). The pEGFP-
C2-GRA477T (GFP-GRdim) was cloned by excising the wild type GR from pEGFP-C2-GR with the 
restriction enzymes XmaI and SalI and replacing it with the mutated GRdim sequence from 
pHisGRA477T. The presence of the mutation was confirmed through sequencing (primer, forward 5'-
AGC TTC AGG ATG TCA TTA TGG AG-3' and reverse 5’-CCC CCC CCG GGG TTT TGA TGA AAC 
AGA-3’). All plasmids were verified by restriction enzyme digest. 
 
2.1.3 Cell culture and DEAE-dextran transfectionMonkey kidney fibroblast cells (COS-1) purchased 
from American Type Culture Collection (ATCC) were cultured in high glucose (4.5g/ml) Dulbecco’s 
modified Eagle’s medium (DMEM) (Sigma) with 2mM glutamine (Merck), 44mM sodium bicarbonate 
(Invitrogen), and 1mM sodium pyruvate (Invitrogen) (unsupplimented DMEM) supplemented with 10% 
fetal calf serum (FCS) (Highveld Biologicals, South Africa), 100IU/ml of penicillin, 100µg/ml of 
streptomycin (Pen/Strep) (Invitrogen). All transfections were done using the DEAE-dextran method 
(8). Cultured cells where plated to achieve a density of 70% to 80% confluence on the target day of 
transfection. The transfection mix consisted of 11550ng DNA/10cm plate added to preheated 
unsupplimented DMEM medium (7,5ml/10cm plate), along with 0.1mM chloroquin and 0.1mg/ml 
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DEAE-Dextran and incubated on the cells at 37°C for  2 hours followed by a 4 minute 10% DMSO in 
PBS shock at 37°C. The cells were then rinsed with PBS and finally 15ml complete DMEM (1% 
Pen/Strep; 10% FCS) was added. 
 
2.1.4 Whole cell binding to determine the expression levels of the GR plasmids COS-1 cells (2 x 
106 cells/10cm plate) were DEAE-Dextran transfected with the indicated amounts of plasmid DNA 
(Fig.3.3) and filled to 15000ng total plasmid DNA/10cm plate with empty vector. Twenty four hours 
after transfection cells were replated (1 x 105 cells/well in 24-well plates) and serum starved (in order 
to remove GCs in the medium which may result in GR down regulation and interfere with the response 
to administered GCs) in medium with 10% dextran-coated charcoal stripped FCS (Highveld 
Biologicals, South Africa) and 1% Pen/Strep (stripped DMEM). Twenty four hours after replating cells 
were incubated for 4 hours at 37°C with 10nM [ 3H]-DEX (total binding) or [3H]-DEX and a 500 fold 
excess of unlabeled DEX (non-specific binding) in unsupplemented DMEM. Cells were then placed on 
ice and washed three times, for 15 minutes each with ice-cold PBS containing 0.2% (w/v) bovine 
serum albumin (BSA) (Roche). Cells were lysed with 100µl of passive lysis buffer (0.2% (v/v) triton, 
10% (v/v) glycerol, 2.8% (v/v) 1M tris-phosphate-EDTA and 0.29% (v/v) 0.5M EDTA) and binding was 
determined by scintillation counting in a 1900CA TRI-CARB liquid scintillation analyzer (Packard) 
using FLO-SCINT II (Perkin Elmer). Total binding and non-specific binding were normalized to protein 
concentration (Bradford assay) (9). Specific binding (total binding - nonspecific binding) was plotted. 
Ligand depletion (LD) was monitored for all whole cell binding assays to ensure that less that 10 
percent of the total [3H]-DEX was removed from solution by specific and non-specific association. LD 
fell between 0.5 to 2.5 percent for all experiments implying that binding of the [3H]-DEX did not 
significantly alter its concentration. 
 
2.1.5 Time course to ligand binding equilibriumCOS-1 cells (2 x 106 cells/10-cm plate) were DEAE-
Dextran transfected with GRwt (low (38.5ng), medium (385ng) or high (11550ng)), GRdim (low 
(385ng) or medium (11550ng)) or GFP-GR (medium (38.5ng) or high (11550ng)) and filled to 11550ng 
total plasmid DNA/10cm plate with empty vector.  Twenty-four hours after transfection cells were 
replated (1 x 105 cells/well in 24-well plates) in stripped DMEM. Twenty four hours after replating cells 
were incubated for varying time periods at 37°C wit h 10nM [3H]-DEX (total binding) or labled DEX and 
a 500 fold excess of unlabeled DEX (non-specific binding) in unsupplemented DMEM. Cells were then 
placed on ice and washed three times, for 15min each with ice-cold PBS containing 0.2% (w/v) BSA. 
Cells were lysed with 100µl of passive lysis buffer and binding was determined by scintillation 
counting. Total binding and non-specific binding were normalized to protein concentration (Bradford 
assay) and specific binding (total binding - nonspecific binding) was plotted against time and curves fit 
using one phase exponential association. 
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2.1.6 Whole cell saturation binding COS-1 cells (2 x 106 cells/10-cm plate) were DEAE-Dextran 
transfected with GRwt (low (38.5ng), medium (385ng) or high (11550ng)), GRdim (low (385ng) or 
medium (11550ng)) or GFP-GR (medium (38.5ng) or high (11550ng)) and filled to 11550ng total 
plasmid DNA/10cm plate with empty vector. Twenty-four hours after transfection cells were replated 
(1x105 cells/well in 24-well plates) and serum starved in stripped DMEM. Twenty four hours after 
replating cells were incubated for 4 hours at 37°C with increasing concentrations of [3H]-DEX (total 
binding) or [3H]-DEX and a constant concentration of 60µM unlabelled DEX (non-specific binding) in 
unsupplemented DMEM. Cells were then placed on ice and washed three times, for 15 minutes each 
with ice-cold PBS containing 0.2% (w/v) BSA. Cells were lysed with 100µl of passive lysis buffer and 
binding was determined by scintillation counting. Total binding and non-specific binding were 
normalized to protein concentration (Bradford assay). Specific binding (total binding - nonspecific 
binding) was determined and fmol GR per mg protein was calculated using a counting efficiency of 
43%. Specific binding was plotted against nM [3H]-DEX and curves fit using one site binding hyperbola 
to obtain Kd and maximal binding (Bmax) values. In addition, specific binding was also plotted against 
logM [3H]-DEX and curves fit using sigmoidal dose-response (variable slope) to obtain Hill slopes. 
 
2.1.7 Competitive whole cell binding.  
COS-1 cells (2 x 106 cells/10-cm plate) were DEAE-Dextran transfected with low (38.5ng), medium 
(385ng) or high (11550ng) levels of GRwt and filled to 11550ng total plasmid DNA/10cm plate with 
empty vector. Twenty-four hours after transfection cells were replated (1 x 105 cells/well in 24-well 
plates) and serum starved in stripped DMEM. Twenty four hours after replating cells were incubated 
for 4 hours at 37°C in unsupplemented DMEM containi ng 40nM [3H]-DEX and EtOH or a range (10-5 to 
10-11M) of unlabelled DEX or CpdA. Cells were then placed on ice and washed three times, for 15 
minutes each with ice-cold PBS containing 0.2% (w/v) BSA. Cells were lysed with 100µl of passive 
lysis buffer and binding was determined by scintillation counting. Total binding was normalized to 
protein concentration (Bradford assay) and expressed as percentage displacement (bottom plateau for 
maximal [3H]-DEX displacement designated as 100% displacement and top plateau where no 
displacement took place as 0% displacement). Sigmoidal dose-response curves where fit to this data 
which generated maximal displacement results. 
 
2.1.8 Co-immunoprecipitation (Co-IP) 
COS-1 cells (2 x 106 cells/10-cm plate) were DEAE-Dextran transfected with low levels (38.5ng) of GR 
(34.22ng Flag-GR and 4.28ng GFP-GRdim or GFP-GRwt), medium levels (385ng) of GR (342.2ng 
Flag-GR and 42.8ng GFP-GRdim or GFP-GRwt) or high levels (11550ng) of GR (10266ng Flag-GR 
and 1284ng GFP-GRdim or GFP-GRwt) and made up to a total of 11550ng plasmid DNA/10cm plate 
with empty vector. Cells were replated (2.5 x 106 cells/10cm plate) and serum starved 24 hours later in 
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stripped DMEM and after 24 hours treated with ethanol (control), 10-6M DEX, or 10-5M CpdA for 1 
hour. After induction cells were washed twice with PBS before being lysed on ice in Buffer A (10mM 
Hepes pH7.5 (Invitrogen), 1.5mM MgCl2, 10mM KCl, 0.1% Nonidet P-40 (Roche Applied Science), 
and Complete Mini protease inhibitor mixture (Roche Applied Science)). After two cycles of freeze-
thaw the lysates were centrifuged at 14,000 x g for 15 minutes, and the supernatant collected. Protein 
concentrations were determined using the Bradford method and 600µg of protein from the low GR 
concentration or 200µg of protein from the medium and high GR concentration samples were 
precipitated with 30µl of EZview Red ANTI-FLAG M2 Affinity Gel beads (Sigma), pre-washed 4 times 
with Buffer A in the presence of 2.5% (w/v) casein protein and Complete Mini protease inhibitor 
mixture. Buffer A, 2.5% casein protein and Complete Mini protease inhibitor mixture, beads and lysate 
forming a minimum volume of 400µl/sample were rotated for 16 hours at 4°C. Beads we re washed 
four times with 200µl of Buffer A supplemented with Complete Mini protease inhibitor mixture, 0.5% 
Triton X-100 (BDH) and 150mM NaCl. 20µl of Laemmli buffer (62.5mM Tris-HCl, pH6.8, 10% (v/v) 
glycerol, 1.25% (m/v) SDS, 0.00125% (m/v) bromphenol blue, and 2.5% (v/v) β-mercaptoethanol) was 
then added to beads, which were boiled for 7.5 minutes at 95°C. For Western blotting, immune 
precipitates (20µl) were separated on a 10% SDS-PAGE gel, together with the inputs of total cell 
lysate (20µg). Following electrophoresis, proteins were electroblotted and transferred to Hybond-ECL 
nitrocellulose membrane (Amersham Biosciences), which was probed for GR (H-300 anti-body (Santa 
Cruz Biotechnology) diluted 1:1000 in 5% (w/v) casein in TBST buffer for low GR concentrations or 
1:3000 dilution for medium and high GR concentrations) and visualized using ECL peroxidase-labeled 
anti-rabbit anti-body (AEC-Amersham Biosciences) diluted in 5% (w/v) casein in TBST buffer (1:5000 
for low GR concentrations and 1:10000 for medium and high GR concentration) and ECL Western 
blotting detection reagents (GE Healthcare) on Hyperfilm (Amersham Biosciences). Densitometric 
analysis of the immunoblots was carried out using UN-SCAN-IT gel 6.1 software (Silk Scientific) and 
GFP-GR pull down was normalized against their respective Flag-GR levels. 
 
2.1.9 Fluorescence resonance energy transfer (FRET) 
COS-1 cells (2 x 106 cells/10cm plate) were DEAE-Dextran transfected with low levels (38.5ng) of GR 
(19.25ng CFP-GR and 19.25ng YFP-GR), medium levels (385ng) of GR (195.5ng CFP-GR and 
192.5ng YFP-GR) or high levels (11550ng) of GR (5775ng CFP-GR and 5775ng YFP-GR) and made 
up to a total of 11550ng plasmid DNA/10cm plate with empty vector. Twenty-four hours after 
transfection cells were replated (3 x 104cells/well) into 8-well Lab-Tek chambered coverglass plates 
(Nunc, Denmark) and serum starved in stripped DMEM. Twenty-four hours after replating cells were 
analyzed in the temperature-controlled chamber (37°C) of an Olympus Cell system attached to an IX-
81 inverted fluorescence microscope (Olympus Corp., Japan) equipped with a F-view-II cooled CCD 
camera (Soft Imaging Systems) and a 150W Xenon lamp as light source which is part of the MT20 
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excitation source. An Olympus Plan Apo N 60X/1.4 oil objective lens and the Cell® imaging software 
were used for image acquisition and analysis. Cells were selected which expressed both CFP-GR and 
YFP-GR. Cells were induced with 10-6M DEX in unsupplemented DMEM. CFP, YFP and FRET 
images were taken every minute over a 30min period. FRET fluorescence was detected using a filter 
set with S430/25x excitation and S535/30m emission. The YFP filter set excites at S500/20x and the 
emission is detected at S535/30m while the CFP filter set excites at S430/25x and the emission is 
detected at S470/30m. All filter sets where supplied by Chroma Technology Corporation (Rockingham, 
USA). An exposure time of 1500ms at 100% light intensity was used and the entire cell area as 
defined by the cellular membrane was selected as the region of interest. The F-don signal (CPF) was 
used to select cells for analysis as these F-don values reflect the CFP signal after 30min of DEX 
stimulation measured in a region of interest in the nucleus of each individual cell. Cells with an F-don 
emission of 0-600 were selected from the low GR concentration population, F-don signals between 
600-1200 from the medium GR concentration population and F-don of >1200 from the high GR 
concentration population. The signals measured in the FRET channel were corrected for cross-talk 
from the cyan (CFP) and yellow (YFP) channels using the following equation: nFRET = FRETsignal - 
(α x YFP signal) - (β x CFP signal) where n is normalized FRET and α and β were determined by 
measuring the crossover into the FRET channel of the YFP and CFP signals, respectively, in cells 
expressing each fusion protein on its own. In our system, 2.6% of the YFP signal (α) and 59% of the 
CFP signal (β) were detected in the FRET channel (10). Background subtraction was carried out on 
CPF, YFP and uncorrected FRET signals using an area where no cells were present. The fold 
increase in FRET response was calculated by normalizing each experiment to its unstimulated FRET 
signal and fit to a sigmoidal dose-response variable slope curve which generates maximal fold 
induction of FRET. CFP, YFP and corrected FRET images are captured in grey scale for optimal 
sensitivity, the images are coloured electronically for ease of differentiation. 
 
2.1.10 Live cell nuclear import 
COS-1 cells (2 x 106 cells/10-cm plate) were DEAE-Dextran transfected with GFP-GR (medium 
(38.5ng) or high (11550ng)) or GFP-GRdim (medium (38.5ng) or high (11550ng)) and filled to 
11550ng total plasmid DNA/10cm plate with empty vector. Twenty-four hours after transfection cells 
were replated (3 x 104 cells/well) into 8-well Lab-Tek chambered coverglass plates and serum starved 
in stripped DMEM. Twenty four hours after replating cells were analyzed in the temperature-controlled 
chamber (37°C) of an Olympus Cell system attached t o an IX-81 inverted fluorescence microscope 
equipped with a F-view-II cooled CCD camera and a 150W Xenon lamp as light source which is part 
of the MT20 excitation source. An Olympus Plan Apo N 60X/1.4 oil objective and the Cell® imaging 
software were used for image acquisition and analysis. The GFP filter set (U-MGFP/XL, Olympus) 
excites at 470 nm (BP 460-490) and emission is collected at 506 nm (BA510IF). Cells were selected 
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which displayed clear cytoplasmic GFP-GR distribution, with cells with low GFP-GR levels selected 
from the medium population while those with greater than average GFP-GR levels selected from the 
high population. Cells were induced with 10-6M DEX in unsupplemented DMEM and GFP images were 
taken every minute over a 60 minute period. Nuclear import was quantified as the increase in GFP 
fluorescence in the nucleus (region of interest) over the period of stimulation. Fluorescence in the 
nucleus at the zero time point was subtracted from all time points and a one phase exponential 
association curve was fit to the data where the generated half time (t½) represents the time it takes to 
achieve 50% of maximal GFP nuclear accumulation. 
 
2.1.11 Live cell nuclear export 
COS-1 cells were DEAE-Dextran transfected, replated and serum starved as for the live cell nuclear 
import assay. Twenty four hours after replating cells were induced with 10-9M DEX for 1 hour after 
which they were rinsed 4 times with sterile PBS and stripped DMEM was added. Cells were selected 
which displayed clear nuclear GFP-GR distribution, with cells with low GFP levels selected from the 
medium GR concentration population while those with greater then average GFP levels selected from 
the high GR concentration population. Nuclear export was analyzed at time points between 0 and 36 
hours after DEX washout in the temperature-controlled chamber (37°C) of an IX-81 Olympus Cell 
system using the same hardware and software as for the live nuclear import assay. Nuclear export 
was quantified as the ratio of GFP fluorescence in the mid point of the nucleus over that in the 
midpoint between nuclear membrane and cellular membrane. Data was fit to a one phase exponential 
decay curve which generates a
 
t½ to maximal cytoplasmic localization.  
 
2.1.12 Nuclear distribution 
COS-1 cells were DEAE-Dextran transfected as for the live cell nuclear import assay. Cells were 
replated 24 hours later onto coverslips in 6-well plates (3 x 105 cells /well) and serum starved in 
stripped DMEM. Twenty four hours after replating cells were induced with 10-6M DEX or 10-5M CpdA 
for 1 hour. After induction cells were fixed and permeabilized by being placed on ice, rinsed with 1ml 
of -20°C methanol, and incubated at -20°C for 15min  with another 1ml of -20°C methanol. Cells were 
then washed three times with ice-cold PBS plus 0.2% BSA and mounted on glass slides. Cells were 
analyzed on an IX-81 Olympus Cell system using the same hardware and software as for the live cell 
nuclear import assay. Cells were selected which displayed clear nuclear GFP-GR distribution, with 
cells with low GFP levels selected from the medium GR concentration population while those with 
greater than average GFP levels selected from the high GR concentration population. Z-stack images 
of the nuclei were taken at various focal planes and used to deconvolute a single nuclear image. As 
long a line as possible was drawn through each nuclei avoiding nucleoi and the Cell® imaging 
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software was used to quantify the coefficient of variation (CV) of GFP fluorescence intensity along this 
line. The lower the percentage CV, the more random the nuclear distribution (11).  
 
2.1.13 Immunofluorescent analysis of nuclear import 
COS-1 cells (2 x 106 cells/10cm plate) were DEAE-Dextran transfected with GRwt (low (38.5ng) or 
medium (385ng)) or GRdim (low (385ng) or medium (11550ng)) and filled to 11550ng total plasmid 
DNA/10cm plate with empty vector. Cells were replated 24 hours later onto coverslips in 6-well plates 
(3 x 105 cells /well) and serum starved in stripped DMEM. Twenty four hours after replating cells were 
induced with 10-6M DEX or 10-5M CpdA at time points ranging from 0 to 60 minutes. After induction 
cells were fixed and permeabilized as for the nuclear distribution assay and transferred to new 6-well 
plates containing 2ml of blocking buffer (PBS with 3% (v/v) FCS and 1% (w/v) BSA). Cells were 
incubated for 1 hour at room temperature and then washed twice with ice-cold PBS plus 0.2% BSA. 
To visualize GR, cells were incubated with the primary rabbit anti-GR H-300 (diluted 1:1000 in 
blocking buffer) over night. Cells were then washed three times with ice-cold PBS plus 0.2% BSA and 
incubated for 1 hour at room temperature with secondary anti-body (Alexa Fluor 488-tagged anti-rabbit 
anti-body (Molecular Probes)) diluted 1:500 in blocking buffer. Nuclei were visualized using Hoechst 
33258 stain (Sigma) according to the manufacturer’s instructions. Cells were then washed three times 
with ice-cold PBS and mounted on glass slides. Cells were analyzed on an IX-81 Olympus Cell 
system using the same hardware and software as for the live nuclear import assay in a double-blind 
fashion. Cells were allocated as either nuclear (where there was clear nuclear localization (>60% of 
signal in nucleus) of the signal) or cytoplasmic and the percentage nuclear of 50 total cells per slide 
counted was fit to a one phase exponential association curve which generated
 
t½ to maximal nuclear 
localization as well as maximal nuclear localization values. 
 
2.1.14 Immunofluorescent analysis of nuclear export 
COS-1 cells were transfected, replated and serum starved as for the immunofluorescent nuclear 
import assay. Twenty four hours after replating cells were induced with 10-6M DEX or 10-5M CpdA for 1 
hour, rinsed three times with sterile PBS at 37°C a nd incubated for time points ranging from 0 to 28 
hours in stripped DMEM. At the end of each time point cells were fixed, fluorescently labelled and 
mounted as for the immunofluorescent import assay. Cells were analyzed on an IX-81 Olympus Cell 
system using the same hardware and software as the live nuclear import assay in a double-blind 
fashion. Cells were allocated as either nuclear (where there was > 60% nuclear localization of the 
signal) or cytoplasmic and the percentage nuclear of 50 total cells counted per slide was fit to a one 
phase exponential decay curve which generated t½ to maximal cytoplasmic localization values. 
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2.1.15 β-Galactosidase assay 
COS-1 cells (2 x 106 cells/10cm plate) were DEAE-Dextran transfected with GRwt (low (38.5ng), 
medium (385ng) or high (11550ng)) or GRdim (low (385ng) or medium (11550ng) and  900ng pSV-β-
gal (Promega) and filled to 12450ng total DNA with empty vector or COS-1 cells (2 x 106 cells/10cm 
plate) were DEAE-Dextran transfected with GRwt (4500ng, 6000ng, 7500ng or 9000ng) or GFP-GR 
(6000ng or 7500ng) and 1500ng pCMV-βgal (Invitrogen) and filled to 10500ng total DNA with empty 
vector. Cells were replated 24 hours later into 96-well plates (4 x 104 cells /well) in stripped DMEM. 
Twenty four hours after replating cells were lysed with 30µl of passive lysis buffer, and subjected to a 
freeze thaw cycle. β-Galactosidase activity was determined using the Galacto-star kit (Tropix). Light 
emission was measured in a Veritas microplate luminometer (Turner Biosystems) and was normalized 
to protein concentration. 
 
2.1.16 Promoter reporter transactivation assays 
COS-1 cells (2 x 106 cells/10cm plate) were DEAE-Dextran transfected with GRwt (low (38.5ng), 
medium (385ng) or high (11550ng)), GRdim (low (385ng) or medium (11550ng)) or GFP-GR (medium 
(38.5ng) or high (11550ng)) and 3000ng pTAT-GRE2-Elb-luc (2 x GRE promoter reporter) or 3000ng 
p∆ODLO (1 x GRE promoter reporter) and filled to 14550ng total plasmid DNA/10cm plate with empty 
vector. Cells were replated 24 hours later onto 96-well plates (4 x 104 cells /well) and serum starved in 
stripped DMEM. Twenty four hours after replating cells were induced with EtOH or a range (10-5 to 10-
12M) of DEX, F, MPA or RU486 in stripped DMEM for 24 hours. Cells were lysed with 30µl of passive 
lysis buffer, and subjected to a freeze thaw cycle. Luciferase activity was determined using a 
luciferase assay kit (Promega) and light emission measured in a Veritas microplate luminometer. 
Luciferase relative light units were normalized against protein concentrations (Bradford method). 
Sigmoidal dose-response curves were fit to the experimental data which generated maximal induction 
as well as log EC50 values. 
 
2.1.17 Promoter reporter transrepresion assays 
COS-1 cells (2 x 106 cells/10cm plate) were DEAE-Dextran transfected with GRwt (low (38.5ng), 
medium (385ng) or high (11550ng)) or GRdim (low (385ng) or high (11550ng)) and 12000ng 
p(IL6Kβ)350hu.IL6P-luc and filled to 23550ng total plasmid DNA/10cm plate with empty vector. Cells 
were replated 24 hours later into 24-well plates (5 x 104 cells /well) and serum starved in stripped 
DMEM. Twenty four hours after replating cells were induced with EtOH alone (uninduced), PMA 
(10ng/ml) and EtOH (maximal induction), or PMA (10ng/ml) plus a range (10-5 to 10-12M) of DEX or 
CpdA in stripped DMEM for 24 hours. Cells were lysed with 50µl passive lysis buffer, and subjected to 
a freeze thaw cycle. Luciferase activity was determined and normalized as for the transactivation 
assay. The EtOH alone value, representing unstimulated luciferase production, was subtracted from 
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all data points, and the resultant values expressed as a percentage of the maximal induction. 
Percentage of maximum induction values were finally subtracted from 100 percent producing 
percentage repression values. Sigmoidal dose-response curves were fit to the data which generated 
log EC50 as well as maximal percentage repression values. 
 
2.1.18 Real time PCR quantification of endogenous gene expression 
COS-1 cells (2 x 106 cells/10cm plate) were DEAE-Dextran transfected with no GR plasmid, GRwt 
(low (38.5ng), medium (385ng) or high (11550ng)) or GRdim (low (385ng) or high (11550ng)) and 
filled to 11550ng total plasmid DNA/10cm plate with empty vector. Cells were replated 24 hours later 
into 12-well plates (3 x 105 cells /well) and serum starved in stripped DMEM. Twenty four hours after 
replating cells were induced with either EtOH or 10-6M DEX in stripped DMEM for 8 hours. Cells were 
then placed on ice and rinsed three times with ice cold PBS before being lysed with 400µl Tri Reagent 
(Sigma) and subjected to a freeze thaw cycle at -80°C. RNA was isolated according to the Tri Reagent 
manufacturer’s guidelines and its integrity checked on a 1 percent agarose gel. 1µg of RNA, as 
determined by spectrophotometry, was reverse transcribed to cDNA using the ImProm-II Reverse 
Transcription system (Promega). Real time PCR was carried out on 200ng of cDNA using 15µl 
SensiMix SYBR Kit (Quantace) made up to a total volume of 25µl with nuclease free water and 
primers for either the glucocorticoid induced leucine zipper (GILZ) or glyceraldehydes-3-phosphate 
dehydrogenase (GAPDH), which is a constitutively expressed gene that is not influenced by DEX (12) 
and was used to normalize GILZ values. The GILZ primers were purchased through QuantiTect 
primers (Qiagen) and have an amplicon size of 69bp. The GAPDH primers were synthesized by 
Integrated DNA Technologies (forward, 5’- TGA ACG GGA AGC TCA CTG G-3’ and reverse 5’-ATT 
CGT TGT CAT ACC AGG-3’) (13) and have an amplicon size of 307bp. Quantitative PCR was carried 
out in a Rotor-Gene 6000 (Corbett) with 45 cycles of 10sec at 95°C, 10sec at 55°C and 10sec at 
72°C. A melting curve for each gene was constructed  by raising the temperature from 50°C to 95°C by 
0.2°C per second. Standard curves of GILZ and GAPDH  amplification in triplicate at 0.32, 1.6, 8, 40 
and 200ng/µl cDNA concentrations were generated using Rotor-Gene 6000 Series Software 1.7 
(Corbett) to determine primer efficiency. GILZ expression was calculated relative to GAPDH for each 
condition according to the Pfaffl mathematical model (14) and expressed as either fold induction 
induced by DEX relative to EtOH for each transfection condition or as maximal DEX induction relative 
to the no GR transfected EtOH condition. Ligand independent transactivation was calculated as the 
EtOH induction of each condition relative to the no GR transfected EtOH condition. 
 
2.1.19 Converting Bmax to mol GR/cell, GR/cell and M GR 
The GR concentration of COS-1 cells transiently transfected with GRwt, GRdim or GFP-GRwt was 
derived from saturation binding curves and was converted from maximal binding (Bmax) (Fig.3.6B) 
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with units of counts per minute (cpm)/mg protein to disintegrations per minute (dpm)/mg protein using 
the experimentally derived counting efficiency (CE) of 43% (equation 1). The dpm/mg protein value 
was then converted to Curies (Ci) per mg protein by dividing dpm by the amount of dpm (2.22 x 1012) 
in one Curie (equation 2). Finally this was converted to GR concentration in mol GR per mg protein by 
dividing Ci by the specific activity (SA) in Ci per mmol of the [3H]-DEX used (equation 3).  
 
Moles GR per cell was calculated by multiplying the GR concentration in mol GR per mg protein by the 
Bradford determination of the average protein concentration of a single COS-1 cell (6.49 x 10-7mg/cell) 
(equation 4). The number of GR molecules per cell was then calculated by multiplying the moles of 
GR per cell by the Avogadro constant (6.02 x 1023) (equation 5) which represents the number of 
molecules in a mole. The molar concentration of GR was calculated by dividing the moles of GR per 
cell by the hematocrite derived average volume of a single COS-1 cell (4.02 x 10-9ml/cell) (equation 6). 
 
 
 
 
 
2.1.20 Statistical analysis and curve fitting 
Statistical analyses and all curve fitting were carried out using GraphPad Prism 5 software. Statistical 
analysis was done using one way analysis of variance (ANOVA) with either Bonferroni, Dunnett or 
Newman-Keuls post-tests or unpaired t tests and carried out on the pooled average ± SEM of each 
individual experiment. Statistical significance of differences is indicated in figure legends. Only bars 
where statistical significance was found are indicated while those left open are non-significant. 
 
 
M GR =                                    x  1000                                                (6)  
GR/cell = mol GR/cell  x  6.02x1023                                                  (5)  
mol GR/cell = mol GR/mg protein  x  6.49x10-7mg protein/cell     (4)  
mol GR/cell 
4.02x10-9ml/cell 
mol GR/mg protein =                                                                (3)  
2.22x1012 
Ci/mg protein =                                                                           (2)  dpm/mg protein 
CE 
Ci 
SA 
Bmax (cpm/mg protein) 
dpm/mg protein =                                                                       (1)  
Stellenbosch University  https://scholar.sun.ac.za
 68
2.2 Mathematical model to calculate percentage monomers from FRET data 
A derivation carried out on corrected FRET, F-don and F-acc fluorescence from the FRET assay 
calculates the percentage moles of GR occurring as either monomers or homodimers prior to ligand 
stimulation. CFP-GR and YFP-GR monomers are defined as C = CFP-GR and Y = YFP-GR, 
respectively. Receptor dimerization will yield three products: 
 
The equilibrium constants of these reactions are expressed as: 
 
The total molar concentration of CFP-GR (Ctot) or YFP-GR total (Ytot) in a cell expressing both 
receptors at the same level consists of a monomeric, heterodimeric and homodimeric fraction. 
 
 
From (8) and (9) we can derive the concentrations of the monomers and express their equations as 
such: 
 
Our FRET experiments generated fluorescence data for total CFP-GR (F-don), total YFP-GR (F-acc) 
as well as for corrected FRET which represents heterodimer formation. We have defined the terms as 
Ctot = F-don, Ytot = F-acc and CY = FRET. Radioactive binding assays reveal similar expression 
levels of pCFP-GR, pYFP-GR and pGRwt (Fig.3.3). As equal amounts of CFP-GR and YFP-GR 
plasmids were transfected we assume that the total average GR content at each receptor level is 
made up of one half CFP-GR and one half YFP-GR. In order to express the fluorescent signal as a 
molar concentration we converted fmol GR/mg protein results from saturation binding of the GRwt to 
nM of GR per cell at low, medium and high GR levels taking into account an experimentally derived 
average COS-1 cell protein content (6.49 x 10-7mg/cell) and volume (4.02 x 10-9ml/cell) (Table 2.1 and 
Section 2.1.19).  
 
 
Ctot = C + CY + CC                                                                           (8) 
Ytot = Y + CY + YY                                                                            (9) 
C = Ctot - CY - CC                                                                             (10)  
Y = Ytot - CY - YY                                                                              (11) 
 
 C x Y       C x C       Y x Y 
 CY           CC            YY 
Keq  =            =              =                                                                      (7)                                 
C + C = CC     Y + Y = YY     C + Y = CY 
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Table 2.1. Average GR concentrations per cell at each GR concentration 
 
 
 
 
 
 
 
Assuming 100 percent dimerization following 25 minutes of 10-6M DEX stimulation (Fig.4.8A, (15,16)), 
one third of all receptor associations will be heterodimeric (equation 8 or 9) consisting of two 
differentially tagged GR monomers. This results in a maximal heterodimer concentration which is 1/6th 
of the total monomeric GR concentration (Table 2.1): 
 
 
We have taken the F-don (CFP-GR) and F-acc (YFP-GR) values at the initial time point (0 minutes) of 
the FRET experiment to represent Ctot and Ytot, respectively. These values were converted to nM 
concentrations for each individual cell by dividing them by the average fluorescence for each 
flourophore in their population and multiplying the result by the respective Ctot or Ytot/cell 
concentrations expressed in Table 2.1.  The concentration of heterodimer prior to stimulation 
represents the uninduced (0 minute) FRET signal normalized to the averaged maximal FRET signal 
consisting of the time points 26 to 30 minutes after DEX induction and multiplied by the maximal molar 
concentration of CY heterodimer for each respective cell in relation to the average concentration 
expressed per population in Table 2.1. 
 
Homodimer concentration cannot be measured in this system. However, using equation 7, homodimer 
concentration may be expressed in terms of the measurable heterodimer (corrected FRET), Ctot and 
Ytot concentrations. Mathematical derivation of equations (7), (10) and (11) generates C as well as Y 
monomer concentrations expressed as a function of Ctot (F-don), Ytot (F-acc) and corrected CY 
(FRET). 
 
Average GR concentration (nM) 
 
Low [GR] Medium [GR] High [GR] 
GR/cell 10.8 24.6 45.8 
Ctot or Ytot/cell 5.4 12.3 22.9 
Maximal CY 1.8 4.1 7.6 
3C + 3Y                 CY   +   CC   +   YY 100%% 
6moles                           1mole    1mole    1mole 
3moles 
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Once the concentration of CFP-GR and YFP-GR monomers are derived it is possible to calculate the 
percentage monomers from the total GR concentration (Ctot + Ytot): 
 
As the GR exists either as a monomer or a dimer we can calculate the percentage molar 
concentration of ligand uninduced GR dimers as such:  
 
 
 
2.3 Bibliography 
 
1. Louw A, Swart P, de Kock SS & van der Merwe KJ (1997) Mechanism for the stabilization in vivo of 
the aziridine precursor 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride by serum 
proteins. Biochem Pharmacol 53: 189-197. 
 
2. Yoshikawa N, et al (2002) Distinct interaction of cortivazol with the ligand binding domain confers 
glucocorticoid receptor specificity: Cortivazol is a specific ligand for the glucocorticoid receptor. J Biol 
Chem 277: 5529-5540. 
 
3. Schaaf MJ & Cidlowski JA (2003) Molecular determinants of glucocorticoid receptor mobility in living 
cells: The importance of ligand affinity. Mol Cell Biol 23: 1922-1934. 
 
4. Dewint P, et al (2008) A plant-derived ligand favoring monomeric glucocorticoid receptor 
conformation with impaired transactivation potential attenuates collagen-induced arthritis. J Immunol 
180: 2608-2615. 
 
5. Tazawa H, et al (2003) Regulation of subnuclear localization is associated with a mechanism for 
nuclear receptor corepression by RIP140. Mol Cell Biol 23: 4187-4198. 
 
6. Jenster G, et al (1997) Steroid receptor induction of gene transcription: A two-step model. Proc Natl 
Acad Sci U S A 94: 7879-7884. 
 
7. Plaisance S, Vanden Berghe W, Boone E, Fiers W & Haegeman G (1997) Recombination signal 
sequence binding protein Ikappa is constitutively bound to the NF-kappaB site of the interleukin-6 
promoter and acts as a negative regulatory factor. Mol Cell Biol 17: 3733-3743. 
 
% GR dimers = 100% - % GR monomers 
C + Y 
Ctot + Ytot            % GR monomers =                              x  100 
3CY2 + (Ytot + Ctot)CY - CtotYtot C = - 
CY + Ytot 
3CY2 + (Ytot + Ctot)CY - CtotYtot Y = - 
CY + Ctot 
Stellenbosch University  https://scholar.sun.ac.za
 71
8. al-Moslih MI & Dubes GR (1973) The kinetics of DEAE-dextran-induced cell sensitization to 
transfection. J Gen Virol 18: 189-193. 
 
9. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of 
protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254. 
 
10. Trinkle-Mulcahy L, Sleeman JE & Lamond AI (2001) Dynamic targeting of protein phosphatase 1 
within the nuclei of living mammalian cells. J Cell Sci 114: 4219-4228. 
 
11. Schaaf MJ, Lewis-Tuffin LJ & Cidlowski JA (2005) Ligand-selective targeting of the glucocorticoid 
receptor to nuclear subdomains is associated with decreased receptor mobility. Mol Endocrinol 19: 
1501-1515. 
 
12. Visser K, Smith C & Louw A (2010) Interplay of the inflammatory and stress systems in a hepatic 
cell line: Interactions between glucocorticoid receptor agonists and interleukin-6. Endocrinology 151: 
5279-5293 
 
13. Ishibashi H, et al (2003) Sex steroid hormone receptors in human thymoma. J Clin Endocrinol 
Metab 88: 2309-2317. 
 
14. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. 
Nucleic Acids Res 29: e45. 
 
15. Wrange O, Eriksson P & Perlmann T (1989) The purified activated glucocorticoid receptor is a 
homodimer. J Biol Chem 264: 5253-5259. 
 
16. Segard-Maurel I, et al (1996) Glucocorticosteroid receptor dimerization investigated by analysis of 
receptor binding to glucocorticosteroid responsive elements using a monomer-dimer equilibrium 
model. Biochemistry 35: 1634-1642. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 72
 
 
 
 
 
_________________________________________________ 
 
 
Chapter 3 
 
 
Results: Positive cooperative ligand binding and 
increased ligand binding affinity at high 
glucocorticoid receptor wild type concentrations 
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Introduction 
 
The basic premise of receptor binding studies involves the association of ligand with a receptor to form 
a ligand-receptor complex (Fig.3.1). The affinity of a ligand for a receptor is defined by the equilibrium 
dissociation constant (Kd) which is equal to the concentration of ligand that is required to occupy 50 
percent of the receptors and is defined as k2/k1 where k1 is the association rate constant and k2 is the 
dissociation rate constant.  
 
Figure 3.1 Ligand binding affinity for a receptor is defined as the Kd which is calculated as k2/k1. 
The rate of conversion from unbound receptor and ligand to the bound receptor/ligand complex is 
termed the association rate constant (k1). The rate of the inverse reaction is termed the dissociation 
rate constant (k2). 
 
Plotting the amount of ligand-receptor complex against the log of ligand concentration yields a 
sigmoidal dose response curve (Fig.3.2). The slope of this curve, also called the Hill slope, is defined 
as the steepness of the curve between the 10 and 90 percent binding levels (Fig.3.2). A standard 
binding curve of a ligand to a receptor with only one binding site that follows the laws of mass action 
has a slope of 1, which implies that an 81-fold increase in ligand concentration will result in an 
increase of ligand binding from 10 to 90 percent. Positive cooperative ligand binding is defined by a 
Hill slope which is greater than 1 and not only implies an increase in ligand affinity but also that less 
ligand is required to shift from 10 to 90 percent of maximal binding. Furthermore, in order for the Hill 
slope to be greater than one there must be more than one ligand binding site as positive cooperative 
ligand binding presumes that binding of the ligand to the first binding site results in a conformational 
change in the second binding site which increases its affinity for the ligand (1). 
 
The ligand binding affinity of a receptor (Kd) has traditionally been thought of as an immutable 
parameter, however, conformational changes in the GR brought about by mutations in the GR (2) 
which stimulate dimerization as well as increasing the concentration of certain co-modulators (3) have 
demonstrated that positive cooperative ligand binding and an increase in ligand binding affinity, 
respectively, can be achieved. Furthermore, recent results from Cho et al., where decreasing the GR 
concentration of cytosolic preparations by 3.75-fold resulted in a Hill slope shift from 1.479 to 0.995, 
indicated positive cooperative DEX binding to the GR at high, but not low, GR concentrations in vitro 
(2). In addition, they demonstrated that positive cooperative ligand binding at high GR concentrations 
is linked to the dimerization of the GR as a chimeric GAL/GR with enhanced dimerization capacity (4) 
k1 
Receptor + Ligand                     Ligand-Receptor Complex 
k2 
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retains a Hill slope of 1.39 at low GR concentrations which display non-cooperative ligand binding with 
the wild type receptor. Due to the positive cooperative nature of ligand binding at low receptor 
concentrations of the GAL/GR chimera and at high GR wild type (GRwt) concentrations, Cho et al. 
proposed that a shift from intramolecular interactions of GR N- and C-terminal sequences at low GR 
concentrations to intermolecular interactions at high GR concentrations involving the dimerization sites 
of the DBD and/or LBD is responsible for positive cooperative ligand binding. The intermolecular 
interactions proposed by Cho et al. (2), which result in positive cooperative ligand binding at high GR 
concentrations, imply that ligand independent dimerization of the GR occurs at high GR 
concentrations. The relationship between high concentrations of GR and positive cooperative ligand 
binding is supported by studies that have shown positive cooperative ligand binding of estradiol to the 
ER (5),(6). These studies found a direct correlation between Hill slope and ER concentration, which 
range from a Hill slope of 1.1 at 0.2 to 0.3nM ER to a Hill slope of 1.58 at 2nM ER in cytosolic 
preparations. Abrogation of ER dimerization resulted in a shift from positive cooperative to non-
cooperative ligand binding at high ER concentrations (5). Despite these results, some controversy 
exists as to the ability of the GR to bind ligand cooperatively as the binding studies of Sheppard et al. 
(7) displayed non-cooperative ligand binding in both whole cell as well as cytosolic saturation binding 
assays with GR concentrations as high as 277 fmol GR per mg protein.  
 
Theoretically, cooperative ligand binding implies ligand independent dimerization of the GR, which 
effectively creates two ligand binding sites where the association of the first ligand facilitates the 
binding of the second in a more energetically favourable reaction and thus increases the affinity of the 
receptor for the ligand (8). However, Cho et al. (2) made no comment as to whether ligand affinity was 
influenced by the change in GR concentration and concomitant shift in binding characteristics to 
cooperative ligand binding. Neither did they calculate the specific GR concentrations required to elicit 
non-cooperative and positive cooperative ligand binding. The literature relating concentration of GR to 
ligand affinity shows considerable variation regarding effects of GR concentration on ligand binding 
affinity. For example, saturation binding studies by Chrousos et al. (9) on cytosolic fractions of cultured 
skin fibroblasts expressing varying concentrations of GR show an increase in ligand binding affinity in 
cells expressing high GR concentrations. Davidson et al. (10) in whole mouse skin cytosol showed a 
similar increase in ligand binding affinity in cells with high GR concentrations. While whole cell 
saturation binding assays by Elakovic et al. (11) demonstrate the exact opposite, namely a correlation 
between an increase in GR concentration in peripheral blood mononuclear cells (PBMC) and a 
decrease in ligand binding affinity reflected in an increase in the dissociation constant (Kd). In contrast 
to the previous studies, saturation binding studies performed by Sun et al. (12) on rat muscle cytosol 
expressing varying levels of GR found no change in ligand affinity at differing GR concentrations. 
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Figure 3.2. Saturation binding curves.  Representative graph demonstrating non-cooperative ligand 
binding (grey dashed line) where an 81-fold increase in ligand concentration results in a shift from 
10% to 90% ligand binding and a Hill slope equal to 1. Positive cooperative ligand binding (black solid 
line) where less ligand is required to shift binding from 10% to 90% and the Hill slope is greater than 1. 
 
Tantalising as these results are they have been carried out under decidedly non-physiological 
conditions. For example the radioactive binding assays of Cho et al. (2) were performed on cytosolic 
fractions diluted at least 3-fold in a solution of sodium molybdate which functions to stabilize the GR 
(13). Ligand binding affinity, defined by the Kd, was shown to be 3-fold lower in whole cells versus 
cytosolic fractions (7), which is believed to be as a result of the differences in the cellular milieu. The 
presence of 11βHSD ((14),(15)), GR concentration and its phosphorylation state (16), ligand binding 
proteins such as CBG (17) and co-modulators of the receptor such as Hsp90 (18), FKBP52 (3) and 
Ubc9 (2) are all known to influence ligand binding affinity and would be altered in cytosolic versus 
whole cell binding assays. In addition, no study explicitly examined the relationship between GR 
concentration and both cooperative ligand binding and affinity.   
 
We thus aim to replicate the difference in GR concentration which Cho et al. (2) demonstrated as 
sufficient to elicit a shift from non-cooperative to positive cooperative ligand binding. Once established 
we will test whether these different GR concentrations result in the same shift to cooperative ligand 
binding and if this can be correlated with a change in ligand binding affinity in whole cell saturation 
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binding assays. In addition we will use the GR dimerization deficient mutant (GRdim) to investigate the 
prerequisite for GR dimerization in cooperative ligand binding. We hypothesis that a GR concentration 
dependent change from non-cooperative to positive cooperative ligand binding will result in an 
increase in ligand binding affinity with the GRwt but not the GRdim mutant. 
 
Results 
 
3.1 Establishing a viable model in which to compare the effects of glucocorticoid receptor 
concentrations 
 
In order to establish whether ligand binding to the GR is cooperative at high levels in whole cells and 
whether this affects ligand binding affinity we sought to conduct whole cell saturation binding studies 
on cells expressing varying concentrations of GR. As the ligand binding affinity of the GR is known to 
vary between cells (11, 19, 20), which may be due to the influence of co-modulators such as the TPR, 
FKBP52, and Hsp90 which are differentially expressed in tissues and have been shown to affect 
ligand binding to the GR (3, 18), we decided to work in a single cell line. We selected COS-1 cells, 
which are immortalised monkey kidney fibroblast cells, as they contain little to no endogenous GR (21) 
(Fig.3.3) and could act as a “blank slate” for our GR concentration studies. Ideally we would have liked 
to have created stable cell lines which have integrated transfected plasmid DNA into their genomes. 
These cell lines would be derived from a single clone and each cell would have the same GR 
concentration and make up a homogenous population. However, of the numerous clones created over 
a 6 month period none resulted in a stable introduction of the GR expressing plasmid and would 
consistently express less and less GR as determined through whole cell binding. After considerable 
effort devoted to this endeavour, with no success, we had to compromise. As a result all of our 
experiments were conducted in COS-1 cells which were transiently transfected with varying amounts 
of GR plasmid. The cells were pooled and replated after transfection to minimize differences in 
transfection efficiency within experiments. Between experiments the expressed GR levels were 
monitored either directly through radioactive ligand binding assays (Fig.3.3) or by monitoring 
fluorescence intensity of fluorescently labelled GR (Fig.4.5) and indirectly through Western blots 
(Fig.6.1).  
 
As our study aimed to elucidate the effects of GR concentration on ligand binding and its down stream 
consequences we chose to focus on the ligand binding of the transcriptionally active GRα as opposed 
to the non-ligand binding and dominant negative GRβ isoform (22, 23). Furthermore we decided to 
focus solely on the human GR as its behaviour has been found to differ from that of rodent GR (24).  
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Figure 3.3. Relative expression levels of GR plasmids. Whole cell binding was carried out on COS-
1 cells DEAE-Dextran transfected with the indicated amounts of plasmid DNA as described in 
materials and methods. Total binding and non-specific binding were normalized to protein 
concentration (Bradford assay). Specific binding (total binding - nonspecific binding) was plotted and 
represents a single experiment preformed in triplicate (±SEM). 
 
Our first task was to establish the maximal and minimal GR expression levels possible through a 
variety of GR plasmids using transient transfections in COS-1 cells. The relationship between the 
amount of plasmid DNA transfected and GR expressed is not linear and varies considerably between 
vectors. What was clear from our radioactive binding study on expression levels of GR plasmids is that 
GR expression levels plateau at 11550ng plasmid DNA per 10cm tissue culture plate forty eight hours 
after DEAE-Dextran transfection (Fig.3.3). We thus chose this plasmid level as our maximal 
transfected GR plasmid level. To represent our lowest GR concentration we selected the 38.5ng 
plasmid amount as it results in GRwt expression levels which are roughly a fourth of the maximum. 
Finally the 385ng plasmid level was included as its GR expression level falls roughly half way between 
the two extremes.  
 
 
The GR wild type (GRwt), D-loop dimerization domain mutant GR (GRdim) and the green fluorescent 
protein tagged GR (GFP-GR) expression levels differ due to the fact that their genes are contained in 
different vectors. In hindsight it would have been optimal for them to have been expressed in a single 
vector but effort has been made through direct and indirect methods to only compare GR 
concentrations that are similar. 
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We do detect trace amounts of endogenous COS-1 cell GR (Fig.3.3), however, these levels are at 
least 10-fold lower than those expressed at the lowest GRwt plasmid concentration and as a result 
may be considered negligible. 
 
Prior to performing competitive and saturation binding assays it was necessary to perform time course 
experiments for each receptor type and concentration in order to establish the incubation time required 
for ligand binding equilibrium (Fig.3.4). In each case ligand binding reached its plateau at or before 
four hours. We therefore selected this as the time of incubation for our binding studies. 
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Figure 3.4. Time courses of GRwt, GRdim and GFP-GR radioactive ligand binding. COS-1 cells 
were transfected with (A) low, medium or high levels of GRwt, (B) low or medium GRdim levels or (C) 
medium or high GFP-GR levels and filled to 11550ng total plasmid DNA/10cm plate with empty vector. 
Time courses to determine binding equilibrium were performed as described in materials and 
methods. Total binding and non-specific binding were normalized to protein concentration (Bradford 
assay) and specific binding (total binding - nonspecific binding) was plotted using one phase 
exponential association curves and represents a single experiment preformed in triplicate (±SEM). 
 
Due to the expense of radioactive ligand and the high concentrations of ligand required for saturation 
binding studies we first investigated whether competitive ligand binding assays could be used in order 
to establish a shift in the Hill slope and in ligand binding affinity. Another advantage of competitive 
binding is that a range of ligands can be tested as the affinity of the unlabeled ligand can be 
determined indirectly by measuring its ability to compete with the binding of a radioactive ligand. In 
these assays varying concentrations of unlabeled ligand compete with a fixed concentration of [3H]-
labelled ligand. As the concentration of unlabeled ligand increases so the amount of [3H]-labelled 
ligand bound to the receptor decreases (Fig.3.5A). The binding parameter obtained from competitive 
binding curves is the concentration of unlabeled ligand that inhibits the binding of the radioactive 
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ligand by 50 percent, this is called the IC50 (25). Unfortunately neither the log IC50 nor the Hill slope 
was influenced by the concentration of GFP-GR expressed (Fig.3.5B,C). In addition, although the log 
IC50 varied significantly between test compounds the pattern of binding affinity was not altered by GR 
concentration (Fig.3.5D). From these results we concluded that competitive binding assays where not 
an effective way to test for variances in Hill slope or ligand binding affinity because of the existence of 
two confounding processes as the competitive ligand binding assay evaluates not only the binding of 
the unlabeled ligand but also that of the [3H]-labelled ligand as well. 
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Figure 3.5. Competitive binding assays do not show any change in log IC50 or Hill slope as a 
result of differences in GR concentration. COS-1 cells (2 x 106 cells/10cm plate) were transfected 
with low (38.5ng), medium (385ng) or high (11550ng) GFP-GR levels and competitive whole cell 
binding was carried out as described in materials and methods using 20nM [3H]-DEX and varying 
concentrations of unlabeled DEX, F, MPA, Prog or RU486. Total binding was normalized to protein 
concentration (Bradford assay) and the baseline plateau representing non-specific binding was 
subtracted from all data points. (A) The specific binding was fit to a sigmoidal dose-response curve 
with a variable slope which generates (B) log IC50 as well as (C) Hill slope values. Statistical analysis 
on both was carried out using one-way analysis of variance followed by Bonferroni's multiple 
comparison test. (D) Statistical analysis of the log IC50 values of various test compounds within the low 
and high GFP-GR populations were carried out using one-way analysis of variance followed by 
Dunnett’s post test against DEX stimulation (*P<0.05, **P<0.01, ***P<0.001). All results represent a 
minimum of three independent experiments preformed in triplicate (±SEM). 
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3.2 Saturation binding was used to designate low, medium and high glucocorticoid receptor 
concentrations 
 
Saturation binding revealed expressed GR concentrations which fell into three statistically different 
groups (Fig.3.6A,B). GR levels ranging from 41.8 to 67.0 fmol GR per mg protein were designated as 
our low GR concentration population, 144.1 to 189.7 fmol GR per mg protein as our medium GR 
concentration population and 283.9 to 292.3 fmol GR per mg protein as our high GR concentration 
population. These reflect GR per cell levels ranging from 16300 to 114000 and GR concentration in 
nM from 6.7 to 47.1 (Fig.3.6B).  
 
All our experiments were carried out in COS-1 cells which were transiently transfected with GR using 
the DEAE-Dextran method. Fluorescence microscopy revealed that there is a considerable variation in 
transfection efficiency and resultant expressed GR levels from cell to cell within a population (Fig.3.7). 
Furthermore fluorescence microscopy showed that roughly 20 percent of cells in a population were 
transfected. In order to acknowledge this fact we have included an average theoretical prediction of 
the fmol GR per mg protein in transfected cells only, assuming a transfection efficiency of 20 percent 
(Fig.3.6B).   
 
Having corrected for transfection efficiency, the GR concentrations studied range from 209 to 1462 
fmol GR per mg protein or 81500 to 570000 GR per cell. Although these levels are higher than most 
GR concentrations reported in human tissue culture cell lines and tissue biopsies (Table 1.1), there 
are certain tissues and pathological states which lead to the expression of GR at similar levels to our 
model system. For example, the concentration of GR reported in mononuclear leukocytes, a form of 
white blood cells, was 191 fmol GR per mg protein (9), while another study revealed GR levels as high 
as 893 fmol GR per mg protein in healthy skin, rising to 2777 fmol GR per mg protein in the skin of 
AIDS patients (26). Cytotrophoblasts (epithelial stem cells) have been shown to contain GR 
concentrations as high as 16200 fmol GR per mg protein (27). We can therefore argue that our 
medium and high GR concentrations reflect physiological GR levels particularly when compared to GR 
levels in skin (26) and epithelial stem cells (27).  
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Figure 3.6. Saturation binding establishes three distinct and statistically different populations 
of GR namely, low, medium and high. COS-1 cells were transiently transfected with GRwt (low, 
medium or high), GRdim (low or medium) or GFP-GR (medium or high) and filled to 11550ng total 
plasmid DNA/10cm tissue culture plate with the empty vector pGL2-basic. After replating cells were 
serum starved for 24 hours and saturation binding was carried out according to materials and 
methods.  (A) Specific binding was plotted against nM [3H]-DEX and curves fit using one site binding 
hyperbola to obtain Bmax values.  (B) Summary table of expressed GR from saturation binding 
results. GR/cell, nM GR concentration and fmol GR/mg protein have all been derived from the 
maximal binding (Bmax) value as described in materials and methods. Statistical analysis on maximal 
binding (Bmax) and fmol GR per mg protein was carried out using ANOVA followed by Newman-Keuls 
multiple comparison post test, where conditions with different letters are statistically different from one 
another (P<0.01). All results represent a minimum of two independent experiments performed in 
triplicate (± SEM). 
 
Stellenbosch University  https://scholar.sun.ac.za
 82
Total cells
(nuclear stain)
Transfected cells
(GFP-GR)
Medium
[GR]
High
[GR]
131 cells 27 cells
261 cells 55 cells
A
B
 
Figure 3.7. The transfection efficiency of COS-1 cells through the DEAE-Dextran method is ~20 
percent. COS-1 cells transiently transfected with (A) medium or (B) high concentrations of GFP-GR. 
The Hoechst nuclear stain is used to visualize the total number of cells present while the GFP signal is 
only detected in cells expressing the GFP-GR plasmid. 
 
Although the expression of GR has been analysed in a comprehensive study of major tissues of the 
human body this was only at the level of GR mRNA (28). The majority of studies which have looked at 
the expression of the GR protein in a single tissue have done so through radioactive binding assays in 
cell lysates (29-32) or through Western blotting (28, 33) neither of which are optimal in terms of 
quantifying GR concentration due to the qualitative nature of Western blot experiments and the altered 
behaviour of GR binding in vitro (19). In addition, in experiments where GR concentration has been 
accurately quantified, values are primarily given in terms of GR per cell which in itself is problematic. A 
more practical measurement for the expression of GR concentration would be in molar. This is also 
the most useful measurement of GR concentration for mathematical modelling. There is a need for a 
systematic study of GR concentrations, expressed in molar and performed through whole cell binding 
assays, in a wide variety of tissue types. 
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3.3 Positive cooperative ligand binding is GR concentration and dimerization dependent 
 
Having established which amounts of GR plasmid would yield 3 statistically different populations of 
GR we set out to determine the effect of GR concentration on cooperative ligand binding and Kd using 
whole cell saturation binding. When specific binding of GRwt and GRdim concentrations was plotted 
against logM [3H]-DEX concentrations and curves fit using sigmoidal dose-response with variable 
slope (Fig.3.8A), there is a clear left shift of the medium and high GRwt concentration curves, but not 
of the GRdim medium concentration curve. This implies that concentration of ligand required to shift 
binding from 10 to 90 percent receptor occupancy is reduced at medium and high GRwt 
concentrations. Specifically, the fold increase in ligand concentration required to shift receptor 
occupancy from 10 to 90 percent is 60-fold at the low GRwt concentration, 11-fold at the medium 
GRwt concentration and 10-fold at the high GRwt concentration. Calculation of Hill slopes indicate that 
ligand binding at low GR concentrations was non-cooperative for all GR types but shifted significantly 
to positive cooperative ligand binding (Hill slope>1) at medium and high GRwt and high GFP-GRwt 
concentrations (Fig.3.8B). The Hill slope at the low GRwt level was 1.08, which is similar to the 0.995 
value Cho et al. (2) found with their low GR concentration, while our medium GRwt concentration’s Hill 
slope of 1.57 is comparable to that of Cho et al.’s high GR concentration of 1.479. We showed a 
further receptor concentration dependent increase in Hill slope at our high GR concentration to 1.72, 
while the high GFP-GR concentration displayed a Hill slope more in line with the medium GRwt 
concentration (Fig.3.8B). Positive cooperative ligand binding at the medium GRwt as well as the high 
GRwt and high GFP-GR concentrations are noteworthy as it represents the first evidence in whole cell 
binding assays of positive cooperative ligand binding to the GR. 
 
Binding to the medium concentration of GRdim (34) remained non-cooperative (Fig.3.8A,B) despite 
the fact that the GR concentrations of medium GRwt and medium GRdim were statistically the same 
(Fig.3.6B). The fact that the medium concentration of GRwt displayed positive cooperative ligand 
binding while that of the medium concentration of GRdim was non-cooperative implies that loss of 
cooperative ligand binding is due to the single point mutation in the D-loop of the GRdim receptor. We 
can thus conclude that the impaired dimerization brought about by this mutation rendered the GRdim 
incapable of positive cooperative ligand binding and that the ability to bind ligand in a positive 
cooperative manner was indeed dependent on the ability of GR to dimerize.  
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Figure 3.8 Saturation binding reveals the extent of GR concentration dependent differences in 
cooperative ligand binding (Hill slope) and ligand binding affinity (Kd). Saturation binding was 
carried out according to materials and methods.  (A) Specific binding of GRwt (low, medium or high) or 
GRdim (low or medium) was plotted against logM [3H]-DEX and curves fit using sigmoidal dose-
response (variable slope) to obtain Hill slopes. (B) Summary table of saturation binding results. 
Statistical analysis on Hill slope was carried out using ANOVA followed by Newman-Keuls multiple 
comparison post test, where conditions with different letters are statistically different from one another 
(P<0.01).  Statistical analysis of Kd values was through a one tailed unpaired t test against the low 
GRwt concentration (*P<0,05, **P<0.01). All results represent a minimum of two independent 
experiments performed in triplicate (± SEM). 
 
The theoretical maximum Hill slope for binding to a receptor with a single binding site is 1, which 
increases to 2 when two binding sites are present. Our GRwt Hill slope values fell between 1.08 and 
1.72, which indicates a shift in ligand binding from binding predominantly to the receptor monomer at 
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low GR concentrations to binding predominantly to the GR dimer at high GR concentrations. The fact 
that the Hill slope approaches but does not reach its theoretical maximum of 2 is to be expected as the 
Hill slope coefficient is known to provide a minimum estimate of the number of binding sites involved 
(1). 
 
From the graph representing specific binding of GRwt and GRdim concentrations plotted against logM 
[3H]-DEX concentration (Fig.3.8A), it is possible to visualize not only the increase in the steepness of 
the slope between 10 and 90 percent ligand binding, which determines the Hill slope, but also the 
decrease in the concentration of ligand required for 50 percent of maximal binding or Kd. Our results 
suggest that there is a correlation between increased positive cooperative ligand binding and a 
decreased Kd compared to the non-cooperatively bound low GRwt concentration (Fig.3.8B). This also 
held true for the high GFP-GR concentration, which displayed positive cooperative ligand binding and 
had a significantly lower Kd than the non-cooperative ligand binding at low GRwt concentration.  This 
supports the theory that positive cooperative ligand binding and increased ligand binding affinity are 
linked. The slight and not significant variations in Kd between the GR types (GRwt versus GFP-GR or 
GRdim) may be ascribed to conformational differences resulting from the mutation in the second zinc 
finger of the DBD in GRdim and the large fluorescent protein tag in GFP-GR, respectively.  
 
The Kd of the GR for DEX in cytosolic preparations has been shown to vary between 3.7nM (35) and 
7.6nM (36). While whole cell saturation binding studies performed on COS-1 cells transiently 
transfected with high levels of GRwt through the highly effective lipofectamine based reagent Fugene 
display a [3H]-DEX binding Kd of 12.6nM (37), which is similar to the 16.8 to 10.9nM ligand binding 
affinity displayed at our high GR concentrations. 
  
Once corrected for 20 percent transfection efficiency the minimum concentration of GRwt at which we 
demonstrate positive cooperative ligand binding and a concomitant increase in ligand binding affinity 
(Kd) is 763 fmol GR per mg protein or 298000 GR per cell (Fig3.6B, Fig3.8B). This may explain why 
Sheppard et al. (7) showed non-cooperative ligand binding in both whole cell as well as cytosolic 
saturation binding assays with GR concentrations of 277 fmol GR per mg protein and casts further 
doubt on the results of Elakovic et al. (11) who demonstrated a shift in Kd from 2.5nM at only 1391 GR 
per cell to a Kd of 98.6nM at 15133 GR per cell in PBMC from a healthy human population. Although 
the study by Chrousos et al. (9) supports our results in terms of showing an increase in affinity 
(decrease in Kd) at higher concentrations of GR, this increase occurred between 53 and 191 fmol GR 
per mg protein, which is much lower than the level we found.  The discrepancy regarding the level of 
GR through which an increase in Kd is observed may be explained by the fact that this saturation 
binding study was conducted on cytosolic fractions and not in whole cells or by the fact that Chrousos 
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et al. was investigating patients with primary cortisol resistance who may have had mutated GR 
receptors. 
 
We have demonstrated that positive cooperative ligand binding occurs at high concentrations of GRwt 
and GFP-GR, that this is GR dimerization dependent and that it results in an increase in ligand binding 
affinity. We thus postulate that as receptor concentrations increase so will the prevalence of ligand 
binding to GR dimer. In order for this to occur there must be a GR concentration dependent increase 
in ligand independent dimerization of the GR. The next step in our study was then to test this possible 
mechanism for positive cooperative ligand binding, notably ligand independent dimerization of the GR 
at GR concentrations that elicit cooperative ligand binding.  
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Introduction 
 
Positive cooperative ligand binding presupposes the existence of more than one binding site. Based 
on the work of Cho et al. (1) and our own findings in whole cell saturation binding studies (Chapter 3) 
we hypothesized that ligand independent dimerization at high GR concentrations is responsible for the 
existence of two ligand binding sites which allows for positive cooperative ligand binding to the GR at 
high, but not at low, GR concentrations.   
 
It has been established through glycerol gradient centrifugation of purified GR (2) as well as through 
FRET experiments in live cells (3) that the activated GR exists as a homodimer independently of DNA 
binding. Two areas of the GR have been identified as influential in GR dimerization namely, the D-loop 
of the DBD and the LBD. Specifically, it was shown that GR dimerization is stabilized through the 
second zinc finger of the DBD (4), which is termed the D-loop, while dimerization can also be achieved 
through the LBD alone (5). Segard-Maurel et al. (6) determined the Kd of activated GR dimerization 
independent of DNA binding as 3.9nM in cell cytosol, while Bledsoe et al. (7) demonstrated that 
dimerization of activated GR LBD has a Kd of 1.5µM under similar conditions, implying that affinity of 
the full length GR is higher than the LBD alone. 
 
Ligand independent dimerization has been demonstrated in the ER (8) but we have not been able to 
find a study which specifically focuses on levels of ligand independent dimerization of the GR. Some 
studies have, however, implicitly investigated ligand independent dimerization. For example, Dewint et 
al. (9) show ligand independent dimerization of the GR in a Co-IP experiment, which was roughly 90% 
of DEX induced dimerization. The explanation they offered was that in transient transfections of GR 
the heightened concentrations of receptor outnumber that of heat shock protein chaperones which are 
required to maintain the monomeric GR conformation. Interestingly, they also reveal CpdA’s ability to 
disrupt GR dimerization in a dose dependent manner. In a follow up article on CpdA, Robertson et al. 
(Addendum B) (10) reported the same finding, namely ligand independent pull down of a differentially 
tagged GR and CpdA induced abrogation of dimerization in a Co-IP experiment. They went on to 
demonstrate the same phenomena in a live cell FRET experiment were the addition of CpdA reduced 
the ligand independent association of CFP tagged and YFP tagged GR. This was reflected in a 
decrease in the FRET signal following CpdA addition. Both these studies as well as a myriad of others 
demonstrate dimerization of the GR as a result of stimulation by the potent synthetic GC, DEX (2, 3, 6, 
11, 12). In fact, dimerization of the GR following ligand binding is a well known characteristic of the 
receptor. 
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Armed with the Co-IP and FRET techniques and the knowledge that ligand independent dimerization 
of the GR was detectable both in vitro and in whole cells, we set about testing our hypothesis that 
ligand independent dimerization increases at GR levels shown to exhibit positive cooperative ligand 
binding. As DEX is known to result in maximal dimerization of the GR, while CpdA abrogates 
dimerization we used these ligands as a positive and negative, respectively, control for dimerization. 
 
Results  
 
4.1 Demonstrating ligand independent dimerization using Co-IP  
 
The Co-IP technique we have used relies on Flag anti-body tagged beads which will associate with 
the Flag protein, a short sequence of 8 amino acids (N-DYKDDDDK-C (1012 Da) (13). When 
incubated with the cell lysate, these beads trap Flag-tagged proteins and any particles associated to 
them. We have used a Flag-GR (molecular mass, 96 kDa), which has a Flag tag, and a GFP-GR 
(molecular mass, 128.5 kDa), which is larger than the Flag-GR due to its fluorescent protein tag. 
Where we have immunoprecipitated the Flag-GR using the Flag anti-body tagged beads we expect to 
co-precipitate GFP-GR if it has dimerized with the Flag-GR. Thus if GFP-GR is visualized in the pull 
down it implies dimerization of the differentially tagged GRs. As visualization of the Co-IP pull down is 
done on a Western blot using a primary anti-body against the GR it is necessary that the two tagged 
GR’s used have a large size difference in order to differentiate between the two. We expect to see the 
128.5 kDa GFP-GR migrate considerably slower than the smaller 96kDa Flag-GR through the 
acrylamide gel which allows for easy differentiation between the two. 
 
 For optimal association and pull down equal concentrations of these tagged GRs is required. A 
radioactive binding experiment revealed vastly different expression levels from the two vectors 
(Fig.4.1). It was therefore necessary to transfect the two plasmids in a ratio of 1:8 of GFP-GR to Flag-
GR. Westerns run on the Co-IP inputs illustrate similar expression levels of the two plasmids at this 
transfection ratio (Fig.4.2B,C). We transfected three populations of GR, which mirror the low, medium 
and high GRwt levels defined through saturation binding studies (Fig.3.6B). Along with the pairing of 
Flag-GRwt and GFP-GRwt we examined the Flag-GRwt and GFP-GRdim pair in parallel. As the name 
suggests GFP-GRdim consists of a GFP tagged dimerization D-loop mutant GR. We have included 
the GFP-GRdim in order to confirm the significance of dimerization in our pull down study and to gain 
a better insight into this mutation. Much work has been done on this specific D-loop mutation (11, 14-
16) and it is generally assumed to be incapable of dimerization, however, its ability to dimerize has 
never been tested directly. 
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Figure 4.1. Flag-GR and GFP-GR expression levels differ considerably. COS-1 cells (2 x 106 
cells/10cm plate) were transfected with 5775ng GFP-GR or 5775ng Flag-GR and filled to 11550ng 
total plasmid DNA/10cm plate with empty vector. Whole cell binding was carried out as described for 
the determination of expression levels of GR plasmids in materials and methods. Total binding and 
non-specific binding was normalized to protein concentration (Bradford assay). Specific binding (total 
binding - nonspecific binding) was plotted and represents a single experiment preformed in triplicate 
(±SEM). 
 
As Co-IP controls (Fig.4.2A) we transfected Flag-GR, GFP-GRwt or GFP-GRdim only at 
concentrations that represent half the total GR levels expressed at the low, medium or high GR 
concentrations. This was done to demonstrate that no non-specific pull down of either GFP-GRwt or 
GFP-GRdim occurs at any of the three GR concentrations studied. As can be seen in the first column 
at each GR concentration (Fig.4.2A), where Flag-GR was transfected alone and the Co-IP experiment 
was carried out, there is a single band which corresponds to the size of the Flag-GR. This result 
confirms that the Flag-GR is effectively pulled down by the Flag-anti-body containing beads. The next 
two columns at each receptor level represent the Co-IP pull down from cells expressing GFP-GRwt or 
GFP-GRdim only. No bands are visible in these columns, which confirm that there is no non-specific 
pull down of either of the GFP-tagged GRs. We have run the inputs of these Co-IP experiments in the 
columns to the right of the Co-IP controls. There is a single distinct band at the Flag-GR size where 
Flag-GR has been transfected. However, the band that can be seen running at the same level as the 
Flag-GR in the GFP-GRwt and GFP-GRdim lanes represent break down products of these receptors 
and are not as a result of incorrect loading or transfection. This is supported by the fact that Co-IP of 
these samples results in no Co-IP pull down, which would have occurred if they contained any Flag-
GR. 
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4.1.1 Co-IP studies show GFP-GR pull down independent of ligand stimulation, which 
increases as GRwt levels do. 
 
COS-1 cells were transfected with low, medium or high levels of GRwt or GRdim and treated with 
solvent to determine the effect of GR concentration on ligand independent dimerization. The inputs of 
each Co-IP experiment were run (Fig.4.2B,C) in order to monitor for transfection efficiency and all 
GFP-GR pull down was normalized against its respective Flag-GR band in order to correct for 
differences in loading and anti-body concentration between the GR concentrations. Due to the 
differences in expressed GR between the three GR concentrations it was necessary to alter the 
primary and secondary anti-body concentrations used as described in materials and methods. 
 
At the low level of GFP-GRwt (Fig.4.2B) as well as GFP-GRdim (Fig.4.2C) we saw little to no GFP-GR 
pull down following solvent (EtOH) induction, which implies almost no ligand independent dimerization. 
However, at the medium GR concentrations there was clear ligand independent GFP-GR pull down of 
both GFP-GRwt and the GFP-GRdim. Results at the high GR concentrations follow a similar trend to 
those at the medium concentration although ligand independent GFP-GR pull down was stronger 
through the GFP-GRwt. Clearly ligand independent dimerization is GR concentration dependent with 
even the GFP-GRdim tending toward it at medium and high GR concentrations. Pooled analysis of the 
ligand independent GFP-GRwt and GFP-GRdim pull down of three independent Co-IP experiments at 
the low, medium and high GR concentrations (Fig.4.3A) indicates marginal ligand independent 
dimerization at the low GR concentrations. This increases significantly at the medium and high GFP-
GRwt concentrations, similarly to the saturation binding results of GRwt, which displayed positive 
cooperative ligand binding at medium and high GRwt concentrations. GFP-GRwt, however, only 
displayed cooperative ligand binding at the high, but not the medium, GR concentration (Fig.3.8B). A 
possible explanaition for the discrepancy between the dimerization results (Fig.4.3A) and the 
saturation binding results (Fig.3.8B) is that for the Co-IP GFP-GR was dimerised to a Flag-GR partner 
and thus saturation binding of these partners should be done to difinitifly establish the correlation 
between dimerization and cooperative ligand binding. Although GFP-GRdim pull down showed a trend 
towards increased ligand independent dimerization at medium and high levels (Fig.4.3A) it was 
significantly (P<0.05) lower than that of the GFP-GRwt pull down. It is also important to note that 
although GFP-GRdim has the dimerization impairing mutation in its D-loop the Flag-GR used in this 
study retains complete ability to dimerize. As dimerization requires the D-loops of both receptors the 
wild type Flag-GR may impart some dimerization ability to the GFP-GRdim. Constructing a Flag-
GRdim in order to better elucidate the dimerization capacity of the GRdim mutant is a future study 
option. 
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Figure 4.2. Co-IP reveals ligand independent dimerization of the GR at high concentrations. (A) 
Representative Western blots of Co-IP controls. Cells were transfected with low levels (38.5ng) of GR 
(34.22ng Flag-GR or 4.28ng GFP-GRwt or 4.28ng GFP-GRdim), medium levels (385ng) of GR 
(342.2ng Flag-GR or 42.8ng GFP-GRwt or 42.8ng GFP-GRdim) or high (11550ng) GR levels 
(10266ng Flag-GR or 1284ng GFP-GRwt or 1284ng GFP-GRdim). Representative Western blots of 
GFP-GRwt (B) and GFP-GRdim (C) Co-IP experiments were carried out as described in materials and 
methods.  
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4.1.2 DEX increases dimerization at the low GRwt concentration while CpdA addition abrogates 
dimerization at the medium and high GRwt concentrations 
 
The addition of DEX at the low GR concentration (Fig.4.2B,C) resulted in dimerization of the Flag-GR 
and GFP-GRwt, which was seen as a GFP-GRwt band in the Co-IP column. No such band appears 
for GFP-GRdim at the low GR concentration supporting the theory that the mutation in the D-loop of 
the DBD impairs dimerization. The addition of CpdA had no influence on the Co-IP at the low GR 
concentrations as ligand independent dimerization at these levels is minimal (Fig.4.2B,C, Fig.4.3A). At 
medium GR concentrations where there was ligand independent GFP-GR pull down of both the GFP-
GRwt and the GFP-GRdim, addition of DEX had a minimal effect on increasing dimerization while 
CpdA reduced the level of dimerization (Fig.4.2B,C). Pull down at the high GR concentrations follow a 
similar trend to those at the medium GR concentration. Ligand independent GFP-GR pull down was 
stronger through the GFP-GRwt and thus the addition of DEX resulted in a greater increase in GFP-
GRdim pull down (Fig.4.2B,C). 
 
In order to compare the pull down of GFP-GR across experiments and GR concentration levels we 
normalized GFP-GR levels from three independent experiments induced by EtOH, DEX or CpdA 
relative to the maximal level of GFP-GRwt pull down at each receptor concentration following the 
addition of DEX. Maximal dimerization is achieved through DEX stimulation of GFP-GRwt and 
because of this we set its level of pull down as 100 percent dimerization and compared EtOH, CpdA 
and all three GFP-GRdim conditions at each GR concentration to this condition (Fig.4.3B). At the low 
GFP-GRwt concentration DEX stimulation caused a significant 2.3-fold increase in GFP-GRwt pull 
down over EtOH stimulation. However, DEX stimulation caused no increase in the GFP-GRwt pull 
down at the medium and high GFP-GRwt concentrations (Fig.4.3B). This suggests that ligand 
independent GR dimerization at medium and high GRwt levels is already so high prior to DEX 
stimulation that addition of DEX does not significantly change the observed level of GRwt dimerization 
in this assay. This result is similar to that seen by Dewint et al. (9) as they showed ligand independent 
dimerization which was 90 percent of the DEX stimulated dimerization. At medium and high GRwt 
concentrations CpdA addition resulted in a significant decrease in GFP-GRwt pull down when 
compared to the ligand independent dimerization levels at these GR concentrations (Fig.4.3B). This 
indicates considerable ligand independent dimerization of the GRwt at the medium and high GRwt 
concentrations which is abrogated by CpdA.  
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Figure 4.3. Ligand independent dimerization of the GRwt and GRdim increases as their 
concentration does. Co-IP was performed as described in materials and methods. (A)  Low, medium 
or high GRwt or GRdim concentrations exposed to EtOH stimulation. Flag-GR and GFP-GR 
concentrations were quantified using UN-SCAN-IT software. GFP-GR pull down was then normalized 
over Flag-GR levels. Statistical analysis was through one tailed unpaired t tests of GRwt against 
GRdim (*P<0.05) and ANOVA followed by Dunnett’s post test against low GR concentration within 
GRwt or GRdim populations (§P<0.05). (B) GR levels were quantified using UN-SCAN-IT software, 
GFP-GR pull down was normalized over Flag-GR and expressed relative to DEX GRwt set at 100 
percent, at each receptor level. Statistical analysis was carried out using ANOVA followed by 
Dunnett’s post test against DEX stimulation of GRwt at each receptor level (P*<0.05, P**<0.01). All 
results are representative of three independent experiments (±SEM). 
 
 
The GFP-GRdim shows a significant increase, from 36 to 66 percent, in ligand independent 
dimerization as receptor levels increase from low to high GR concentration (Fig.4.3B). DEX addition 
also results in a trend toward increased dimerization at the medium and high GRdim concentrations, 
which peaks at 90 percent of that of DEX stimulated GRwt at the high GRdim concentration (Fig.4.3B), 
while CpdA addition at the high GRdim concentration results in a decrease in dimerization, from 66 
percent through EtOH to 51 percent following CpdA stimulation (Fig.4.3B). These results imply that the 
GRdim is capable of considerable levels of dimerization at medium and high GR concentrations. As 
discussed earlier this is most probably enhanced by binding to the wild type Flag-GR. Optimally a 
Flag-GRdim should have been used in conjunction with the GFP-GRdim. The high levels of GFP-
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GRdim ligand independent pull down, notably 60 percent of the GFP-GRwt at medium GR 
concentrations and 66 percent of GFP-GRwt at the high GR concentration, indicate at most an 
impairment of dimerization by the D-loop mutation in the GFP-GRdim and not abrogation of 
dimerization. It would be useful to expand on this assay by including a full D-loop mutant pair (Flag-
GRdim/GFP-GRdim) in order to definitively evaluate the dimerization capacity of GRdim. We 
hypothesis that ligand independent dimerization of GRdim to GRdim at medium and high GR 
concentrations would be considerably reduced as saturation binding remains non-cooperative at these 
GR concentrations.  
 
Finally these Co-IP experiments have demonstrated that ligand independent dimerization of the GFP-
GRwt to Flag-GRwt increases from 43 percent at the low GR concentration to ~100 percent at the 
medium and high GR concentrations (Fig.4.3B). The medium and high GR concentrations are also the 
GR concentrations that demonstrate positive cooperative ligand binding in GRwt (Chapter 3). Ligand 
independent dimerization of GR at these elevated levels is thus a promising explanation for positive 
cooperative ligand binding although positive cooperative ligand binding is only seen at the high GFP-
GR concentration. To further strengthen our argument we evaluated GR dimerization in live cells using 
the FRET technique. 
 
4.2 Demonstrating ligand independent dimerization using FRET  
 
The FRET technique is often termed a molecular ruler.  Excitation of a donor fluorophore when in 
close proximity (typically < 10nm) to its acceptor fluorophore will result in a nonradiative, long-range 
dipole-dipole energy transfer (Fig.4.4). This energy transfer from stimulated donor to the acceptor 
molecule may be detected as an increase in the emission level of the acceptor fluorophore (17). CFP 
and YFP make up a  robust FRET donor and acceptor pair. They are resistant to photo bleaching and 
have excitation and emission wavelengths which are far enough apart to minimize spectral crosstalk 
(18, 19). Some crosstalk into the FRET channel (excitation at 430nm, emission at 535nm) was 
detected from the YFP channel (excitation at 500nm, emission at 535nm) as well as from the CFP 
channel (excitation at 430nm, emission at 470nm). The signals measured in the FRET channel were 
corrected for cross-talk from the YPF and CFP channels using the following equation:  
 
 
Where n is normalized FRET and α and β were determined by measuring the crossover into the FRET 
channel of the YFP and CFP signals, respectively, in cells expressing either CFP-GR or YFP-GR on 
its own. In our system, 2.6% of the YFP signal (α) and 59% of the CFP signal (β) were detected in the 
FRET channel. Trinkle-Mulcahy et al. (20) demonstrated similar levels of crossover, notably 67% of 
 
nFRET = FRETsignal – (α x YFPsignal) – (β x CPFsignal) 
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the CFP signal and 19% of the YFPsignal. The crosstalk correction we used was devised by Trinkle-
Mulcahy et al. and is based on previous FRET studies by Tron et al. (21).  
The yellow fluorescent protein tagged GR (YFP-GR) we used as our acceptor fluorophore has been 
shown to be transcriptionally active (22). It occurs in the same vector as the CFP-GR and they have 
equal expression levels (Fig.3.3). As their expression levels match one another as well as that of the 
GRwt we transfected equal amounts of each fluorescently tagged GR at the same total levels of 
plasmid DNA as for the low, medium and high GRwt concentrations in the whole cell saturation 
binding assay.  
A
B
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GR GR
YFP
FRET
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~10nm
CFP YFP
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430nm 500nm
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Figure 4.4. Diagram illustrating FRET energy transfer when donor (CFP) and acceptor (YFP) 
molecules are in close association. (A) When the CFP-GR and YFP-GR occur as monomers, 
excitation of CFP will result in an emission at 470nm while YFP excitation results in an emission at 
535nm. (B) Dimerization of CFP-GR and YFP-GR brings their fluorophores into close association. 
Excitation of CFP results in a lowered emission at 470nm and an energy transfer (FRET) to YFP 
causing its excitation and emission at 535nm. 
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Due to the inherent variation in transfection efficiency within transient transfections it was necessary to 
monitor the relative GR expression levels within each cell analysed. The F-don signal (CPF) was used 
to monitor the transfection efficiency of each cell using an exposure time of 1500ms at 100 percent 
light intensity. These F-don values reflect the CFP signal after 30 minutes of DEX stimulation 
measured in a region of interest (ROI) in the nucleus of each individual cell (Fig.4.5). As the shape 
and size of COS-1 cells vary considerably we found that the normalization was most effective 
following DEX stimulation as this resulted in nuclear import of the CFP-GR and the concentration of its 
signal within the nucleus. Of course it also meant that selection of cells could only be made following 
the 30 minute FRET time course. Cells with an F-don emission of 0-600 (arbitrary units) were selected 
to represent the low GR concentration population, cells with F-don signals between 600-1200 to 
represent the medium GR concentration population and cells with F-don signals of >1200 for the high 
GR concentration population (Fig4.5). 
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Figure 4.5. Relative CFP-GR (F-don) expression levels in individual cells within low, medium 
and high GR concentration populations. FRET was carried out as described in materials and 
methods. Exposure time of 1500ms at 100% light intensity was used. F-don values reflect the CFP 
signal after 30 minutes of DEX stimulation measured in a region of interest in the nucleus of each 
individual cell. Cells with an F-don emission of 0-600 where selected for the low [GR] concentration (*, 
n=10), F-don signals between 600-1200 for the medium [GR] population (†, n=7) and F-don of >1200 
for the high [GR] population (§, n=7). 
 
4.2.1 Ligand independent dimerization of the GR occurs in the cytoplasm at high GR 
concentrations 
As has been demonstrated for GFP-GR (23, 24) there is rapid import into the nucleus of the CFP-GR 
(F-don) and YFP-GR (F-acc) following DEX stimulation (Fig.4.6A,B,C). As dimerization levels of the 
heterodimer pair CFP-GR and YFP-MR have been shown to be influenced by ligand concentration 
(25), we decided to use 10-6M DEX to induce complete dimerization as this is a saturating 
concentration of the ligand (26).  
Stellenbosch University  https://scholar.sun.ac.za
 100
0 5 10 15 20 30
F-
do
n
F-
ac
c
FR
ET
Time after DEX administration (min)
F-
do
n
F-
ac
c
FR
ET
F-
do
n
F-
ac
c
FR
ET
Lo
w
 
[G
R
]
M
ed
iu
m
 
[G
R]
Hi
gh
 
[G
R
]
A
B
C
 
Figure 4.6. Representative F-don, F-acc and FRET signals over time. FRET was carried out as 
described in materials and methods. Cells were transfected with (A) low levels of GR, (B) medium 
levels of GR or (C) high levels of GR and treated with 10-6M DEX for 30 minutes while F-don, F-acc 
and FRET intensity was monitored on an Olympus IX 81 motorized inverted microscope at 37°C. The 
white lines in the FRET images designate the cellular membrane which has been used as the ROI. 
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The corrected FRET signal is indicated by the blue fluorescent signal bellow the yellow F-acc images 
(Fig.4.6). The corrected FRET signal will only appear where there is interaction of the CFP-GR and 
YFP-GR, it therefore indicates areas of dimerization of the CFP-GR and YPF-GR. At the low GR 
concentration the corrected FRET signal increases over time following DEX simulation (Fig.4.6A) with 
very little initial dimerization of the GR that gradually increases after DEX stimulation. There is a low 
level of ligand independent GR dimerization in the perinuclear space at the medium GR concentration 
which migrates to the nucleus and increases following DEX addition (Fig.4.6B). The level of ligand 
independent dimerization prior to DEX stimulation at the high GR concentration is considerable and 
clearly cytoplasmic (Fig.4.6C). Following DEX induction at the high GR concentration there is nuclear 
import as for the low and medium GR concentrations (Fig.4.6A,B). Ligand independent dimerization of 
the GR as indicted by the corrected FRET signal, occurs in the cytoplasm as is demonstrated at the 
medium and high GR concentrations. We have therefore selected the cellular membrane (as indicated 
by the white line) to represent our region of interest (ROI) for FRET analysis (Fig.4.6A,B,C). 
Arguments have been made that the GR dimerizes once bound to glucocorticoid response elements 
(GRE) (27, 28). However, these results as well as those of Savory et al. (3) indicate both ligand 
independent and ligand dependent dimerization of the GR in the cytoplasm.  
 
With the assistance of J. Rohwer (Department of Biochemistry, Stellenbosch University) we developed 
a mathematic model which calculates the level of ligand independent GR dimerization prior to DEX 
administration (refer to materials and methods) (Fig.4.7). The model indicates a significant shift from 
37 percent ligand independent dimerization at low GR concentrations to 60 and 63 percent ligand 
independent dimerization at medium and high GR concentrations, respectively. Roughly two thirds of 
the low GR concentration is monomeric, which changes to roughly one third at the medium and high 
GR concentrations (Fig.4.7).  
 
Although the level of ligand independent dimerization of the FRET technique calculated by the 
mathematic model (Fig.4.7) is lower than the ~100 percent demonstrated at the medium and high 
GFP-GRwt concentrations in the Co-IP experiment (Fig.4.3B), the calculated ligand independent 
dimerization of the low GR concentration closely matches the 43 percent displayed by the low GFP-
GRwt concentration in the Co-IP results. The difference at the medium and high GR concentrations 
may be symptomatic of the in vitro versus the whole cell nature of the Co-IP and FRET experiments. 
Despite this fact, both experiments indicate a similar trend namely, predominantly monomeric 
fluorescent protein tagged GRwt at the low GR concentration, which shifts to predominantly dimeric at 
the high GR concentrations.  
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Figure 4.7. Mathematic derivation of CFP, YFP and FRET signal indicate that ligand 
independent dimerization of the GR increases as GR concentration increases. FRET was carried 
out as described in materials and methods. Mathematical derivation as described in materials and 
methods was carried out on the corrected FRET, F-don and F-acc fluorescence and reveals the 
percentage moles of GR occurring as either monomers or homodimers prior to ligand stimulation. 
Statistical analysis was through ANOVA followed by Dunnett’s post test against low GR concentration 
within medium and high GR concentration monomers (§P<0.05) or dimers (†P<0.05) and one tailed 
unpaired t tests comparing percentage monomers against percentage dimers at each GR 
concentration (*P<0.05). Results represent a minimum of four independent experiments (±SEM). 
 
4.2.2  The fold induction of DEX induced maximal FRET decreases as GR levels increase  
 
There are obvious differences in the levels of corrected FRET between the three GR concentrations; 
ligand induced as well as uninduced FRET levels increase as GR concentration increases (Fig. 4.8A). 
It is also clear that FRET levels plateau well before the 30 minutes time point of DEX stimulation and 
remain constant from roughly the 20th minute of DEX stimulation onwards. This differs from the 
findings of Nishi et al. (25) who demonstrate GR and MR heterodimerization peaking after 60 minutes 
and only in the nucleus. 
 
Due to the nature of our studies, direct comparison of FRET levels between the three receptor 
concentrations can not be made without first normalizing for differences in GR expression (Fig.4.8B). 
Even if we assumed an equal degree of dimerization across these GR populations we would still 
demonstrate higher FRET at the high GR concentration than at the low GR concentration simply as a 
result of its greater levels of GR. In order to correct for this, the raw corrected FRET data for each cell 
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was normalized over its ligand uninduced FRET value (Fig.4.8B). This gives curves which represent 
the fold increase in FRET at each of the three GR concentrations (Fig.4.8B). By fitting sigmoidal dose-
response variable slope curves to this normalized FRET data, maximal fold induction of FRET 
(Fig.4.8C) may be generated for each of the three GR concentrations.  
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Figure 4.8. Ligand induced dimerization decreases as GR concentration increases reflecting a 
higher uninduced dimer percentage. FRET was carried out as described in materials and methods. 
Cells were treated with 10-6M DEX for 30 minutes while F-don, F-acc and FRET intensity was 
monitored on an Olympus IX 81 motorized inverted microscope at 37°C. ( A) Average FRET signal 
plotted against time and fit to a sigmoidal dose-response variable slope curve. (B) Fold increase in 
FRET response was calculated by normalizing each experiment to its unstimulated FRET signal and 
fit to a sigmoidal dose-response variable slope curve which generates (C) maximal fold induction of 
FRET. Statistical analysis was carried out using one-way analysis of variance followed by Bonferroni's 
multiple comparison test (***P<0.001). The figure is representative of seven independent experiments 
(±SEM). 
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The levels of maximal fold FRET induction following DEX stimulation decrease significantly as GR 
concentration increases (Fig.4.8C). This reflects the increase in ligand independent FRET values we 
see as GR concentrations increases (Fig.4.7, Fig.4.8A). Similarly to the DEX induced 2.3-fold increase 
in GFP-GRwt pull down seen at the low GRwt concentration in our Co-IP experiments (Fig.4.3B) there 
is a DEX induced 2.63-fold increase in dimerization at the low GR concentration in the FRET assay 
(Fig.4.8C). Reassuringly the calculated theoretical increase in dimerization derived from the 
mathematical model at low GR concentrations, from the 37 percent ligand independent dimerization to 
100 percent after DEX addition is a similar 2.7-fold (Fig.4.7). The fold increase in DEX induced 
dimerization drops to 1.79 and 1.36 at the medium and high GR concentrations, respectively 
(Fig.4.8C).  Again these reflect the theoretical maximal fold increase in dimerization at the medium 
(1.67) and high (1.59) GR concentrations calculated by our mathematical model (Fig.4.7). The low GR 
concentration undergoes a 1.5-fold greater increase in dimerization relative to the medium GR 
concentration following DEX administration, which rises to a 1.9-fold greater increase in dimerization 
at the low GR concentration relative to the high GR concentration. In order for the DEX induced fold 
induction of dimerization to decrease as receptor levels increase there must be an increase in the 
amount of ligand independent dimerization as receptor levels increase. This is an indirect proof which 
demonstrates a statistically significant increase in ligand independent dimerization at the medium and 
high GR concentrations when compared to the low GR concentration. 
 
In summary, both the Co-IP and FRET results demonstrate a significant increase in ligand 
independent dimerization at the high fluorescent protein tagged GRwt concentrations, which does 
display cooperative ligand binding (Fig.3.8). Although saturation ligand binding was not carried out on 
the specific CFP-GR/YFP-GR or Flag-GR/GFP-GR pairs used in the Co-IP and FRET assays, but 
rather on GFP-GR alone (Fig.3.8), we suggest that this GR concentration dependent increase in 
ligand independent dimerization may be the mechanism whereby positive cooperative ligand binding 
is elicited. However, definitive correlatoion between cooperative ligand binding and ligand independent 
dimerization awaits saturation binding of the specific GR pairs used in the Co-IP and FRET assays.   
 
Having demonstrated that cooperative ligand binding results at medium and high levels of GRwt 
(Chapter 3) and that it may be correlated to ligand independent dimerization (Chapter 4) we have 
focused our further research on the implications of cooperative ligand binding. The first characteristic 
we studied is the translocation of the GR, focusing on its rate of ligand dependent import into the 
nucleus, distribution once nuclear and rate of export following the withdrawal of stimulating ligand.  
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Results: The influence of dimerization on GR nuclear 
import, export and distribution 
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Introduction 
 
Having established the GR levels at which non-cooperative and positive cooperative ligand binding 
takes place (Chapter 3), we demonstrated that ligand independent dimerization of the GR at high 
concentrations may account for cooperative ligand binding (Chapter 4). In the current results chapter 
we report on the investigation of the influence of GR concentration, the ability to dimerize and positive 
cooperative ligand binding on the rate of nuclear import, nuclear distribution and the rate of nuclear 
export of the GR.  
 
Upon ligand binding the GR undergoes a ligand dependant conformational change which results in its 
rapid and active nuclear import (1, 2). There is clear evidence that the nuclear import rate is ligand 
dependent (3) and that the degree of GR nuclear localization is a critical factor in determining the level 
of GR function (4). The rate of nuclear import of the GFP tagged GR in live cell fluorescent studies has 
also been shown to be cell type (5) and ligand concentration dependant (6). In addition, previous 
research demonstrated that once imported nuclear mobility (7) and the pattern of GR distribution (8) in 
the nucleus are differentially affected by ligands and ligand concentration. Nuclear mobility is primarily 
influenced by the association of the activated GR with DNA or other transcription factors, thus the 
greater the capacity for transcription the slower the mobility and the more particulate (or non-random) 
the distribution of the GR in the nucleus. Finally, following the withdrawal of ligand, the GR undergoes 
passive nuclear export (9, 10) where the GR diffuses from the nucleus back into the cytoplasm. 
 
In order to quantify nuclear import and export we have used either direct fluorescence labelling where 
a GFP tagged GR was used in live cell experiments or indirect fluorescence labelling of the GR where 
a fluorescent secondary anti-body was used to visualize a GR specific primary anti-body complexed 
with the GR in fixed and permeabilized cells. The advantage of using direct fluorescent labelling is that 
nuclear import and export may be monitored in an individual live cell in real time. However, we were 
concerned that the large protein tag may in some way impede GR movement and have thus also 
conducted indirect immunofluorescent studies on the unlabeled GR. Another difference between these 
two assays lies in the quantification method employed. Where as the direct fluorescence procedure 
directly measures the accumulation of fluorescence either in the nucleus or in the cytoplasm of an 
individual cell, depending on whether import or export is being studied, the immunofluorescent 
technique requires manual counting of a population of cells where the average localization of 
fluorescence within the population of cells, either in the nucleus or in the cytoplasm, is determined.    
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Results 
 
5.1 Nuclear import of the glucocorticoid receptor 
 
Following exposure to ligand, the rate of activated GR nuclear import exceeds receptor export, 
resulting in high concentrations of GR in the nucleus (11). The active process of nuclear import of the 
GR occurs quickly and relies on the association of the GR with Hsp90 (12), FKBP52 (13) and importin-
α (14). This complex is actively shuttled into the nucleus by dynein (15, 16) along the cytoskeleton (12) 
through the nuclear pore complex (17). The nuclear import of GFP-GR in transiently transfected COS-
7 cells has been shown to be both ligand and ligand concentration dependent, displaying greater 
differences in import rate at low ligand concentrations (18).  
 
5.1.1 The t½ of live cell nuclear import of GFP-GR decreases as receptor concentrations 
increase. 
 
Live cell nuclear translocation assays were conducted in COS-1 cells transiently transfected with 
medium and high GFP-GR concentrations, receptor levels which demonstrated non-cooperative and 
positive cooperative ligand binding (Chapter 3), respectively.  
 
Following the induction of test compound, live cell images of nuclear import were taken every minute 
over a 60 minutes period (Fig.5.1, Fig.5.2A). Nuclear import was quantified as the increase in GFP 
fluorescence in the nucleus over the period of stimulation, taking the zero time point as 0% and the 
maximal fluorescence as 100%. The entire nuclear area was selected as the ROI and is indicated by 
the interior of a white border (Fig.5.1). A one phase exponential association curve was fit to this data 
which generated a half time (t½) to maximal nuclear localization.  
 
Increasing GFP-GRwt concentration from medium to high resulted in a significant decrease in the t½ of 
nuclear import through DEX (Fig.5.2B). This was also the case for DEX induction through the 
dimerization impaired D-loop mutant GFP-GRdim (Fig.5.2B). Although GFP-GRwt had a significantly 
faster rate of nuclear import than GFP-GRdim at both GR concentrations, the difference in GR import 
t½ decreased from 2.8-fold longer for GFP-GRdim at the medium GR concentration to 1.9-fold longer 
for the GFP-GRdim at the high GR concentration. GFP-GRdim import at the high GR concentration is 
identical to the nuclear import rate of the medium GFP-GRwt concentration. Based on our Co-IP 
results which demonstrate a high degree (90 percent of GRwt levels) of ligand dependent dimerization 
of the high GR concentration GFP-GRdim (Fig.4.3B) we hypothesize that at this saturating 
concentration of DEX the high concentration of GFP-GRdim starts to display ligand dependent 
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dimerization similar to that of the GFP-GRwt. Although the significantly increased rate of import for the 
GRwt as compared to the GRdim could suggest a role for cooperative ligand binding that requires the 
ability to dimerize, the fact that the GFP-GRdim also displays a shift in import rate at high 
concentrations excludes any influence that positive cooperative ligand binding may have on this 
parameter as saturation ligand binding demonstrated that the GRdim is incapable of positive 
cooperative ligand binding (Fig.3.8B). It is thus more likely that the observed phenomena of increased 
nuclear import rate at increased GR levels is due to the laws of mass action namely, a faster reaction 
rate at increased concentration of GR and that loss of GR dimerization may play a role in enhancing 
the rate of nuclear import and in nuclear retention (to be discussed in section 5.3). 
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Figure 5.1. Live cell nuclear import studies were carried out as described in materials and methods. 
A single cell was induced with 10-6M DEX and GFP images were taken every minute over a 60 minute 
period. The white circle around the nucleus represents the region of interest. 
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Figure 5.2. Higher GR concentrations decrease the nuclear import half-time (t½) of a range of 
test compounds. (A) Representative graph depicting nuclear import following 10-6M F induction at 
medium and high GFP-GRwt concentrations which was quantified as the increase in GFP 
fluorescence in the nucleus over the period of stimulation, taking the zero time point as 0% and the 
maximal fluorescence as 100%. A one phase exponential association curve was fit to this data which 
generated a t½ to complete nuclear localization. (B) Live cell nuclear import of 10-6M DEX stimulated 
cells expressing medium and high GFP-GRwt or GFP-GRdim. Statistical analysis of t½ to maximal 
nuclear localization was through one tailed unpaired t tests, GFP-GRwt against GFP-GRdim 
(**P<0.01, ***P<0.001) and medium against high GFP-GRwt concentration (††P<0.01) and medium 
against high GFP-GRdim concentration (§§P<0.01). (C) Cells were induced with 10-6M DEX, F, MPA, 
Prog or RU486. Statistical analysis of t½ to maximal nuclear localization comparing medium to high 
GFP-GR concentrations was carried out using one tailed unpaired t test (*P<0,05, **P<0.01, 
***P<0.001). ANOVA followed by Newman-Keuls post test was used to compare ligands within the 
medium GFP-GR concentration (lower case letters) or high GFP-GR concentration (capital letters). 
Conditions with different letters are statistically different from one another (P<0.01). Results represent 
a minimum of five cells, each from independent experiments (±SEM). 
 
We show that the nuclear import rate decreases significantly as GFP-GR concentration increases for 
DEX, cortisol (F), MPA and Prog and that the import rate stimulated by these test compounds varies 
significantly at the medium GFP-GR concentration, while RU486 does not display the same behaviour 
(Fig.5.2C). Although the sequence of ligand import rates at  the medium GFP-GR concentration (DEX 
> RU486 > F > MPA > Prog) does not match any of the order of potency parameters tested by 
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Ronacher et al. (19), a general trend does emerge in that DEX, which they show to be the most potent 
ligand in GR binding, GRE driven transactivation and NFĸB driven transrepression, resulted in the 
fastest GR import rate, while Prog, which is the least potent ligand in these assays, had the slowest 
GR import rate. At the high GFP-GR concentration there is less variation in the import rates between 
test compounds with only DEX and Prog demonstrating significantly different import times (Fig.5.2C). 
Although at the medium GR concentration the import rates of DEX, F, MPA and Prog are all 
significantly different from one another, at the high GR concentration the statistical differences are 
decreased. For example, the difference between DEX and Prog induced nuclear import t½ falls from 
24.3 minutes at the medium GR concentration to 12.4 minutes at the high GR concentration. We 
propose that increasing the receptor level sufficiently will decrease all ligand import rates to a 
theoretical minimum where the import machinery required for this active process becomes limiting. 
 
Results in the literature suggest that the t½ of GFP-GR import following the addition of 10-6M DEX is ~5 
minutes (12), while maximal nuclear localization of GFP-GR is achieved 30 minutes after 10-7M DEX 
stimulation (20). Our live cell nuclear import results are similar to those seen in the literature, namely 
nuclear import t½ of GR following 10-6M DEX stimulation of between 7.5 and 3.9 minutes, depending 
on the concentration of GFP-GRwt studied. We also tested the nuclear import following stimulation 
with a non-saturating, 10-9M, DEX concentration, which displayed a significantly reduced nuclear 
import rate of 11.1 minutes compared to the 3.9 minutes following stimulation with 10-6M DEX in the 
high GR concentration population (Fig.5.3). In order to ensure a plateau in the level of nuclear import 
after 60 minutes and to minimize the differences in receptor occupation due to differing ligand affinities 
we, however, decided to conduct most of our further studies at saturating (10-6M) ligand 
concentrations. 
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Figure 5.3. Nucear import is ligand concentration dependent. Live cell nuclear import was carried 
out as described in the materials and methods on COS-1 cells transfected with the high concentration 
of GFP-GRwt following either 10-6M or 10-9M DEX stimulation. Statistical analysis was carried out 
using two tailed unpaired t test (***P<0.001). Results represent a minimum of three cells, each from 
independent experiments (±SEM). 
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5.1.2 The ability to dimerize influences both maximal nuclear localization as well as the t½ of 
nuclear import in immunofluorescent nuclear import assays 
 
Where as the live cell nuclear translocation assay illustrates the mobility of GFP-GR within a single 
live cell in real time, immunofluorescent analysis relies on anti-body directed fluorescent labelling of 
the GR in cells fixed and permeabilized at specific time points. Nuclear import was quantified by 
double blind counting of cells in a population of 50 cells per time point and per condition. Cells were 
classified as nuclear when they displayed distinct nuclear localization of the GR (60 percent nuclear 
and above), where GR concentration was clearly higher in the nucleus than that in the cytoplasm 
(Fig.5.4A). The percentage nuclear cells were calculated as the ratio of nuclear over total cells 
counted. Hoechst staining of the nucleus of cells which was detected through the DAPI-signal, aided 
in nuclear quantification (Fig.5.4A). Although, this method of classification is commonly used (18), it is 
important to note that what is measured is in fact not absolute nuclear or cytoplasmic GR localization, 
but rather greater than 60 percent nuclear distribution.   
 
COS-1 cells were transiently transfected with low and medium levels of GRwt or GRdim. To reiterate, 
whole cell saturation binding assays showed positive cooperative ligand binding to the medium GRwt 
concentration but was non-cooperative at the low GRwt concentration and at both low and medium 
GRdim concentrations (Fig.3.8B). The maximal percentage of cells displaying nuclear localization 
following DEX induction is significantly higher for the low and medium GRwt concentrations (~95 
percent) than for that of GRdim (~76.5 percent) (Fig.5.4C). This effect is independent of positive 
cooperative ligand binding, which occurs at the medium GRwt concentration but not at the low GRwt 
concentration, as both GRwt concentrations display roughly equal levels of nuclear import. However, 
maximal nuclear import is clearly influenced by dimerization as induction with the dimerization 
abrogating dissociative GC, CpdA, results in similar levels of nuclear import through both the GRwt 
and the GRdim (Fig.5.4B,C). What a decrease in the percentage of cells displaying nuclear GR 
localization signifies in this assay is that within the populations counted not all cells reach 60 percent 
nuclear localization of GR. Therefore, the ability to dimerize although not an absolute requirement for 
nuclear import, does play a role in the extent of GR import. These results are similar to those 
presented by Robertson et al. (Addendum B) (21) for DEX or CpdA induced nuclear import of the 
mouse GRwt (mGRwt) and mouse GRdim (mGRdim), where DEX stimulation of the mGRwt resulted 
in 93 percent nuclear import and CpdA stimulation of mGRwt resulted in 66 percent nuclear import. 
Both the study by Robertson et al. as well as these results (Fig.5.4C) demonstrate similar behaviour 
for DEX through the dimerization impaired GRdim as for CpdA through the GRwt. We therefore 
hypothesis that the dimerization abrogating CpdA results in a similar conformation of the GRwt as 
exists for the dimerization impaired GRdim mutant following DEX stimulation. 
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Figure 5.4. The ability to dimerize influences t½ and extent of nuclear import. Immunofluorescent 
analysis of nuclear import was performed as described in materials and methods. (A) Representative 
images of a single cell displaying 60% nuclear GRwt localization. The GFP-signal depicts the position 
of the GR and the DAPI-signal detects the nuclear Hoechst stain, while the merged image is a 
combination of the two. (B) Representative graph of low and medium GRwt concentrations stimulated 
with 10-6M DEX or 10-5M CpdA. Statistical analysis was carried out on (C) percentage maximal nuclear 
localization and (D) t½ to maximal nuclear localization using ANOVA followed by Dunnett’s post test 
against DEX stimulated low GRwt concentration (*P<0.05, **P<0.01***P<0.001). Results represent 50 
cells counted per condition and time point from three independent experiments (±SEM). 
 
We demonstrate a significantly slower rate of nuclear import through the low GRdim concentration 
following either DEX or CpdA stimulation (Fig.5.4D). What is noteworthy is that the medium 
concentration of GRdim behaves in a more similar manner to the GRwt in terms of nuclear import rate 
than the low concentrations of GRwt and GRdim do, which is the same trend we saw in the live cell 
nuclear import assays (Fig.5.2B). Our Co-IP results suggest that the medium concentration of GRdim 
Stellenbosch University  https://scholar.sun.ac.za
 115
displays a degree of ligand independent dimerization (Fig.4.3), albeit significantly lower than that of 
the GRwt. We therefore conclude that the medium concentration GRdim approaches wild type like 
behaviour, which results in an increase in its nuclear import rate to a level that is similar to the GRwt, 
despite displaying insufficient ligand independent dimerization for positive cooperative ligand binding 
to be observed (Fig.3.8B).  Where as the live cell nuclear import assay demonstrated clear GR type 
and concentration dependent differences in the t½ of nuclear import (Fig.5.2B), the indirect 
immunofluorescent analysis of nuclear import does not show a difference in the nuclear import rate 
between low and medium GRwt concentrations or between medium concentrations of GRwt and 
GRdim (Fig.5.4D) and only mimics the live cell analysis at the low GR concentration where GRdim 
results in a slower rate of import. However, as the immunofluorescent analysis represents a population 
of cells and not the import within a single cell it is inherently a less accurate means of measuring the t½ 
of nuclear import and may simply not be sensitive enough to detect the differences in nuclear import 
rate. In a similar assay Robertson et al. (Addendum B) (21) also demonstrated no differences in the 
nuclear import rate when studying DEX or CpdA induced import of mGRwt or mGRdim.  
 
It is important to note that the import rate reflects both the rate of nuclear import as well as the rate of 
nuclear export. As nuclear export is primarily through passive diffusion it is an on going process which 
occurs even during ligand stimulation and therefore primary nuclear import. A possible cause for the 
reduced nuclear import rate at the low GRdim concentration (Fig.5.4D) and incomplete nuclear 
localization at both low and medium GRdim concentrations (Fig.5.4C) may be faster nuclear export. 
An increase in nuclear export rate is associated with a reduced ability to bind to Hsp90 in the nucleus 
(9, 10) and may be linked to increased nuclear mobility as a result of a decrease in DNA affinity as 
revealed by agonist bound YFP-GR (3),(9, 10). It is enticing to speculate that the significant increase 
in nuclear import rate and significant decrease in nuclear localization of the GRdim is as a result of an 
increased nuclear export rate. We will explore this possibility in Section 5.3.   
 
As immunofluorescent analysis of nuclear import measures the t½ to 60% or greater nuclear import 
and not the time to maximal nuclear import as the live cell study does, this results in a reduced t½ of 
nuclear import when compared to the live cell nuclear import assay. This is best illustrated at the 
medium GRwt concentration where DEX stimulation results in a nuclear import t½ of 3.2 minutes 
(Fig.5.4D) in the immunofluorescent assay and an import t½ of 7.5 minutes in the live cell assay 
(Fig.5.2B). Our study demonstrates similar import rates to results in the literature, which show indirect 
immunofluorescent studies of GR import t½ of 4 to 5 minutes following 10-6M DEX addition (3, 7). 
 
The fact that the GRwt concentration shows no influence on nuclear import may be a short coming of 
the assay itself. When compared to the live cell import assay the time points analyzed are greatly 
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reduced and represent the average import of a wide variety of cells. Due to the fact that the 
quantification of nuclear localization is performed by physical human observation at 20-fold 
magnification and not by the Cell® imaging software at 60-fold magnification it is highly likely that cells 
with low GR and therefore reduced fluorescent labelling are simply not accounted for. As described in 
materials and methods we actively selected cells with low GR expression from our low GFP-GRwt and 
low GFP-GRdim concentration populations for live cell import analysis. They therefore represent cells 
with a truly reduced GR level. Unfortunately the rather blunt instrument of indirect immunofluorescent 
labelling relies on human observation of a population of cells where those expressing the very lowest 
GR concentrations are most likely undetectable to the human eye. This technique is simply not 
sensitive enough due to the short comings of the human optical threshold which are exposed by the 
indirect labelling technique and which can not hope to match the efficiency of direct fluorophore 
labelling and the increased level of magnification. It must also be noted that the level of background 
fluorescence is vastly increased in the immunofluorescent assay due to the nature of this assay further 
hampering the detection of cells expressing low GR concentrations. 
 
5.2 Nuclear distribution is ligand as well as dimerization dependent 
 
Results in the literature indicate that induction with the potent GR agonist, DEX, results in discrete 
nuclear foci, areas within the nucleus where the activated GR aggregates, while induction with the GR 
antagonist RU486 leads to diffuse nuclear localization of the activated GR (3, 6, 9). It has been 
demonstrated that GFP-GR mobility within the nucleus, which is an active process, is determined by 
ligand concentration and affinity for GRE binding. For example, in transiently transfected COS-1 cells 
binding of ligands with high affinity for the GR results in a clear decrease in GR nuclear mobility (22). 
Furthermore, increasing the concentration of GFP-AR in transiently transfected cells also leads to 5-
fold decrease in its nuclear mobility, which may be as a result of enhanced HRE binding at increased 
receptor concentration (23).  It is hypothesized that conformational changes of the GR following ligand 
binding enable it to transiently bind nuclear structures or domains that are slow moving and that this is 
reflected in decreased receptor mobility in the nucleus as demonstrated by fluorescence recovery after 
photobleaching (FRAP) of GFP-GR (9). Furthermore, nuclear mobility has been shown to be slower in 
areas of high GR concentration than in areas of low GR concentration (8). The theory that receptor 
mobility is slowed by associations with transcription machinery and through direct binding to DNA is 
consistent with RNA fluorescence in situ hybridization (FISH) studies that have demonstrated active 
transcription close to receptor nuclear foci (24-26), which is ligand dependent (27, 28). As nuclear 
distribution is an important factor for predicting the level of transcriptional activation we have 
investigated the influence of positive cooperative ligand binding and GR dimerization on nuclear 
distribution. 
Stellenbosch University  https://scholar.sun.ac.za
 117
We have based our study of nuclear distribution of the GFP-GRwt and GFP-GRdim on those 
performed by Schaaf et al. (8) who quantified nuclear distribution in terms of the variation in 
fluorescent intensity along a line drawn through the nucleus. The resulting quotient of variation (CV) 
along this nuclear line represents the distribution of fluorescently labelled GR. A high CV (typically >17 
percent) (8) signifies a non-random nuclear distribution where discrete foci or speckles of fluorescence 
are visible. A low CV indicates random nuclear distribution typified by a diffuse distribution of 
fluorescence. Our results demonstrate a quotient of variation (CV) value of ~18 percent following 10-
6M DEX stimulation (Fig.5.5C), which is very similar to the ~19 percent shown by Schaaf et al. at the 
same concentration of DEX in COS-1 cells expressing YPF-GRwt.   
 
Our nuclear distribution assay displays similar results to those of Schaaf et al. (8) despite the fact that 
we have not used a confocal microscope but have relied on the deconvoluting capability of the Cell® 
imaging software of an IX-81 inverted fluorescence microscope (Olympus Corp., Japan). Initial studies 
prior to the use of the deconvoluting software generated fluorescent intensity profiles through the 
nucleus which where bell shaped.  This was as a result of the three dimensional structure of the 
nucleus. When viewed in its entirety the spherical nucleus has a greater concentration of GFP-GR in 
its centre than at its periphery. By taking images above and below the chosen focal plane the software 
can deconvolute the influence of this intensity to generate an image which is in effect the fluorescent 
profile of a single focal plane. The graphs of our deconvoluted nuclear fluorescence intensity have a 
linear axis (Fig.5.5B) as is demonstrated for those using the confocal imaging (8).  
 
Distribution of activated GR in the nucleus has been shown to be influenced by ligand. Previous 
studies from the literature demonstrate that stimulation with the agonist DEX results in a non-random 
particulate distribution of the GR in the nucleus while stimulation with the antagonist RU486 leads to a 
random distribution of the GR in the nucleus (3, 6, 9). Our studies demonstrate that stimulation with 
the dissociated GC, CpdA, results in random nuclear distribution of the GR, which is reflected in a 
lower percentage CV than the potent agonist DEX (Fig.5.5C). A high percentage CV equates to non-
random nuclear distribution, which indicates the formation of discrete foci within the nucleus where the 
GR is sequestered (Fig.5.5A,C). These foci have been shown to correspond with areas of the nucleus 
where active transcription takes place (24, 25). CpdA induces random nuclear distribution through 
both the GFP-GRwt and the GFP-GRdim, which supports the evidence that CpdA is incapable of 
inducing transactivation (29) via the GR. 
 
Stellenbosch University  https://scholar.sun.ac.za
 118
0
5
10
15
20
25
DEX CpdA
Medium [GR] High [GR] Medium [GR] High [GR]
** *** ***
** **
GFP-GRdim
GFP-GRwt
18%
15%
18% 18%
14% 15% 14% 15%
CV
 
o
f n
u
cl
ea
r
di
st
rib
u
tio
n
 
(%
)
0 2 4 6 8 10 12
15000
20000
25000
30000
35000
40000
45000
50000
55000
Fl
u
o
re
s
ce
n
c
e
in
te
n
si
ty
Distance (µm)
GFP-GRwt Dex (26% CV)
GFPGRdim CpdA (12% CV)
A
B C
Dex
CpdA
GFP-GRwt GFP-GRwtGFP-GRdim GFP-GRdim
Medium [GR] High [GR]
 
Figure 5.5. CpdA stimulation results in the random nuclear distribution of GR while DEX 
stimulation results in a non-randon distribution of GRwt and high concentrations of GRdim. 
The nuclear distribution assay was performed as described in materials and methods. Cells 
expressing medium or high GFP-GRwt or medium or high GFP-GRdim were induced with 10-6M DEX 
or 10-5M CpdA for 1 hour. Z-stack images of the nuclei were taken at various focal planes and these 
were used to deconvolute a single nuclear image. As long a line as possible was selected in each 
nuclei avoiding nucleoli and the Cell® imaging software was used to quantify the coefficient of 
variation (CV) of GFP fluorescence intensity along this line in 5 cells per condition from 4 separate 
experiments (±SEM). (A) Representative deconvoluted nuclear images of either 10-6M DEX or 10-5M 
CpdA stimulated cells. (B) Representative graph of fluorescent intensity from two cells demonstrating 
fluorescent intensity along two nuclear lines with a CV of 12% and 26%, respectively. (C) Statistical 
analysis of CV of nuclear distribution was carried out using ANOVA followed by Dunnett’s post test 
against DEX stimulated medium GFP-GRwt concentration (*P<0.05, **P<0.01***P<0.001). 
 
The pattern of GFP-GRwt nuclear distribution following DEX induction was not influenced by receptor 
concentration. We therefore conclude that positive cooperative ligand binding to the GR does not 
affect this parameter (Fig.5.5A,C). However, the random distribution of the DEX induced low GFP-
GRdim concentration as well as that elicited through CpdA induction (Fig.5.5C) indicates a role of 
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dimerization in nuclear sequestering. Dimerization impaired GR mutants have been shown to bind to 
DNA with a reduced capacity relative to the wild type receptor (30-33), which would explain the 
random distribution demonstrated by the low concentration of GFP-GRdim. Interestingly DEX induced 
nuclear distribution of the GFP-GRdim shifts from a random to a non-random pattern as the receptor 
concentration increases (Fig.5.5A,C). This is similar to our nuclear import results which demonstrate 
wild type like behaviour at the high GFP-GRdim concentration. Again we hypothesis that at high 
concentrations the GFP-GRdim is capable of a degree of ligand induced dimerization which affords it 
a degree of wild type behaviour which, however, is not sufficient to elicit positive cooperative ligand 
binding. 
 
5.3 Nuclear export of the glucocorticoid receptor 
 
The export of GR from the nucleus upon ligand withdrawal occurs over a time period of hours and is a 
passive process (34). Indirect immunofluorescence studies by Hache et al. of GR export from the 
nucleus following the washout of 10-6M cortisol (F) show a t½ of 8-9 hours and that the GR remains 
predominantly nuclear 48 hours after 10-6M RU486 washout in GrH2 cells (7). Carrigan et al. saw no 
nuclear export of the GR 24 hours after washout of 10-6M F in transiently transfected COS-7 cells (35). 
Export of endogenous GR from isolated thymocytes was shown to have a t½ of 12 hours following the 
washout of 10-6M DEX (3). The nuclear export of GFP-GR in a live cell assay 5 hours after the 
washout of 5 x 10-8M DEX demonstrated predominant nuclear localization (10). Retention of the GR in 
the nucleus has been shown to be linked to GR association with nuclear Hsp90 (10). Due to the rapid 
rate of GR dissociation from DNA following ligand withdrawal of 30 to 60 minutes (36) and the 
subsequent localization of GR to transcriptionaly inactive areas of the nucleus (34) it is unlikely that 
the export rate of GR plays a major role in GR function. 
 
5.3.1 The t½ of live cell nuclear export is dimerization dependent 
 
In order to represent nuclear export of the GR in terms of both the level of GFP-GR diffusion out of the 
nucleus and the level of its concomitant accumulation in the cytoplasm we quantified nuclear export as 
the ratio of GFP in the centre of the nucleus divided by that in the mid point of the cytoplasm (Fig.5.6, 
Fig.5.7A).  
 
Our initial studies on the GFP-GRwt following induction and washout of 10-6M DEX revealed 
protracted nuclear export rates (t½ ~20 hours) (Fig.5.7A), which is similar to results shown in the 
literature where export studies on transiently transfected GFP-GR in COS-7 cells demonstrated ligand 
dependent export rates as well as 75 percent nuclear distribution 24 hours after 10-6M DEX washout 
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(18). In order to visualize complete nuclear export of the GR from the nucleus we thus stimulated with 
10-9M DEX where the average t½ of nuclear export was reduced to ~4 hours (Fig.5.8B). These findings 
indicate that nuclear export is ligand concentration dependent.  
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Figure 5.6. Live cell nuclear export studies. COS-1 cells were transiently transfected with pEGFP-
C2-GR (GFP-GR) using the DEAE-Dextran method. A single cell was induced with 10-6M DEX for 1 
hour after which it was rinsed 4 times with sterile PBS and stripped DMEM was added. Nuclear export 
was analyzed at 0, 4, 12, 20 and 36 hours after washout. The small white circles represent the ROIs, 
situated at the mid point of the nucleus and the mid point between nuclear membrane and cellular 
membrane. As the cell is alive and moves considerably over the 36 hour period, ROIs must be 
redrawn for each time point. 
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As the live cell nuclear export study was carried out over a 36 hour period we were concerned that a 
build up of GFP-GR in the cytoplasm may have been as a result of new protein expression and not of 
GFP-GR export into the cytoplasm. We therefore ran an experiment where cycloheximide or solvent 
was incubated along with the cells during the assay. Cycloheximide blocks translational elongation 
and is therefore an inhibitor of protein biosynthesis, furthermore Avenant et al. (37) have 
demonstrated that the same cyclohexamide treatment is capable of blocking protein biosynthesis in 
COS-1 cells. We found no difference between the export time of medium concentrations of GFP-GRwt 
or GFP-GRdim with or without cycloheximide (Fig.5.7B). It is therefore possible to assume that the 
build up of GFP-GR in the cytoplasm is as a result of nuclear export and not due to significant effects 
attributable to the synthesis of new GFP-GR over the 36 hour assay. 
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Figure 5.7. Induction with 10-6M DEX results in protracted export rates while administration of 
cyclohexamide does not influence the live cell nuclear export rate. Live cell nuclear export was 
performed as described in materials and methods. (A) Protracted nuclear export (t½ ~20 hours) 
following induction with 10-6M DEX. (B) COS-1 cells expressing medium concentrations of either GFP-
GRwt or GFP-GRdim were induced with 10-9M DEX for 1 hour after which they were rinsed 4 times 
with sterile PBS and stripped DMEM containing either EtOH or 1µM cycoheximide (Sigma). Nuclear 
export was quantified as the ratio of GFP fluorescence in the mid point of the nucleus over that in the 
midpoint between nuclear membrane and cellular membrane. Data was fit to a one phase exponential 
decay curve which generates a
 
t½ to maximal cytoplasmic localization. Statistical analysis was carried 
out using one tailed unpaired t test. Results represent three individual cells from one experiment (± 
SEM).  
 
There was no statistical difference in nuclear export rate between the medium or high GFP-GRwt or 
medium and high GFP-GRdim (Fig.5.8B). However, nuclear export studies do offer a possible 
explanation for the slower nuclear import rate and lower maximal localization levels of GFP-GRdim 
when compared to that of GFP-GRwt (Fig.5.2B,C,D), as there is a significant trend towards faster 
nuclear export of the GFP-GRdim (Fig.5.8A,B). To reiterate, the nuclear import rate comprises both 
the rate of import as well as that of export. We therefore propose that the faster rate of nuclear export 
demonstrated by GFP-GRdim contributes to its reduced nuclear import rate (Fig.5.2B). Furthermore, 
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the diffuse pattern of nuclear distribution elicited by stimulation with dimerization abrogating CpdA and 
demonstrated by the low concentration of GFP-GRdim following DEX stimulation (Fig.5.5C), suggest 
that dimerization is necessary to retain the GR in the nucleus. We thus propose that the reduced 
levels of nuclear localization shown by GRdim as well as CpdA stimulated GRwt (Fig.5.4C) may be 
linked to the increased nuclear export rate displayed by dimerization impaired GR (Fig.5.8A,B), which 
is possibly caused by a decrease in nuclear retention reflected by the random pattern of nuclear 
distribution (Fig.5.5C). 
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Figure 5.8. GR dimerization decreases the rate of nuclear export. (A) A representative graph 
depicting nuclear export in cells expressing medium GFP-GRwt or GFP-GRdim following the washout 
of 10-9M DEX quantified as the ratio of GFP fluorescence in the nucleus over that in the cytoplasm. A 
one phase exponential decay curve was fit to the data which generated a t½ to maximal cytoplasmic 
localization. (B) Nuclear export rates of medium and high GFP-GRwt or GFP-GRdim. Statistical 
analysis was carried out using one tailed unpaired t test (*P<0,05). All results represent a minimum of 
six individual cells from independent experiments (±SEM). 
 
5.3.2 Increased ligand binding affinity of the medium GRwt concentration results in protracted 
nuclear retention following the washout of 10-6M DEX 
 
Immunofluorescence has been used to quantify nuclear export in much the same way it was for 
nuclear import. Low and medium concentrations of GRwt or GRdim were stimulated for one hour with 
10-6M DEX after which the DEX was washed out and cells where fixed, permeabilized and 
fluorescently labelled at time points following the washout from 0 to 28 hours.  Figure.5.9 depicts 
representative cells expressing the medium GRwt concentration.  
 
Immunofluorescent analysis of nuclear export was conducted following the washout of either 10-6M 
DEX or 10-5M CpdA. The export t½ value reflects the half time to less than 60 percent nuclear GR 
localization (Fig5.10). Our live cell nuclear export studies revealed a dramatically faster rate of nuclear 
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export (Fig.5.8B) as compared to immunofluorescent results (Fig.5.10). However, this is to be 
expected due to the lowered concentration of DEX used to induce nuclear import (10-9M versus 10-
6M).   
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Figure 5.9. Immunofluorescent analysis of nuclear export. Immunofluorescence analysis of nuclear 
export was performed as described in materials and methods. Representative images at varying time 
points following the washout of 10-6M DEX at medium concentrations of GRwt. The GR and nuclear 
overlay depict the Hoechst nuclear stain and GFP signal which indicates the position of the GR. The 
GR images demonstrate the GFP-signal. 
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The medium GRwt concentration following DEX stimulation and washout (Fig.5.10A,B) is the only 
export t½ which significantly differs from the other DEX induced GR levels and constructs. 
Demonstrating an increase in nuclear export t½ from 13.3 hours at the low GRwt concentration 
following DEX withdrawal to 21.4 hours at the medium GRwt concentration. Furthermore the nuclear 
export rate of the low and medium GRwt concentrations following CpdA washout is similar and non-
significantly different from the DEX stimulated low GRwt concentration in the immunofluorescent 
assay (Fig.5.10B). Although it is tempting to attribute the increase in export rate at the medium GRwt 
concentration to cooperative ligand binding, the fact that live cell nuclear export of GFP-GR displayed 
no such receptor concentration dependent difference in nuclear export rate (Fig.5.8B) cautions against 
this interpretation. Rather, the explanation we offer for this phenomenon is that ligand independent 
dimerization of the medium GRwt concentration increases its sensitivity to DEX and thus the thousand 
fold greater concentration of stimulating DEX in the immunofluorescent assay versus the live cell 
export assay may result in trace amounts of DEX remaining in the cell after washout which only the 
ligand independent dimerized GR can bind due to its increased ligand binding affinity as revealed by 
saturation binding assays (Fig.3.8B), thus prolonging its nuclear export. This is not observed with 
CpdA as CpdA abrogates dimerization of the GR and export rates following its washout remain the 
same for both receptor types and concentrations.  
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Figure 5.10. Immunofluorescent analysis of nuclear export shows an increased t½ at medium 
GRwt following DEX stimulation only. Immunofluorescent nuclear export studies were carried out 
as described in materials and methods. Cells were stimulated with 10-6M DEX or 10-5M CpdA for 1 
hour, rinsed three times with sterile PBS at 37°C a nd incubated for 0, 4, 8, 12, 20, 24 and 28 hours in 
stripped DMEM. The percentage nuclear of total cells counted was fit to a one phase exponential 
decay curve, (A) graph of low and medium GRwt concentrations exposed to DEX, (B) which 
generates a
 
t½ to maximal cytoplasmic localization. Statistical analysis was carried out on t½ to 
maximal nuclear localization, percentage maximal nuclear localization and t½ to maximal cytoplasmic 
localization using ANOVA followed by Dunnett’s post test against DEX stimulated low GRwt 
concentration (*P<0.05, **P<0.01***P<0.001). All results represent 50 cells per condition from three 
independent experiments (±SEM). 
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5.4 Overview of Chapter 5 results 
 
Our results in this chapter demonstrate significant variation in the rates of GR nuclear import and 
export as well as nuclear distribution at varying GR concentrations, with different constructs and 
following DEX or CpdA stimulation. However, it is not obvious whether these differences arise due to 
cooperative ligand binding at the high GRwt concentrations or because of GR concentration and 
dimerization effects. One may argue that if cooperative ligand binding was the cause for differences in 
GR mobility and distribution then DEX stimulation would alter the behaviour of only the concentration 
of GRwt, which displays cooperative ligand binding. GRwt concentrations that display non-cooperative 
ligand binding should behave similarly to all GRdim concentrations. Furthermore, CpdA stimulation 
should result in a difference in behaviour compared to DEX stimulation at GRwt concentrations that 
elicit cooperative ligand binding. 
 
The arguments for the influence of cooperative ligand binding on nuclear import include an increase in 
the live cell nuclear import rate at high GFP-GRwt concentration, which was significantly faster than 
that of the high concentration of GFP-GRdim (Fig.5.2), the decrease in the DEX induced maximal 
nuclear localization of the medium concentration of GRdim as compared to GRwt (Fig.5.4C) and the 
fact that stimulation with CpdA decreased the maximal nuclear localization of GRwt to parity with DEX 
stimulated GRdim (Fig.5.4C). However, the case against the influence of cooperative ligand binding 
on nuclear import is stronger. The live cell assay revealed a GRdim concentration dependent increase 
in nuclear import rate (Fig.5.2), while nuclear import quantified through immunofluorescence 
demonstrated no difference in the DEX stimulated nuclear import rate or maximal nuclear localization 
through low and medium GRwt concentrations (Fig5.4). Furthermore, the nuclear import rate following 
DEX stimulation at medium GRwt and GRdim concentrations is also similar (Fig.5.4). These counter 
arguments against the influence of cooperative ligand binding on GR nuclear import suggest that the 
ability of GR to dimerize and increased GR concentration, rather than cooperative ligand binding, 
promote an increase in GR nuclear import rate and maximal nuclear localization at saturating ligand 
concentrations. Intriguingly, immunofluorescent import studies at subsaturating DEX concentrations 
suggest an influence of cooperative ligand binding. Although the nuclear import rate of the low and 
medium GRwt concentrations are statistically the same following 10-6M DEX stimulation, there is a 
significant difference in their import rates at lower DEX concentrations (Fig.5.11). Where as the 
nuclear import rate of the medium concentration of GRwt following the stimulation with 10-6M, 10-9M or 
10-10M DEX remains statistically similar, that of the low concentration of GRwt decreases significantly 
as stimulating DEX concentrations decrease (Fig5.11). Thus, cooperative ligand binding may enhance 
nuclear import of the GR, but only at subsaturating GC concentrations. 
 
Stellenbosch University  https://scholar.sun.ac.za
 126
0
10
20
30
40
Low [GR] Medium [GR]
a
3.2
a
3.2
b
18.8
a
9.4
c
35.2
a,b
12.2
10-6M 10-9M 10-10M
DEX
t ½
 
to
 
m
ax
im
al
 
n
u
cl
ea
r
lo
ca
liz
at
io
n
 
(m
in
)
 
Figure 5.11. Immunofluorescent nuclear import stimulated by various DEX concentrations. 
Immunofluorescent analysis of nuclear import stimulated by 10-6M, 10-9M or 10-10M DEX was 
performed as described in materials and methods on COS-1 cells expressing low or medium 
concentrations of GRwt. Statistical analysis was carried out on t½ to maximal nuclear localization using 
ANOVA followed by Newman-Keuls post test. Conditions with different letters are statistically different 
from one another (P<0.01). Results represent 50 cells counted per condition and time point from three 
independent experiments (±SEM). 
 
The fact that CpdA stimulation resulted in uniform nuclear distribution through both the GFP-GRwt and 
GFP-GRdim supports an influence of cooperative ligand binding on this parameter (Fig.5.5). However, 
GFP-GRwt concentration has no influence on nuclear distribution and DEX stimulated high GFP-
GRdim concentration behaves similarly to the high GFP-GRwt concentration (Fig.5.5). These results 
thus rather suggest an influence of GR dimerization on nuclear distribution.  
 
The fact that the live cell nuclear export rate of high GFP-GRdim concentration is significantly faster 
than high GFP-GRwt concentration supports an influence of cooperative ligand binding on this 
parameter. However, the same behaviour is also observed at the medium GFP-GR concentrations 
(Fig.5.8). Also arguing against the influence of cooperative ligand binding on nuclear export following 
the washout of subsaturating DEX concentrations is the fact that GFP-GRwt concentration does not 
significantly affect the nuclear export rate (Fig.5.8). The immunofluorescent analysis of nuclear export 
following the washout of saturating concentrations of ligand, revealed behaviour suggestive of an 
influence of cooperative ligand binding.  
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The nuclear export rate was significantly slower at the medium GRwt concentration than at the low 
GRwt concentration, while GRdim, at both low and medium concentrations,   behaves like the low 
GRwt concentration. Furthermore, stimulation with CpdA results in a uniform rate of nuclear export 
(Fig.5.10). Taken together the results suggest that dimerization enhances nuclear retention following 
the washout of subsaturating DEX concentrations, while cooperative ligand binding may result in 
enhanced nuclear retention following the washout of saturating DEX concentrations. 
 
Having established the influence of GR concentration, dimerization and positive cooperative ligand 
binding on GR translocation and nuclear distribution we next focused our study on the effects these 
parameters may have on the ability of the GR to transactivate and transrepress genes and specifically, 
the consequence of positive cooperative ligand binding on GR’s role as a transcription factor.  
 
5.5 Bibliography 
1. DeFranco DB (2002) Navigating steroid hormone receptors through the nuclear compartment. Mol 
Endocrinol 16: 1449-1455.  
2. Shahin V (2006) Route of glucocorticoid-induced macromolecules across the nuclear envelope as 
viewed by atomic force microscopy. Pflugers Arch 453: 1-9.  
3. Vicent GP, Pecci A, Ghini A, Piwien-Pilipuk G & Galigniana MD (2002) Differences in nuclear 
retention characteristics of agonist-activated glucocorticoid receptor may determine specific 
responses. Exp Cell Res 276: 142-154.  
4. Hayashi R, Wada H, Ito K & Adcock IM (2004) Effects of glucocorticoids on gene transcription. Eur 
J Pharmacol 500: 51-62.  
5. Nishi M, Ogawa H, Ito T, Matsuda KI & Kawata M (2001) Dynamic changes in subcellular 
localization of mineralocorticoid receptor in living cells: In comparison with glucocorticoid receptor 
using dual-color labeling with green fluorescent protein spectral variants. Mol Endocrinol 15: 1077-
1092.  
6. Htun H, Barsony J, Renyi I, Gould DL & Hager GL (1996) Visualization of glucocorticoid receptor 
translocation and intranuclear organization in living cells with a green fluorescent protein chimera. 
Proc Natl Acad Sci U S A 93: 4845-4850.  
7. Hache RJ, Tse R, Reich T, Savory JG & Lefebvre YA (1999) Nucleocytoplasmic trafficking of 
steroid-free glucocorticoid receptor. J Biol Chem 274: 1432-1439.  
8. Schaaf MJ, Lewis-Tuffin LJ & Cidlowski JA (2005) Ligand-selective targeting of the glucocorticoid 
receptor to nuclear subdomains is associated with decreased receptor mobility. Mol Endocrinol 19: 
1501-1515.  
9. Schaaf MJ & Cidlowski JA (2003) Molecular determinants of glucocorticoid receptor mobility in living 
cells: The importance of ligand affinity. Mol Cell Biol 23: 1922-1934.  
Stellenbosch University  https://scholar.sun.ac.za
 128
10. Tago K, Tsukahara F, Naruse M, Yoshioka T & Takano K (2004) Regulation of nuclear retention of 
glucocorticoid receptor by nuclear Hsp90. Mol Cell Endocrinol 213: 131-138.  
11. Liu J & DeFranco DB (2000) Protracted nuclear export of glucocorticoid receptor limits its turnover 
and does not require the exportin 1/CRM1-directed nuclear export pathway. Mol Endocrinol 14: 40-51.  
12. Galigniana MD, et al (1998) Heat shock protein 90-dependent (geldanamycin-inhibited) movement 
of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton. Mol 
Endocrinol 12: 1903-1913.  
13. Banerjee A, et al (2008) Control of glucocorticoid and progesterone receptor subcellular 
localization by the ligand-binding domain is mediated by distinct interactions with tetratricopeptide 
repeat proteins. Biochemistry 47: 10471-10480.  
14. Tanaka M, Nishi M, Morimoto M, Sugimoto T & Kawata M (2003) Yellow fluorescent protein-
tagged and cyan fluorescent protein-tagged imaging analysis of glucocorticoid receptor and importins 
in single living cells. Endocrinology 144: 4070-4079.  
15. Harrell JM, et al (2004) Evidence for glucocorticoid receptor transport on microtubules by dynein. J 
Biol Chem 279: 54647-54654.  
16. Davies TH, Ning YM & Sanchez ER (2002) A new first step in activation of steroid receptors: 
Hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem 277: 4597-4600.  
17. Pemberton LF & Paschal BM (2005) Mechanisms of receptor-mediated nuclear import and nuclear 
export. Traffic 6: 187-198.  
18. Yoshikawa N, et al (2002) Distinct interaction of cortivazol with the ligand binding domain confers 
glucocorticoid receptor specificity: Cortivazol is a specific ligand for the glucocorticoid receptor. J Biol 
Chem 277: 5529-5540.  
19. Ronacher K, et al (2009) Ligand-selective transactivation and transrepression via the 
glucocorticoid receptor: Role of cofactor interaction. Mol Cell Endocrinol 299: 219-231.  
20. Usuku T, et al (2005) Visualization of glucocorticoid receptor in the brain of green fluorescent 
protein-glucocorticoid receptor knockin mice. Neuroscience 135: 1119-1128.  
21. Robertson S, et al (2010) Abrogation of glucocorticoid receptor dimerization correlates with 
dissociated glucocorticoid behavior of compound a. J Biol Chem 285: 8061-8075.  
22. Elbi C, et al (2004) Molecular chaperones function as steroid receptor nuclear mobility factors. 
Proc Natl Acad Sci U S A 101: 2876-2881.  
23. Marcelli M, et al (2006) Quantifying effects of ligands on androgen receptor nuclear translocation, 
intranuclear dynamics, and solubility. J Cell Biochem 98: 770-788.  
24. van Royen ME, et al (2007) Compartmentalization of androgen receptor protein-protein 
interactions in living cells. J Cell Biol 177: 63-72.  
25. Wrange O, Eriksson P & Perlmann T (1989) The purified activated glucocorticoid receptor is a 
homodimer. J Biol Chem 264: 5253-5259.  
Stellenbosch University  https://scholar.sun.ac.za
 129
26. Stavreva DA, Muller WG, Hager GL, Smith CL & McNally JG (2004) Rapid glucocorticoid receptor 
exchange at a promoter is coupled to transcription and regulated by chaperones and proteasomes. 
Mol Cell Biol 24: 2682-2697.  
27. Meijsing SH, Elbi C, Luecke HF, Hager GL & Yamamoto KR (2007) The ligand binding domain 
controls glucocorticoid receptor dynamics independent of ligand release. Mol Cell Biol 27: 2442-2451.  
28. Voss TC, John S & Hager GL (2006) Single-cell analysis of glucocorticoid receptor action reveals 
that stochastic post-chromatin association mechanisms regulate ligand-specific transcription. Mol 
Endocrinol 20: 2641-2655.  
29. De Bosscher K, et al (2005) A fully dissociated compound of plant origin for inflammatory gene 
repression. Proc Natl Acad Sci U S A 102: 15827-15832.  
30. Dahlman-Wright K, Siltala-Roos H, Carlstedt-Duke J & Gustafsson JA (1990) Protein-protein 
interactions facilitate DNA binding by the glucocorticoid receptor DNA-binding domain. J Biol Chem 
265: 14030-14035.  
31. Drouin J, et al (1992) Homodimer formation is rate-limiting for high affinity DNA binding by 
glucocorticoid receptor. Mol Endocrinol 6: 1299-1309.  
32. Tanner TM, et al (2010) A 629RKLKK633 motif in the hinge region controls the androgen receptor 
at multiple levels. Cell Mol Life Sci 67: 1919-1927.  
33. Adams M, Meijer OC, Wang J, Bhargava A & Pearce D (2003) Homodimerization of the 
glucocorticoid receptor is not essential for response element binding: Activation of the 
phenylethanolamine N-methyltransferase gene by dimerization-defective mutants. Mol Endocrinol 17: 
2583-2592.  
34. Yang J, Liu J & DeFranco DB (1997) Subnuclear trafficking of glucocorticoid receptors in vitro: 
Chromatin recycling and nuclear export. J Cell Biol 137: 523-538.  
35. Carrigan A, et al (2007) An active nuclear retention signal in the glucocorticoid receptor functions 
as a strong inducer of transcriptional activation. J Biol Chem 282: 10963-10971.  
36. Reik A, Schutz G & Stewart AF (1991) Glucocorticoids are required for establishment and 
maintenance of an alteration in chromatin structure: Induction leads to a reversible disruption of 
nucleosomes over an enhancer. EMBO J 10: 2569-2576.  
37. Avenant C, Ronacher K, Stubsrud E, Louw A & Hapgood JP (2010) Role of ligand-dependent GR 
phosphorylation and half-life in determination of ligand-specific transcriptional activity. Mol Cell 
Endocrinol 327: 72-88.  
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 130
 
 
 
 
 
_________________________________________________ 
 
 
Chapter 6 
 
 
Results: Transactivation and transrepression of genes is 
influenced by positive cooperative ligand 
binding to the GR 
 
 
_________________________________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 131
Introduction 
 
The human GRα is a potent ligand dependent transcription factor, which has been shown to directly 
influence the expression of 2978 out of 41079 genes monitored in human osteosarcoma U2OS bone 
cells after 6 hours of induction with 10-7M DEX (1). Of these genes 1522 were repressed while 1456 
were induced by DEX stimulated GRα. Chromatin immunoprecipitation-microarray work in A549 
human lung cells following 1 hour stimulation with 10-7M DEX demonstrated that of the 548 known or 
potentially GC responsive genes studied, 68 percent were regulated through direct GR binding to 
GRE, which suggests that 32 percent of GR responsive promoters in this system function through 
tethering of the GR to other transcription factors (2) and not through direct interaction of the GR with 
DNA. Thus the activated GR influences gene transcription in two distinct ways (3),(4),(5). Through 
direct binding to GREs and nGRE, which up or down regulate transcription, respectively, or via 
tethering to DNA bound transcription factors such as NFĸB, AP-1 or signal transduction and activation 
of transcription-5 (STAT5) (4). 
 
Direct binding of the GR to DNA occurs predominantly through the GRE, which consists of two 
palindromic 6bp half-sites that are separated by a 3bp spacer (5’-GGTACAnnnTGTTCT-3’) (6). While 
most GREs contain this sequence, whether conserved or degenerate, their orientation, distance from 
transcription start site (TSS) and number vary greatly from gene to gene. This is of great importance 
as GRE occupancy is a primary determinant of GC responsiveness (2) and is known to vary from 
gene to gene (7). It has been shown that each GRE half-site binds one subunit of the GR homodimer 
(8). Drouin et al. (9) demonstrated that the affinity of GR homodimers for the GRE are 5-fold higher 
than that of GR monomers (Kd = 0.2nM for dimers versus 1nM for monomers) and that GR dimers 
bind to DNA more stably in vitro than GR monomers (9). Furthermore, they demonstrated that GR 
dimerization was a rate limiting step in high affinity GRE binding by the GR and that dimerization of the 
GR occurred before association with the GRE. Results from Segard-Maurel et al. (10) that indicate an 
increased affinity of the GRE for GR dimer relative to monomer as well as greater stability of the GRE 
dimer binding support these findings and suggest that GR dimerization precedes GRE binding.  
 
The question of whether GR binds to GREs as a preformed dimer or dimerizes following binding of 
two GR monomers to each of the two half-sites within the GRE is controversial. Our Co-IP (Fig.4.2B) 
and FRET results (Fig.4.6, Fig.4.7) indicate ligand independent dimerization of the GR, which is 
independent of DNA binding, while the work of Savory et al. (11) demonstrate ligand dependent 
dimerization of the GR in the cytoplasm. A recent article by Ong et al. (12) has questioned the 
influence of dimerization prior to DNA binding in first-order Hill dose-response curves (FHDC). 
Furthermore, they claim that the majority of GR association with DNA is through monomeric GR, the 
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evidence is based on theoretical considerations as well as transactivation assays which demonstrate 
FHDC for both the GRwt and a range of dimerization defective GR mutants. Although the dimerization 
mutants display weaker efficacy than the GRwt their capacity to induce transactivation reflects the fact 
that GR monomer binding to DNA is possible and results in activation of the GRE driven promoter 
reporter. In support of their theory they site binding of one retinoid X receptor (RXR) to its DNA half-
site which induces a conformational change in the dimer interface of this receptor which facilitates 
binding of the second RXR at the neighbouring half-site (13). However, the same conformational 
change has not been shown for the complete GR and has only been demonstrated in studies 
performed on the DBD of the GR (14). A further argument they offer is a study which sites ligand 
dependent as well as ligand independent binding of the ER monomer to the estrogen response 
element (ERE) (15), which is also controversial in light of evidence which indicates ligand dependent 
as well as independent homodimerization of the ER-LBD, which shows a Kd of less than 0.1nM 
independent of ERE binding (16). Ong et al. (12), however, concede that dose-response curves which 
do not demonstrate FHDC behaviour may arise due to binding of the preformed GR dimer, a theory 
we will examine in Section 6.3.1. 
 
McNally et al. (17) were the first to demonstrate the dynamic behaviour of GR binding to GREs. In 
cells expressing GFP-GR as well as an array of 200 copies of the mouse mammary tumour virus 
(MMTV) promoter, recruitment and occupancy of the GFP-GR could be visualized directly in live cells. 
Incredibly the receptor bound the GRE for only 10 to 20 seconds at a time before dissociating, which 
gave rise to the ‘hit and run’ theory of transcription where the initial transient binding of the GR is 
sufficient to recruit a secondary set of transcription factors that form a stable complex, which initiates 
transcription (18, 19). This ‘hit and run’ behaviour leaves the GR free to form further associations with 
the promoter that can initiate the next wave of transcription.  
 
In contrast to dimer mediated transactivation via GREs there is mounting evidence that the GR’s 
ability to repress inflammatory and immune genes is primarily through tethering of the GR monomer to 
proinflammatory transcription factors such as NFĸB and AP-1 (20-22). Research conducted in mice 
expressing only the D-loop dimerization mutant, GRdim, indicate that, despite drastically impaired 
transactivation via the GRdim, these mice are still viable due to the capacity of the GRdim to 
transrepress pro-inflammatory genes (23). The GRdim has been shown to be capable of repressing 
NFĸB driven transcription both in vivo as well as in vitro (24). Although initial studies questioned the 
ability of the GRdim to induce transactivation of genes (23), recent studies have demonstrated that the 
GRdim transactivates more strongly than the GRwt through multiple (two or more) GRE’s (25). The 
capacity of both GRwt and GRdim to transactivate depends on the promoter in question, where as 
most promoters favour transactivation through the GRwt, there are a few that favour the GRdim (7).   
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The dissociative GC, CpdA, is capable of transrepression via NFĸB and AP-1 (26),(27) but does not 
induce transactivation (28),(29). This dissociative behaviour has been linked to CpdA’s ability to 
abrogate dimerization of the GR (Addendum B) (30, 31). There is clearly a link between dimerization 
of the GR and transactivation.  
 
Having shown that increasing GR concentration results in ligand independent dimerization of the GR 
(Chapter 4) and positive cooperative ligand binding to the GR (Chapter 3), we were interested in 
exploring the effects of GR concentration on both transactivation and transrepression. In order to test 
the influence of positive cooperative ligand binding on the transcriptional capacity of the GR we 
selected three promoter reporters representing either repression of an NFĸB driven gene (32) or 
activation of a composite GR promoter containing either one or two GRE’s from the tyrosine amino 
transferase gene (TAT) (33). As GR’s ligand dependent ability to transrepress NFĸB is a primary 
function of its anti-inflammatory nature and the fact that GRE’s are known to elicit a robust 
transactivation response, these where natural choices for our promoter reporter assays. Furthermore, 
we also studied the level of GR induced mRNA production of the endogenous GILZ gene in COS-1 
cells. The GILZ protein is a potent anti-inflammatory transcription factor (34) whose promoter is known 
to contain multiple GRE’s (35), which has been shown to be under the direct control of activated GR 
(36),(37). As the promoter reporter assays are a relatively artificial transactivation system we have 
included the endogenous GR responsive GILZ gene in order to replicate a more physiologically 
relevant test of transactivation within the context of genomic DNA and complete promoter structure. 
Although the GILZ gene has not been characterized in monkey cells, such as COS-1 (green monkey), 
Avenant et al. (36) have demonstrated GC dependent up regulation of GILZ mRNA in COS-1 cells 
using commercially available primers for the human GILZ gene. A similar strategy has been employed 
in this study in order to allow for direct comparison with the rest of the assays performed in the same 
cell line. 
 
There are three parameters through which ligand induced transcription may be quantified namely, the 
maximal level of agonist induced gene activation or repression (efficacy), the concentration of agonist 
required to illicit half of the maximal response (potency), and the amount of agonist activity elicited by 
partial agonists when compared to the response of a potent agonist (biocharacter) (38). Increasing GR 
concentration has been shown to increase the efficacy and potency of DEX as well as to shift the 
biocharacter of the weak GR agonists, RU486 and MPA, towards full agonist behaviour in 
transrepression promoter reporter assays (39-41). Similarly, increasing GR concentrations in 
transactivation promoter reporter assays has resulted in an increase in DEX induced efficacy and 
potency and a shift from weak agonist to full agonist behaviour of dexamethasone 21-mesylate (Dex-
Mes), RU486 and Prog (41-44). To our knowledge, however, no studies have explicitly investigated 
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the connection between GR concentration, cooperative ligand binding and the three parameters of 
ligand induced transcription.  Thus we aim to test whether the differences in GR concentration shown 
to shift ligand binding from non-cooperative to positive cooperative will also result in a shift in efficacy, 
potency and biocharacter in transactivation. 
 
Results 
 
6.1 Establishing promoter reporter assay conditions 
 
In the majority of reporter promoter assays involving transient transfections plasmids which 
constitutively express β-galactosidase or renilla luciferase are transfected along with the reporter 
promoter constructs. This is done in order to normalize for differences in transfection efficiency and 
non-specific squelching between individual conditions within experiments and between experiments 
themselves.  The most popular of these transfection normalization constructs are the commercially 
available pSV-β-gal (Promega) (40, 45, 46) and pCMV-β-gal (Invitrogen) (41, 47-49). Optimization 
assays using either of these constructs revealed a significant ligand independent decrease in β-
galactosidase expression as the level of transfected GR increased (results no shown).  Due to this fact 
normalization by the different β-galactosidase levels would result in skewed results and we thus 
decided to forgo this form of transfection control. Instead we transfected large populations of cells, 
pooled them and replated them for each reporter promoter assay and then normalized by protein 
concentration to correct for differences in plating (we have done so for all experimental techniques). 
This ensures uniform transfection efficiency within experiments. We have confirmed that changes in 
GR concentration do not result in non-specific squelching of transcription through induction of the 
NFĸB driven promoter reporter (Fig.6.3A,B) and monitoring of the expression of the endogenous 
GAPDH gene (Fig.6.17) are low, medium and high GR concentrations. 
 
In order to monitor GR levels between experiments we ran lysates from each transfection condition of 
each promoter reporter assay on Western blots. Experiments that displayed aberrant tranfection rates 
of GR (GR levels which fell outside of their respective population concentration) were excluded 
(Fig.6.1A,C). Pixels from digitized Western blots was used to compare the expression levels of 
transiently transfected GR to levels determined in saturation binding assays (fmol GR per mg protein) 
and revealed a good correlation (R2 = 0.97) between the two methods of determining GR 
concentration (Fig.6.1B). Although saturation binding was not carried out on the 385ng GRdim 
transfection level we have used pixel intensity from Western blots and the GR correlation curve 
(Fig.6.1B) to derive its concentration in fmol GR per mg protein (Fig.6.1C). We estimate the GR 
concentration at this transfection condition to be 65.5 fmol GR per mg protein, which shows no 
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statistical difference to the low concentration of GRwt (67.0 fmol GR per mg protein). We have 
therefore compared these two populations directly and term them both low GR concentrations 
(Fig.6.1C). This method of quantifying GR concentration is in accordance with a comparative study by 
O’Donnell (50), which compares Western blots and radioactive ligand binding as means of GR 
quantification. Western blots have been run on the lysates from all promoter reporter assays as well 
as from the RT-PCR assay in order to monitor GR concentration levels between experiments. 
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Figure 6.1. The use of Western blots to monitor and determine GR levels. Cells were DEAE-
Dextran transfected with GRwt (38.5ng, 385ng or 11550ng) or GRdim (38.5ng, 385ng or 11550ng). 
Replated 24 hours later into 24 well plates (4 x 105 cells/plate) in stripped DMEM. (A) Representative 
Western blotting, carried out 24h after replating on all transfections. 20µg of protein was loaded and 
separated on a 10% SDS-PAGE gel. Following electrophoresis, proteins were electroblotted and 
transferred to Hybond-ECL nitrocellulose membrane (Amersham Biosciences), which were probed for 
GR with H-300 anti-GR (Santa Cruz Biotechnology) diluted 1:3000 in 5% (w/v) casein in TBST buffer  
followed by ECL peroxidase-labeled anti-rabbit anti-body (AEC-Amersham Biosciences) diluted 
1:10000 in 5% (w/v) casein in TBST buffer. Blots were visualized with ECL Western blotting detection 
reagents (GE Healthcare) on Hyperfilm (Amersham Biosciences). Densitometric analysis of the 
immunoblots was carried out using UN-SCAN-IT gel 6.1 software (Silk Scientific). (B) Correlation 
between GR concentrations in fmol GR per mg protein derived from saturation binding carried out 48h 
after transfection on the 38,5ng, 385ng and 11550ng GRwt as well as 38.5ng and 11550ng GRdim 
transient transfections and their respective densitometric values from Westerns. Using this curve the 
GR concentration of the 385ng GRdim population was estimated to be 65.5fmol GR/mg protein. (C) 
Comparison between transfected GR plasmid and GR concentration (right axis) or pixels (left axis). 
The derived 385ng GRdim concentration is indicated with a circle. Statistical analysis was through one 
tailed unpaired t tests. All results represent a minimum of two independent experiments performed in 
triplicate (±SEM). 
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6.2 Transrepression of a NFĸB containing promoter construct is influenced by cooperative 
ligand binding to the GR 
 
To investigate the effects of GR concentration and cooperative ligand binding on transrepression we 
chose a reporter promoter which contains three copies of the NFĸB transcription factor binding site 
from the IL-6 cytokine gene promoter. The promoter of this potent pro-inflammatory cytokine contains 
the binding sequence for NFĸB (5’-GGGATTTTCC-3’) and is activated by direct binding of the NFĸB 
protein (32). A constant concentration of the p(IL6ĸβ)350h.IL6P-luc promoter reporter was transfected 
along with either the GRdim or GRwt expressing plasmid at levels that produce either low or medium 
GR concentrations. The low GR concentration reflects the level of GRwt at which ligand binding is 
non-cooperative, while the medium GRwt concentration is the receptor level at which the GRwt starts 
to display positive cooperative ligand binding (Fig3.8B). Ligand binding to the GRdim remains non-
cooperative at both GR concentrations. We have stimulated the activation of NFĸB with phorbol 12-
myristate 13-acetate (PMA), which leads to the downstream release of the inhibitory protein ĸB (IĸB) 
from NFĸB (51), which then binds to the p(IL6ĸβ)350h.IL6P-luc promoter leading to the transcription of 
luciferase protein (Fig.6.2A).  
 
The ability of activated GR to repress NFĸB transcription has been shown to be dependent on a direct 
interaction between the two transcription factors and is independent of GR binding to DNA (3, 5). The 
repression of NFĸB driven interleukin-8 (IL-8) expression by the GR was shown to be ligand 
dependent due to differential recruitment of co-factors to the GR following ligand binding. This in turn 
influences the ability of GR to bind to the p65 subunit of NFĸB, the primary mechanism through which 
GR represses NFĸB (45, 52). Induction of GR with either DEX or CpdA results in interaction between 
the activated GR and the p65 subunit of NFĸB resulting in repression of luciferase transcription 
(Fig.6.2B). Reichardt et al. (23, 24) have demonstrated that transrepression of an NFĸB responsive 
gene occurs equally well through the GRwt as through the GRdim, suggesting that binding to the p65 
subunit is possible by both the GR monomer as well as the GR dimer. 
 
Stimulation with PMA results in maximal luciferase transcription that is not significantly different at any 
receptor concentration of either the GRwt or GRdim constructs (Fig.6.3A,B). These results are similar 
to results seen by Zhao et al. (40). In other words there is no ligand independent influence of GR 
concentration on the level of NFĸB driven transcription at levels of GR, which have been shown to 
result in non-cooperative as well as positive cooperative ligand binding (Chapter 3).  
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Figure 6.2. Repression by the activated GR of the transcription of an NFĸB driven promoter 
reporter. (A) PMA stimulation results in the down stream phosphorylation of inhibitory protein-ĸB (IĸB) 
and its subsequent degradation. This frees the NFĸB heterodimer which consists of p50 and p65 
proteins. NFĸB then migrates to the nucleus where it binds to the three NFĸB binding elements of the 
p(IL6ĸβ)350hu.IL6P-luc promoter reporter stimulating the transcription of luciferase. (B) Activation of 
the GR by either DEX or CpdA results in its migration into the nucleus where it binds directly to the 
p65 subunit of NFĸB, repressing expression. 
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Figure 6.3. PMA induction is unaffected by variation in receptor concentration. Cells expressing 
low, medium or high concentrations of GRwt or low or medium concentrations of GRdim and the 
promoter reporter p(IL6ĸβ)350hu.IL6P-luc were induced with PMA or EtOH as described for 
transrepression in materials and methods. (A) Induction and (B) maximal fold induction representing 
maximal induction by PMA normalized to EtOH induction for each transfection condition was plotted. 
Statistical analysis was carried out using ANOVA followed by Newman-Keuls post test within the EtOH 
and PMA stimulated as well as maximal fold induction populations. Results represent four 
independent experiments performed in triplicate (±SEM).  
 
We have chosen to compare the ability of the potent GR agonist, DEX, and the dissociative GC, 
CpdA, in our transrepression assay as DEX stimulation has been shown to result in GR dimerization 
while CpdA impairs it (Chapter 4). This strategy, together with the use of varying GR concentrations of 
GRwt and GRdim, should allow for elucidation of the role of GR dimerization and cooperative ligand 
binding in transrepression. The maximal induction achieved through PMA stimulation alone (Fig.6.3) is 
repressed by GR activated by either DEX or CpdA (Fig.6.2B, Fig.6.4A). In order to better interpret our 
data we firstly converted the relative light units (RLU) of luciferase normalized to protein concentration 
(Fig.6.4A) to percentage induction, where we set the top plateau (PMA and EtOH induction) as 100 
percent induction (Fig.6.4B). Finally, we subtracted the percentage induction values from 100 percent 
to generate percentage repression data (Fig.6.4C), which we fit to sigmoidal dose-response curves in 
order to generate maximal percentage repression (efficacy) and the log EC50 (potency) of 
transrepression. 
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Figure 6.4. Percentage repression is derived from induction results. The transrepression 
promoter reporter assay using p(IL6ĸβ)350hu.IL6P-luc was carried out as described in materials and 
methods in COS-1 cells expressing the medium concentration of GRwt. (A) Luciferase activity was 
determined and normalized against protein concentrations. (B) RLU/mg protein values are expressed 
as a percentage of the maximal response (PMA and EtOH = 100%) and finally subtracted from 100% 
producing percentage repression (C). Sigmoidal dose-response curves were fit to the percentage 
repression data to generate potency (log EC50) and maximal repression results. Results represent four 
independent experiments performed in triplicate (±SEM).  
 
6.2.1 Potency of transrepression 
 
The potency (log EC50) of repression through DEX induced GRwt was significantly reduced by an 
increase in GR concentration (Fig.6.5A). A trend is visible, where increasing GRwt concentrations 
result in decreasing levels of potency culminating in a significant difference between the EC50 at the 
low GRwt concentration (1nM) and the high GRwt concentration (5nM). The potency of DEX induced 
transrepression through GRdim is not significantly different between the low and medium 
concentrations (Fig.6.5A). The medium concentration of GRdim displays statistically greater potency 
as reflected by an EC50 of 0.40nM compared with an EC50 of 2.0nM at the medium concentration of 
GRwt. The fact that GRdim displays a similar transrepression potency as compared to GRwt at the 
low GR concentration, where both receptors show non-cooperative ligand binding, while at medium 
GR concentrations, where GRwt shows cooperative ligand binding, we see a significant difference in 
potency suggests that cooperative ligand binding influences the potency of transrepression. We thus 
demonstrate that a shift to cooperative ligand binding may result in a decrease in the potency of 
transrepression. We hypothesize that the high affinity GR dimer, which predominates at the medium 
and high GRwt concentrations, binds ligand preferentially resulting in fewer activated GR monomers at 
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subsaturating ligand concentrations. The greater potency reflected by the GRdim suggests that 
repression of NFĸB favours the activated GR monomer, which would explain why cooperative ligand 
binding results in a decrease in transrepression potency.  The potency of CpdA induced 
transrepression within each concentration of GR and between the two constructs is statistically not 
significantly different (Fig.6.5A). This is most likely due to the fact that CpdA is known to abrogate GR 
dimerization (Chapter 4) creating an essentially monomeric population of activated GR through either 
the GRdim or the GRwt. 
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Figure 6.5. DEX displays reduced potency of transrepression through the GRwt and greater 
efficacy (maximal repression) as GR levels increase, while CpdA’s ability to repress 
transcription decreases as GR levels increase. Cells were transiently transfected with low, medium 
or high GRwt or low or medium GRdim and 12000ng p(IL6ĸβ)350hIL6β-luc and transrepression was 
carried out as described in materials and methods. Statistical analysis of (A) log EC50 and (B) 
percentage repression was through two tailed unpaired t tests of GRwt against GRdim (*P<0.05), low 
GRwt against medium GRwt or high GRwt concentration (†P<0.05, ††P<0.01, †††P<0.001) and low 
GRdim against medium GRdim concentration (§P<0.05). (C) Percentage repression by CpdA 
representing maximal repression relative to that of DEX repression (set to 100 percent and indicated 
with a dotted line) within the same GR concentration and type. Statistical analysis for GRwt was with 
ANOVA followed by Dunnett's post test against the low GRwt concentration (*P<0.05, ***P<0.001) 
while a two tailed unpaired t test of low GRdim against medium GRdim was carried out (*P<0.05). 
Results represent four independent experiments performed in triplicate (±SEM).  
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Contrary to our results, it has been reported that increasing the levels of GRwt transfected into COS-7 
cells has led to an increase in potency, reflected in a decrease in the EC50 of DEX induced NFĸB 
repression from 2.2nM at low GR concentrations to 0.1nM at high GR concentrations (40). However, it 
was not made clear whether this was a statistically significant observation. While our EC50 values for 
DEX fall within a similar range namely, 1nM at the low GRwt concentration and 5nM at the high GRwt 
concentration, we do not see the same 22-fold increase in potency as GR concentrations increase. 
Instead we demonstrate a 5-fold decrease in potency as GRwt concentration increases from a level at 
which non-cooperative ligand binding occurs to a level where positive cooperative ligand binding 
occurs. We can also not be sure whether the results of Zhoa et al. (40) reflect similar GR 
concentrations to those tested by us and if ligand independent dimerization of the GR occurred at their 
increased GR concentration. It may be that their levels of GR are not sufficiently high enough to result 
in positive cooperative ligand binding to ligand independent GR dimers and that the increase in GR 
concentration in their system simply results in a greater population of GR monomers and therefore a 
larger pool of activated GR once DEX stimulation has occurred. In addition, the promoter reporter 
construct they used differs from ours in terms of the copies of the NFĸB-site (Zhoa et al. 5 copies 
versus our construct with 3 copies). It is possible that promoter architecture modulates responses to 
GR concentration. 
 
6.2.2 Efficacy of transrepression 
 
We saw no significant difference between GRwt and GRdim at the same concentrations of receptor 
when comparing the efficacy for transrepression elicited by DEX or CpdA (Fig.6.5B). Positive 
cooperative ligand binding occurs at the medium concentration of GRwt, but not at the medium 
concentration of GRdim. Thus the fact that these two conditions elicit the the same efficacy implies 
that positive cooperative ligand binding has no influence on the efficacy of transrepression at the 
saturating concentrations of ligand required to elicit maximal repression. There is, however, a 
significant increase in maximal repression via DEX as GR concentrations increase, which reflects the 
basic premise that an increase in transcription factor concentration will result in an increase in 
response (Fig.6.5B) and has been shown in previous studies with the GRwt (39, 40). The high GRwt 
concentration shows a significantly elevated efficacy despite displaying the weakest potency of the 
DEX induced population (Fig.6.5B). This may seem counter intuitive, however, it is important to note 
that the concentration of ligand required to elicit maximal efficacy (1µM) (Fig.6.4) is 200-fold higher 
than the potency (5nM) at the high GRwt concentration. Where as a subsaturating concentration of 
ligand will bind almost exclusively to the dimerized GRwt due to its high affinity, at the saturating 
ligand concentration there will be sufficient ligand available to activate GR monomers as well.  
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The similar levels of DEX efficacy demonstrated by the two GR constructs at the low and medium GR 
concentration (Fig.6.5B) do suggest that repression can occur through the GR dimer. This is 
supported by previous work by Reichardt et al. (23, 24) in mouse tissue expressing GRdim, where 
dimerization impaired GR was shown to be as capable of repressing transcription as the wild type 
receptor. In addition, a GRdim was shown to repress an AP-1 driven promoter reporter with the same 
efficacy as the GRwt (21) following DEX stimulation. 
 
6.2.3 Biocharacter shift of CpdA 
 
Having explored the capacity of DEX to induce transrepression we moved onto the efficacy of CpdA 
induced transrepression of our promoter reporter. Previous studies have shown mixed results for 
CpdA repression. De Bosscher et al. (26) demonstrated dose dependent CpdA repression on the 
same promoter reporter construct as the one we used, while Yemelyanov et al. (28) also displayed 
CpdA induced repression of a promoter reporter containing 3 NFĸB elements. Contrary to these 
findings Avenant et al. (47) demonstrated no transrepression by CpdA of a promoter reporter 
containing 5 NFĸB elements.  
 
Our own findings demonstrate that, contrary to the behaviour of DEX, CpdA displays a significant 
decrease in efficacy as GR concentration increases (Fig.6.5B). When expressed relative to DEX 
repression at each GR type and concentration, where DEX efficacy is set at 100 percent, CpdA 
efficacy falls from 86 percent of that of DEX at the low GRwt level to only 17 percent of that of DEX at 
the high GRwt concentration. GRdim displays a similar trend (Fig.6.5C). Unlike previous work on 
RU486 and MPA, which displayed a biocharacter shift from weak or partial agonist to full agonist 
behaviour relative to DEX as GR concentration increased in a PMA induced NFĸB promoter reporter 
assay (40), our results indicate that CpdA demonstrates a shift from full agonist to weak agonist 
behaviour as receptor levels increase (Fig.6.5C).  
 
Although CpdA has been shown to abrogate ligand independent dimerization of the GR (30, 31), its 
capacity to bind to the medium and high concentrations of GRwt, which display positive cooperative 
ligand binding, is drawn into question by competitive binding assays in the current study (Fig.6.6). We 
demonstrated that the ability of CpdA to displace [3H]-DEX decreased as GR concentration increased, 
dropping from a high of 97 percent displacement at the low GR concentration (Fig.6.6A) to 15 percent 
displacement at the high GR concentration (Fig.6.6C). Previous results demonstrated a similar trend in 
cell lines expressing disparate levels of GR. For example, in the L929sA cell line, which expresses GR 
at a low level, De Bosscher et al. (26) demonstrate 81 percent [3H]-DEX displacement, while results 
shown in Addendum B (30, 31) using BWTG3 cells that have high GR expression levels, show only a 
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47 percent displacement of [3H]-DEX. Clearly GR concentration influences the ability of CpdA to bind 
to the GR and thus impairs its ability to cause repression at GR concentrations which display positive 
cooperative ligand binding (Fig.6.5C, Fig.3.8B). Furthermore, the competitive whole cell binding 
results in the L929sA cell line (26) demostrated an IC50 of CpdA which was 4-fold lower than that of 
DEX, indicating greater affinity than DEX for the GR in this cell line, while t in the BWTG3 cells (30, 
31) CpdA displayed a Kd which was 63-fold higher than for DEX. This shift from a higher affinity for 
CpdA than DEX at low GR concentrations in the L929sA cell line to a lower affinity than DEX in the 
BWTG3 cells with a higher GR concentration is not displayed by our results where CpdA maintains a 
greater affinity than DEX at all three GR concentrations. What is, however, tantilizing is the fact that 
the IC50 of CpdA rises from 13.6nM at the low GRwt concentration to 32.1nM at the medium GRwt 
concentration, peaking at 57.4nM at the high GRwt concentration (Fig.6.6), which indicates a 
decrease in CpdA’s binding affinity to the GR as GR concentrations increase.  
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Figure 6.6. As GR levels rise CpdA displaces less [3H]-DEX from the GRwt. Cells were transfected 
with (A) low GRwt, (B) medium GRwt or (C) high GRwt and competitive whole cell binding was carried 
out as described in materials and methods. Total binding was normalized to protein concentration and 
expressed as percentage displacement (bottom plateau for maximal labelled DEX displacement 
designated as 100% displacement and top plateau where no displacement took place as 0% 
displacement). Sigmoidal dose-response curves were fit to this data which generated maximal 
percentage displacement results. (D) Maximal percentage [3H]-DEX displacement by DEX or CpdA at 
low, medium and high GR concentrations. Statistical analysis was through two tailed unpaired t tests 
of DEX or CpA stimulated low [GR] against medium [GR] or high [GR] (§P<0.05, §§§P<0.001) and DEX 
against CpdA stimulation (**P<0.01, ***P<0.001). All results represent two independent experiments 
performed in triplicate (±SEM) 
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We suggest that ligand independent dimerization of the GR at high receptor concentrations leads to a 
conformational change in the ligand binding pockets of the dimerized GR, which increases the affinity 
of the GR for DEX (reflected by both a decreased DEX binding Kd and positive cooperative DEX 
binding (Fig.3.8B)), which would make it harder for the CpdA to displace DEX from the receptor at 
high GR concentrations. In addition, as CpdA has a vastly different and non-steroidal chemical 
structure from that of the steroidal potent synthetic agonist, DEX (Fig.1.1), it is quite possible that 
ligand independent dimerization of the GR, which has been shown to result in positive cooperative 
DEX binding, may result in a reduction in CpdA’s binding affinity. This is supported by the fact that the 
DEX independent effects of GR concentration on CpdA’s repression efficacy indicate that CpdA has a 
lowered capacity to interact with GR at concentrations, which display ligand independent dimerization 
(Fig.6.5C).  
 
However, the fact that we have shown CpdA’s ability to abrogate ligand independent dimerization at 
the medium and high GR concentrations to levels seen at the low GR concentration (Fig.4.3B) is a 
difficult point to resolve and one which requires greater attention. Future competitive binding studies of 
CpdA’s ability to displace [3H]-DEX at the low and medium concentration of GRdim may help us to 
unravel this conundrum.  The discovery that CpdA has a greatly reduced capacity to induce repression 
at high GR concentrations may explain why Avenant et al. (47), who performed their transrepression 
assays in transiently transfected COS-1 cells expressing a high GR level, saw no activity through 
CpdA. 
 
6.3 Transactivation of GRE containing promoter reporters is influenced by ligand independent 
dimerization as well as the dimerization status of the GR 
 
We chose to investigate the activation of a multiple GRE containing promoter reporter, namely pTAT-
GRE2-Elb-luc (Fig.6.7) as this form of promoter represents the majority of direct GR DNA interactions 
(53) and provides a robust transactivation response. The promoter of this construct consists of two 
copies of the GRE from the tyrosine amino transferase gene (TAT) as well as the TATA box from the 
E1b promoter, which serves as a generic docking site for secondary transcription factors (54, 55).  
 
Similarly to the transrepression assay we transfected a constant amount of promoter reporter plasmid 
while varying the levels of GRwt or GRdim plasmid in order to achieve GR concentrations that match 
those defined in our saturation binding assays (Fig.3.6B). The medium and high GRwt concentrations 
have been shown to display positive cooperative ligand binding (Fig.3.8B) as a result of ligand 
independent dimerization of the GR at these concentrations (Chapter 4). The low GRwt concentration 
and both low and medium GRdim concentrations display non-cooperative ligand binding (Fig.3.8B) 
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and greatly reduced ligand independent dimerization (Chapter 4). It is important to note that the low 
GRwt and low GRdim receptor levels as well as the medium GRwt and medium GRdim receptor 
concentrations have been demonstrated to be statistically the same through whole cell binding and 
through Western blotting, respectively (Fig.6.1). 
 
Representative dose response curves of transactivation illustrates the large differences in maximal 
response (efficacy) and log EC50 (potency) brought about by changes in GRwt and GRdim 
concentration (Fig.6.8). We will discuss these differences, as well as biocharacter shifts of a range of 
test compounds compared to the potent synthetic agonist DEX. 
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Figure 6.7. Activation by the GR of the multiple GRE driven pTAT-GRE2-Elb-luc promoter 
reporter. (A) Ligand binding to the GRwt results in association of the activated dimer to each of the 
two GRE’s stimulating the transcription of luciferase. (B) Ligand binding to the GRdim results in its 
association as a monomer to each of the two GRE half-sites within the two GREs stimulating the 
expression of luciferase. 
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Figure 6.8. GR levels and the ability to dimerize influence potency (log EC50) and efficacy 
(maximal induction) in transactivation assays. Representative dose response curves of 
transactivation, which represent a single experiment performed in triplicate (±SEM). Cells were DEAE 
Dextran transfected with (A) low, medium or high GRwt or (B) low or medium GRdim and 3000ng 
pTAT-GRE2-Elb-luc and the transactivation assay using DEX as test compound was carried out as 
described in materials and methods. Average potency (log EC50) for each condition from a minimum of 
three independent experiments performed in triplicate is indicated with the dotted lines 
 
6.3.1 Potency of transactivation 
 
The characteristic of transactivation we will analyse first is potency, namely the concentration of ligand 
required to elicit 50 percent of the maximal response. Results in the literature suggest an influence of 
GR concentration on potency. For example, Szapary et al. (44) demonstrated a shift for 1nM DEX 
induced promoter reporter activation from 41.6 percent to 77.7 percent of 1µM DEX activation as GR 
concentration increased. This implies greater sensitivity to ligand as the receptor level increases. In 
more thorough examinations by the Simons group where dose response curves were generated, a 
clear increase in DEX potency was demonstrated as a left shift in the dose response curves as GR 
concentration increased (43, 56). All of these studies where conducted with a promoter reporter which 
contained 2 GREs. Unfortunately, none have defined the actual GR concentration studied or specified 
EC50 values, nor have they made an explicit connection to cooperative ligand binding and ligand 
independent dimerization of the GR. 
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Representative dose response curves from our DEX induced promoter reporter assays demonstrate a 
clear left shift as GRwt concentration increases (Fig.6.8A). The same can not be said for GRdim, 
which displays basically the same log EC50 value at both low and medium GRdim concentrations 
(Fig.6.8B). When these potency values were statistically compared a clear trend emerges, namely 
significantly increased potency at GRwt concentrations which were shown to display positive 
cooperative ligand binding, namely the medium and high GRwt concentrations (Fig.6.9A). Despite 
having the same receptor concentration as the medium GRwt, the medium GRdim concentration has 
the same potency as the low levels of GRwt and GRdim. In addition, GRdim in contrast to GRwt, 
shows no significant change in potency as its concentration increases from low to medium levels 
(Fig.6.9A). These GR populations (low GRwt concentration, low GRdim concentration and medium 
GRdim concentration) have all been shown to display non-cooperative ligand binding (Fig.3.8B) in 
whole cell saturation binding. Thus, there is a direct correlation between increased potency in 
transactivation and positive cooperative ligand binding, both of which occur at the medium and high 
GRwt concentrations only. 
 
The potency values expressed in log EC50 units represent vastly different levels of sensitivity to DEX 
stimulation as the EC50 values of DEX induced GRwt drop from 2.5nM at the low, to 0.006nM at the 
medium and to 0.002nM at the high GRwt concentration. This equates to a 417 and 1250-fold 
increase in potency at the medium and high GRwt concentrations, respectively. The physiological 
relevance of this massive increase in potency at GR concentrations which display positive cooperative 
ligand binding is that in tissues with high enough GR concentrations genes with GRE containing 
promoters will be maximally activated by even low concentrations of GC. Even the lowest levels of 
endogenous or pharmacologically administered GC will be enough to induce maximal induction in 
tissues with high enough GR concentrations. To illustrate, exposure to 1 mg of DEX, a common 
pharmacological dosage, results in plasma DEX levels ranging from 1 to 10nmol per litre 24 hours 
later (57). Where as a concentration of 1nM DEX would result in roughly 10 percent of maximal 
induction in cells expressing low levels of GR, cells expressing GR levels above the medium GR 
concentration of 763 fmol GR per mg protein (Fig.3.6B) would display maximal levels of 
transactivation. When DEX levels drop further to 0.1nM, cells expressing low levels of GR would 
essentially not respond at all, while those expressing GR levels at which positive cooperative ligand 
binding occurs would still respond at their maximal level. Even at a concentration of 0.006nM DEX, 
167-fold lower than the 1nM shown at physiological concentrations, cells expressing the medium GR 
level would respond with 50 percent of their maximal efficacy, while tissue with GR levels displaying 
non-cooperative ligand binding would show no transactivation at all. Cells with GR concentrations high 
enough to result in positive cooperative ligand binding would therefore be hypersensitive to DEX and 
would exist in a state of maximal transactivative response once exposed to DEX were it not for ligand 
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induced down regulation of the GR. It is important to stress that the medium to high GRwt 
concentrations reflect a GR concentration range of 763 to 1420 fmol GR/mg protein or 298000 to 
555000 GR/cell. Although some tissues do express GR at these elevated levels, as demonstrated in 
Tables 1.1 and 1.2, the majority of healthy cells within the human body will retain the capacity to 
respond to changes in GC concentration due to their relatively low GR levels. 
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Figure 6.9. Potency (log EC50) increases due to positive cooperative ligand binding. 
Transactivation assays using low, medium or high GRwt and low or medium GRdim concentrations 
were performed as described in materials and methods. Sigmoidal dose-response curves where fit to 
the experimental data which generated log EC50 values for (A) DEX as well as for (B) F, MPA and 
RU486. Statistical analysis was through two tailed unpaired t test of low GRwt concentration against 
medium GRwt or high GRwt concentrations (†P<0.05, †††P<0.001), low GRdim concentration against 
medium GRdim concentration or GRwt against GRdim at the same GR concentration (*P<0.05, 
**P<0.01, ***P<0.001). All results represent a minimum of three independent experiments performed 
in triplicate (±SEM). 
 
The t½ of unstimulated GR following incubation with cycloheximide has been shown to be 44 hours, 
while the t½ of GR drops to 10 hours following stimulation with 10-5M DEX and cycloheximide (47). 
Thus down regulation of the GR would eventually result in GR levels low enough to no longer result in 
positive cooperative ligand binding, although this would probably take longer than the t½ quoted in a 
system that was not exposed to cycloheximide. A decrease in GR concentration would blunt the 
hypersensitivity of cells expressing GR concentrations, which result in positive cooperative ligand 
Stellenbosch University  https://scholar.sun.ac.za
 149
binding, however, our results clearly indicate that this blunting of response has not occurred following 
24 hours of DEX exposure. Furthermore, it has been demonstrated in binding assays conducted on 
human tissue biopsies that elevated GR levels are maintained despite exposure to physiologically 
basal GC levels (58, 59). 
 
Although their potency shifts are less extreme, we see the same trend emerging for F, MPA and 
RU486 as for DEX (Fig.6.9B). A significant increase in potency occurs at the medium GRwt 
concentration, which has been shown to display positive cooperative ligand binding (Fig.3.8B). The 
fold-increase in potency from low to medium GRwt concentrations for these ligands is 53, 3.2 and 2.5-
fold for F, MPA and RU486, respectively, which is less than that seen with DEX. The concentration of 
free F in the blood varies from ~18.7nM in the morning to ~3.3nM at night (60), which would mean that 
the increased EC50 value from 1.6nM at low GRwt concentrations to 0.03nM at medium GRwt 
concentrations for F would entail a shift from a varying circadian influence of endogenous F on cells 
expressing GR at the low concentration to a maximal response in cells expressing the medium GR 
concentration. The lower increase in EC50 seen with MPA and RU486 as a result of increased GR 
concentration suggests that positive cooperative ligand binding and the potency increase it elicits may 
be ligand specific. The potent synthetic agonist, DEX, and the potent endogenous agonist, F, respond 
more strongly (417-fold increase for DEX and 53-fold increase for F) to the increase in ligand 
independent dimerization at the medium GR level than the partial agonists, MPA and RU486 (3.2-fold 
increase for MPA and 2.5-fold increase for RU486). To clarify this issue it would be of great interest to 
test whether these test compounds also bind to the medium and high GR concentrations in a positive 
cooperative fashion. 
 
Transactivation assays performed using the same promoter reporter but at the medium and high GFP-
GR concentrations revealed similar results to those seen for the GRwt (Fig.6.10). Although the high 
GFP-GR concentration displays similar potency to high GRwt, medium GFP-GR displays consistently 
higher potency than low GRwt. The discrepancy between low GRwt and medium GFP-GR potencies 
may reflect effects due to GR concentration that are unrelated to cooperative ligand binding as the 
concentrations of these two GR species are significantly different (Fig.3.6) while their Hill slopes both 
indicate non-cooperative ligand binding (Fig.3.8). in contrast for the high GRwt and high GFP-GR 
levels both GR concentrations and Hillslopes are comparable. There was a significant increase in 
potency for DEX, F and RU486 at the high GFP-GR concentration, which displays positive cooperative 
ligand binding for DEX (Fig.3.8B). Although MPA and Prog did not show a significant change in 
potency they displayed the same trend as the other test compounds. Prog and RU486 display 
potency’s similar to that of the potent agonist, DEX, at the high GFP-GR concentration which may 
suggest a difference in the behaviour of the GFP-tagged receptor compared to that of the wild type as 
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with GRwt this was not observed (Fig.6.9A,B). The increase in potency as we shift from medium to 
high GFP-GR concentration is 32-fold for DEX, 40-fold for F, 53-fold for MPA, 160-fold for Prog and 
75-fold for RU486. The increase in potency we saw between low and medium GRwt concentrations 
was 397-fold for DEX, 53-fold for F, 3.2-fold for MPA and 2.5-fold for RU486. Thus there is 
considerable difference in the fold potency changes demonstrated for MPA and RU486 between the 
GRwt and GFP-GR, when moving from GR concentration that display non-cooperative to cooperative 
ligand binding. In addition the rank order of potency increases change from DEX > F > MPA > RU486 
for GRwt to Prog > RU486 > MPA > F > DEX for GFP-GR. Again it would be of interest to test whether 
these test compounds display a greater or lesser disposition for positive cooperative ligand binding 
through the high GFP-GR concentration than through the medium GRwt concentrations. For DEX, for 
example, we have shown that positive cooperative ligand binding is elicited at a higher GR 
concentration for GFP-GR than for GRwt (Fig.3.6B, Fig.3.8B). 
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Figure 6.10. Positive cooperative ligand binding to GFP-GR increases potency (log EC50). Cells 
were transfected with medium (38.5ng) or high (11550ng) GFP-GR levels and 3000ng pTAT-GRE2-
Elb-luc and induced with EtOH or a range of 10-5 M to 10-11M of DEX, F, MPA, Prog or RU486 in 
stripped DMEM for 24 hours. Transactivation assays were performed as described in materials and 
methods. Sigmoidal dose-response curves were fit to the experimental data which generated log EC50 
Statistical analysis was through one tailed unpaired t test (*P<0.05, **P<0.01). Results represent three 
independent experiments performed in triplicate (±SEM). 
 
Zhang et al. (42) show a 2.1-fold increase in transactivation potency for DEX but not for RU486, as 
GRwt levels increase, in the same system. As the increase in fold potency at our medium GRwt 
concentration for MPA and RU486 (3.2 and 2.5-fold, respectively) differs so markedly from the 417-
fold seen with DEX, it raises the question of whether positive cooperative ligand binding, which was 
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only demonstrated for DEX, occurs for partial agonists and antagonists. Interestingly, while MPA 
displays lower potency than DEX at both low and medium GRwt levels, RU486 displays similar 
potency as DEX at the low GR concentration. It is therefore not as simple as relaying the potency 
values at GR concentrations which display non-cooperative DEX binding to relative increases in 
potency at GR levels, which display positive cooperative DEX binding. Positive cooperative binding 
would first have to be established for the partial agonists as well. This is an avenue which may be 
explored in follow up research. 
 
A recent paper by Ong et al. (12) describes a mathematical model which predicts the FHDC of steroid 
hormone induced protein product. This model aims to clarify how, despite changes in the potency and 
maximum activity of dose response curves due to the influence of cofactors or GR concentration, dose 
response curves retain a first order Hill coefficient. As can be seen in Figs.6.8 & 6.11, our dose 
response curves maintain FHDC characteristics, which are not influenced by positive cooperative 
ligand binding at medium and high GRwt concentrations. Despite displaying positive cooperative 
ligand binding at the medium and high GRwt concentrations, the Hill slope for transactivation dose 
response curves remains non-cooperative. This result is consistent with the model of Ong et al. (12) 
which predicts that GR dimerization is not a necessary step for gene induction.  
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Figure 6.11. The Hill slope of dose response curves remains FHDC and is not influenced by 
positive cooperative ligand binding. Transactivation assays were performed as described in 
materials and methods on COS-1 cells expressing low, medium or high GRwt or low or medium 
GRdim concentrations. Log (agonist) plotted against response was analyzed using variable slope 
curves. This generated Hill slope values for DEX stimulation. Statistical analysis was through ANOVA 
followed by Newman-Keuls multiple comparison post test. All results represent a minimum of three 
independent experiments performed in triplicate (±SEM). 
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However, Ong et al. (12) do raise the question of whether GR binding to DNA occurs via preformed 
dimers or through the sequential binding and subsequent dimerization of GR monomers. Their 
mathematical model suggests that to retain FHDC, DNA binding must occur via the sequential binding 
of GR monomers. However, our FRET results (Chapter 4) confirm GR dimerization in the cytoplasm, 
independent of DNA binding. Furthermore, the electro mobility shift studies of Drouin et al. (9) are 
direct confirmation that DNA binding by preformed GR dimers does occur. Although DNA independent 
GR dimerization does not preclude the binding of GR monomers to the DNA and their subsequent 
dimerization, it would suggest that where DNA independent GR dimerization does occur it would lead 
to a decrease in potency due to the reduced availability of monomers. Tellingly, however, Ong et al. 
(12) as well as our own results display far greater potency through the GRwt than via the GRdim. 
 
To summarize, the increase in potency seen at medium and high GRwt and high GFP-GR 
concentrations, but not with GRdim, support our observation that ligand independent dimerization of 
the GR at high concentrations allows for positive cooperative ligand binding, which results in increased 
potency through transactivation of a range of test compounds. Generally an overview of the literature 
confirms our findings that an increase in GR concentration results in an increase in transactivation 
potency (42-44, 61), however, none of these studies correlated the increase in potency with 
cooperative ligand binding to the GR, as we have done. 
 
6.3.2 Ligand independent transactivation 
 
Ligand independent activation of promoter reporter constructs is an often encountered characteristic of 
the assay and constructs which display a high level are termed leaky vectors. It is common practice to 
normalize activation results against the ligand independent transactivation in order to generate specific 
fold induction by test compounds. Ligand independent transactivation is generally considered a non-
specific function, however, our results indicate that increasing the concentration of GRwt or GRdim 
leads to an increase in ligand independent transactivation through both a multiple GRE containing 
construct (Fig.6.12A) as well as a single GRE containing promoter construct (Fig.6.12B). 
 
We will discuss the multiple GRE (pTAT-GRE2-Elb-luc a 2 x GRE promoter reporter) first. Although 
we see a significant difference in ligand independent transactivation at the low GR concentration 
between GRwt and GRdim we do not see any at the medium GR concentration (Fig.6.12A). We 
therefore exclude positive cooperative ligand binding as the cause for this behaviour because both the 
low GRwt and GRdim concentrations display non-cooperative ligand binding, while the medium 
concentration of GRwt, but not the medium GRdim concentration, displays positive cooperative ligand 
binding (Fig.3.8B). Although increasing the concentration of a transcription factor, in this case GR, is 
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expected to result in an increase in transactivation this should propose a linear relationship between 
GR concentration and ligand independent transactivation. However, the relationship we see is an 
exponential rise in transcription. While the GRwt concentration increases 2.3 and 4.2-fold above the 
low GR concentration at the medium and high GRwt concentrations, respectively, they result in a fold 
increase in ligand independent transcription of 4.7 and 22.2, respectively. The relatively modest 
increase in ligand independent transcription from low to medium GR concentration is followed by a 
steep increase in ligand independent transactivation at the high GR concentration. Although this 
behaviour can not be linked to ligand independent dimerization of the GRwt at the medium GR 
concentration it may be that at the high GR concentration the equilibrium shifts towards even greater 
ligand independent activation of transactivation. Intriguingly in MCF-7 cells over expressing ERα 8-
fold, ligand independent endogenous promoter occupancy and gene expression has been 
documented (48). Thus, increasing GR concentrations may result in more non-specific associations of 
the GR with the promoter resulting in an increase in ligand independent transactivation.  
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Figure 6.12. Ligand independent transactivation increases as receptor concentration does. 
Transactivation assays were performed on cells were transfected with (A) 3000ng pTAT-GRE2-Elb-luc 
(2 x GRE promoter reporter) or (B) 3000ng p∆ODLO (1 x GRE promoter reporter) as described in 
materials and methods in a minimum of two independent experiments performed in triplicate (±SEM). 
Results are expressed as uninduced (EtOH) RLU/mg protein values following 24 hours EtOH 
stimulation. Statistical analysis was through two tailed unpaired t tests of low GRwt concentration 
against medium GRwt or high GRwt concentrations (†††P<0.001), low GRdim concentration against 
medium GRdim concentration (§§P<0.01, §§§P<0.001) and GRwt against GRdim (*P<0.05, **P<0.01, 
***P<0.001).  
 
As for the multiple GRE containing promoter reporter construct (Fig.6.12A), both the GRwt and GRdim 
also display significant ligand independent transactivation via the single GRE containing promoter 
reporter construct (Fig.6.12B). However, with the single GRE containing promoter reporter, in contrast 
to the multiple GRE containing promoter reporter, the GRwt displays significantly higher levels of 
ligand uninduced transactivation than the GRdim. We have to rule out the influence of ligand 
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independent dimerization on this behaviour as uninduced transactivation is 2.3-fold higher through the 
GRwt than through the GRdim at the low GR concentrations, which is similar to the 2.4-fold greater 
ligand uninduced transactivation through the medium GRwt concentration compared to the medium 
GRdim concentration. This despite the fact that the medium GRwt concentration, but not the medium 
GRdim concentration, displays positive cooperative ligand binding due to ligand independent 
dimerization. However, the significant difference between ligand uninduced transactivation between 
GRwt and GRdim does suggest that at the single GRE containing promoter reporter construct, but not 
the multiple GRE containing construct, the ability to dimerize may play a role. 
 
6.3.3 Efficacy, fold induction and biocharacter shift 
 
As has been stated earlier, the concentration of transcription factor is closely linked to the transcription 
response as has been demonstrated in numerous GR concentration studies (42-44, 56, 62). Our 
findings support this assumption for both the GRwt as well as the GRdim for all test compounds 
analyzed (Fig.6.13A, Fig.6.14A) through the multiple GRE promoter construct. Similarly to ligand 
independent transactivation (Fig.6.12A), we find that the effect of GR concentration on transactivation 
efficacy becomes larger the more GR is present with a 3.7 to 12.3-fold increase in DEX induced 
efficacy at medium and high GRwt concentrations, respectively, reflecting a 2.3 and 4.2-fold increase 
in GRwt concentration (Fig.6.13A). Where as when GRdim concentration increases 2.2-fold from low 
to medium GR concentration we see a 5.5-fold increase in transactivation efficacy via DEX 
(Fig.6.13A).  
 
Intriguingly we demonstrated significantly higher efficacy of transactivation via the multiple GRE 
containing promoter reporter through the GRdim than through the GRwt at both low as well as at 
medium receptor concentrations for all ligands tested (Fig.6.13A, Fig.6.14A). Specifically, for DEX at 
the low GR concentration the increased efficacy due to GRdim is 5.1-fold, while at the medium GR 
concentration it was 7.7-fold, relative to GRwt. Early work with a similar D-loop dimerization impaired 
GRdim mutant displayed greatly reduced transactivation relative to the wild type receptor through a 
promoter reporter containing two GREs (21, 23, 63). It was therefore assumed that this mutation 
attenuated transactivation. However, more recent studies have contradicted this assumption. For 
example, Adams et al. (64) using an analogous D-loop GRdim demonstrated that DEX transactivation 
efficacy of the phenylethanolamine N-methyltransferase (PNMT) promoter, which contains at least two 
GREs, was roughly 3 fold greater than that of the GRwt, while this fell to roughly 0.4-fold through a 
single GRE containing promoter reporter. They also show that the GRdim binds directly to DNA 
although with a lower affinity than the GRwt. In addition, Liu et al. (25) demonstrated that the GRdim 
fold DEX activation of transcription through a promoter containing 3 GREs is 79.4-fold higher than 
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through a single GRE containing promoter. The GRwt also favoured transcription through the multiple 
GRE but only produces a 7.2-fold difference in DEX transactivation fold induction of the multiple GRE 
containing promoter relative to the single GRE containing promoter in their system. They also 
demonstrated enhanced GRdim efficacy through a promoter containing 2 GREs from the TAT gene, 
which is similar to our promoter reporter. 
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Figure 6.13. DEX efficacy (maximal induction) increases as receptor levels increase as does 
GRdim fold induction while GRwt fold induction decreases. Transactivation assays of the multiple 
GRE containing pTAT-GRE2-Elb-luc induced with DEX were performed as described in materials and 
methods. Sigmoidal dose-response curves were fit to the experimental data which generated (A) 
maximal induction. (B) Fold induction was calculated as maximal induction normalized to ligand 
uninduced induction. Statistical analysis was through two tailed unpaired t tests of low GRwt 
concentration against medium GRwt or high GRwt concentrations (†P<0.05, ††P<0.01, †††P<0.001), 
low GRdim concentration against medium GRdim concentration (§P<0.05, §§P<0.01) and GRwt 
against GRdim (*P<0.05, **P<0.01***P<0.001). Results represent a minimum of three independent 
experiments performed in triplicate (±SEM). 
 
The efficacy of transactivation through F, MPA and RU486 of the multiple GRE containing promoter 
reporter showed similar trends to that of DEX (Fig.6.14A). Efficacy increased significantly as the 
concentration of both GRwt, as well as GRdim, increased, while GRdim demonstrated a significantly 
greater efficacy than the GRwt at both low and medium GR concentrations for most compounds. 
Although the levels of maximal induction differ between ligands the major trends towards enhanced 
efficacy at increased GR concentrations and through the GRdim seem universal. 
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Figure 6.14. Efficacy (maximal induction) increases as receptor levels increase as does GRdim 
fold induction for a range of test compounds. Transactivation assays on the multiple GRE 
containing pTAT-GRE2-Elb-luc were performed as described in materials and methods. Sigmoidal 
dose-response curves were fit to the experimental data which generated (A) maximal induction. (B) 
Fold induction was calculated as maximal induction normalized to ligand uninduced induction. 
Statistical analysis was through two tailed unpaired t test of low GRwt concentration against medium 
GRwt concentration (††P<0.01, †††P<0.001), low GRdim concentration against medium GRdim 
concentration (§P<0.05, §§P<0.01) and GRwt against GRdim (*P<0.05, **P<0.01, ***P<0.001). Results 
represent a minimum of three independent experiments performed in triplicate (±SEM). 
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Transactivation efficacy through the single GRE containing promoter reporter was also investigated. 
We transiently transfected the same concentration as for our multiple GRE promoter reporter assays 
of a promoter reporter containing only a single GRE from the GR responsive TAT gene (p∆ODLO) 
along with low and medium GRwt or GRdim concentrations. As the literature suggests we saw no 
ligand induced activation through the GRdim and transactivation efficacy generally increased with an 
increase in GRwt concentration, as was seen with the multiple GRE containing promoter reporter 
(Fig.6.15A).  
 
As a matter of interest we converted the maximal induction (efficacy) results of the multiple GRE 
containing promoter construct (Fig.6.13A, Fig.6.14A) to fold induction (Fig.6.13B, Fig.6.14B) by 
normalizing them to the ligand uninduced induction values (Fig.6.12A). Due to the exponential 
increase in ligand uninduced transactivation at the medium and high GRwt concentrations our fold 
induction values decrease statistically as GRwt levels increase (Fig.6.13B). We did not see the same 
trend through the GRdim, which maintained an increase in fold induction as GRdim concentration 
increases. This may be due to the fact that the ligand independent transactivation for the GRdim is 
smaller relative to ligand induced transactivation with the multiple GRE containing promoter reporter 
construct. Fold induction of the single GRE containing promoter reporter through GRwt was also seen 
to decrease at the medium GRwt concentration relative to low GR concentration (Fig.6.15B). Once 
again this was due to an increase in ligand uninduced activation at the medium GRwt concentration 
(Fig.6.12B, Fig.6.15A). 
 
The disparity between maximal induction and fold induction results for the GRwt highlight the effect 
elicited by ligand independent transactivation on the analysis of transactivation results. Are we to 
believe that increasing GRwt concentrations result in an increase or a decrease in efficacy via the 
GRE containing constructs? Based on the maximal response data it would look as though increasing 
GRwt concentration leads to an increase, while fold induction implies the opposite. Most researchers 
present transactivation results in the form of fold induction (2, 48), however, where differences in GR 
concentration or the transfection levels of GR co-factors are being studied efficacy is almost always 
presented as a percentage of the maximal response of a positive control such as a saturating 
concentration of DEX (41-44, 56, 65). As changes in the level of GR (43) and GR cofactors, such as 
TIF2 (44), SRC-1 (44) and SMRT (44), result in large changes in maximal response (efficacy) as well 
as the level of ligand independent transactivation of promoter reporter assays, presenting these 
results as a percentage of a control makes for easier comparison. It is clear that where changes have 
been made to the level of expressed transcription factors, presenting maximal transactivation as fold 
induction is avoided. The reason for this, as our results indicate (Fig.6.12), is the large difference in 
ligand independent transactivation that is seen through variances in transcription factor concentration 
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(44). We suggest no hard or fast rules to govern the presentation of transactivation efficacy results, 
however, it is advisable for the researcher to be aware of the impact variances in uninduced 
transcription could make on fold induction results. It would also be useful if the levels of ligand 
uninduced transcription are acknowledged in order to better interpret fold induction data, which may 
be misleading where differences in transcription factor concentrations exist. 
 
Previous work indicates that mutations in the D-loop of the GR result in a loss of cooperative binding 
by the receptor to the GRE (66), which is reflected by a 5-fold lower affinity for DNA binding by the GR 
monomer relative to the GR dimer (9). Work by Tanner et al. (67) on the AR suggests a possible 
explanation for enhanced transcription at multiple HREs by DNA binding impaired receptors. Their 
research suggests that mutations in the hinge region of the AR, which result in weaker association of 
the activated mutant AR to HREs and a shorter residence time, results in enhanced transactivation. 
They ascribe this to the ‘hit and run’ theory of transcription (18, 19) where faster cycling of 
transcription factors at response elements results in higher activity. In defense of this theory Meijsing 
et al. (7) demonstrated that the TAT promoter, despite having the lowest GR binding affinity of a range 
of GREs, also had the highest fold transactivation, while the PAL promoter, which had the highest GR 
binding affinity, displayed the lowest fold transactivation.   
 
One may envisage a scenario where dimerization of the GR results in the effective halving of potential 
transcription factors, which may explain the reduced efficacy seen through the GRwt, however, it has 
been demonstrated that transactivation can not occur through binding to a GRE half-site alone (68). 
Therefore, two monomers of the GRdim would be necessary to activate a GRE in the same way as a 
single GR dimer would (Fig.6.7). Thus the most plausible explanation for the observed enhanced 
efficacy of the GRdim over the GRwt in our study is the ‘hit and run’ theory. While the primarily dimeric 
activated GRwt forms more stable longer lasting associations with the promoter, the primarily 
monomeric GRdim shuttles on and off the promoter more rapidly. However, as each association by 
either the GRwt or the GRdim has the capacity to elicit a round of transcription, the increased cycling 
by the GRdim results in greater maximal transcription through the GRdim. 
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Figure 6.15. GRdim shows no ligand induced transactivation through a single GRE, however, 
ligand uninduced transactivation increases with GRdim concentration. Cells were transfected 
with low or medium GRwt or GRdim and 3000ng p∆ODLO filled to 14550ng total plasmid. Induction 
was with EtOH, 10-6M DEX, F, MPA or RU486 in stripped DMEM for 24 hours. Transactivation assays 
were performed as described in materials and method. (A) Maximal induction and (B) fold induction 
calculated as maximal induction normalized to ligand uninduced induction were plotted. Statistical 
analysis was through ANOVA followed by Dunnett’s post test comparing uninduced (EtOH) conditions 
to the ligand induced conditions within the low (†P<0.05, ††P<0.01, †††P<0.001) or medium (§P<0.05) 
concentration populations of GRwt or GRdim and two tailed unpaired t tests of GRwt against GRdim 
(*P<0.05, **P<0.01, ***P<0.001). Results represent two experiments performed in triplicate (±SEM). 
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Maximal induction occurs at saturating concentrations of test compound, unlike potency, which is 
determined at sub-saturating levels. We thus hypothesis that variations in ligand affinity brought about 
by positive cooperative ligand binding will be less apparent for efficacy (maximal induction) than it was 
for potency. Furthermore, the analysis of the influence of positive cooperative ligand binding on 
efficacy is complicated by the inherent differences in the capacity of GRwt and GRdim to transactivate, 
as well as the non specific tendency for increased transcription at increased concentrations of GR (44, 
56, 65). As a result it is not possible to ascertain any clear influence of positive cooperative ligand 
binding on the efficacy of transactivation, whether expressed as maximal induction or fold induction. 
However, when comparing the biocharacter of the range of test compounds investigated in our study 
against that of DEX we can discern an influence of positive cooperative ligand binding on individual 
ligands in comparison to that of DEX. MPA and RU486 both display significant increases in efficacy 
via the multiple GRE containing promoter reporter at GRwt as well as GFP-GR concentrations, which 
display positive cooperative ligand binding, while no such shift is evident with the GRdim 
(Fig.6.16A,B). This is unlike the biocharacter shift displayed through the single GRE containing 
promoter reporter (Fig.6.15B). For example, the biocharacter of MPA displayed a shift from full agonist 
behaviour displaying 95 percent of the DEX fold induction at the low GRwt concentration to partial 
agonist behaviour displaying 65 percent of the DEX fold induction at the medium GRwt concentration 
through the single GRE containing promoter reporter (Fig.6.15A). Conversely, MPA shifted from a 
partial agonist to a supra-agonist via the multiple GRE containing promoter, while the weak agonist 
RU486 shifted to partial agonist behaviour with GRwt and GFP-GR (Fig.6.16). However, we see no 
significant change in the biocharacter of the endogenous agonist F through the multiple GRE 
containing promoter reporter. GR concentration dependent biocharacter shifts from weak to partial 
agonist behaviour normalized to DEX have previously also been presented for RU486 (42, 43), Prog 
(42-44, 56) and dexamethasone 21-mesylate (Dex-Mes) (43, 44, 56). However, no previous study has 
correlated this behaviour with cooperative ligand binding and ligand uninduced GR dimerization. 
 
We demonstrated no significant biocharacter shift in F, MPA or RU486 through an increase in the 
GRdim concentration from low to medium concentration (Fig.6.16A). As the ligand binding to the 
GRdim remains non-cooperative, even at the medium GR concentration, the fact that no biocharacter 
shifts are elicited through the GRdim, strengthens our argument for cooperative ligand binding induced 
biocharacter shifts in the GRwt. Interestingly, it was demonstrated that the shift from partial to full 
agonist behaviour (56) as well as receptor dependent increases in potency (62) are saturatable. Voss 
et al. (62) suggest that GR co-factors and non-specific transcription machinery start to become limiting 
which impairs any further rise in efficacy.  
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Our results suggest that the efficacy of MPA and RU486 increase via the multiple GRE containing 
promoter reporter construct at GR concentrations which show positive cooperative ligand binding for 
DEX. Ligand independent dimerization of the receptor may prime its response and shift the 
biocharacter towards that of a more potent agonist. The biocharacter of the agonist F does not 
demonstrate the same shift and we hypothesis that its transcription response already demonstrates a 
theoretical maximum, which is similar to that of DEX. We propose that it is only weak or partial 
agonists that are affected by positive cooperative ligand binding at saturating ligand concentrations. It 
would be beneficial to test the capacity of these test compounds to induce GR dimerization at GRwt 
concentrations which display non-cooperative as well as positive cooperative ligand binding in order to 
correlate ligand independent dimerization with the shift in biocharacter. 
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Figure 6.16. The ability to cooperatively bind ligands influences the biocharacter of MPA and 
RU486 in transactivation assays. Transactivation assays on the pTAT-GRE2-Elb-luc were 
performed as described in materials and methods in COS-1 cells expressing (A) low, medium or high 
GRwt or low or medium GRdim or (B) medium or high GFP-GR. Percentage induction of F, MPA or 
RU486 representing maximal induction of each of these test compounds relative to that of DEX (set at 
100 percent) at the same GR concentration and GR construct either GRwt or GRdim. Statistical 
analysis was through two tailed unpaired t tests (*P<0.05, ***P<0.001). Results represent three 
independent experiments performed in triplicate (±SEM). 
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In summary, efficacy is GR concentration dependent, displaying a promoter specific sensitivity to GR 
dimerization. The single GRE containing promoter reporter construct requires GR dimerization in order 
to facilitate ligand dependent transactivation, while the transactivation of the multiple GRE is actually 
enhanced by the reduced capacity of GRdim to dimerize. It is unlikely that cooperative ligand binding 
influences the efficacy of transactivation through either the single or multiple GRE containing promoter 
reporter constructs. On the other hand the biocharacter shifts of MPA and RU486 through the multiple 
GRE containing promoter reporter may be attributed to the influence of cooperative ligand binding. 
 
6.4 Transactivation of the endogenous GILZ gene 
 
Having established the relevance of dimerization and receptor concentration in ligand independent 
transactivation as well as ligand induced potency and efficacy with promoter reporter assays we 
sought to compare these characteristics in a more endogenous system. We used transiently 
transfected COS-1 cells expressing low, medium or high GRwt concentrations as well as the low or 
medium GRdim concentrations. Following an 8 hour induction with either EtOH or 10-6M DEX we 
determined the relative mRNA expression levels of the GR-responsive endogenous GILZ gene (33, 
34, 37) through RT-PCR. In order to correct for cDNA loading we determined the concentration of 
GAPDH mRNA within each sample. As has been recently demonstrated by Visser et al. (69) as well 
as by Burkhart et al. (70), the ubiquitously expressed house keeping gene, GAPDH is not influenced 
by DEX stimulation. Our own raw data confirms that DEX did not affect GAPDH levels and also 
indicates that GAPDH expression is not significantly affected by the transfection of varying GR 
concentrations either (Fig.6.17). 
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Figure 6.17. The relative expression of GAPDH is not affected by varying concentrations of 
transfected GR. RT-PCR on the GAPDH gene was carried out on cells expressing low, medium or 
high concentrations of GRwt as described in materials and methods. Statistical analysis was carried 
out using ANOVA followed by Newman-Keuls multiple comparison post test. Results represent a 
minimum of two independent experiments performed in quadruplicate (±SEM). 
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As a necessary control, melting curves were run on all GILZ and GAPDH RT-PCR products 
(Fig.6.18A,B). A single peak per sample confirmed that only one product was amplified in the PCR 
reaction and that no primer dimers were formed. Standard curves of a range of cDNA concentrations 
where created in order to determine the cycle threshold (CT) of the GILZ and GAPDH primers 
(Fig.6.18C,D) and to calculate the efficiency (E) of amplification. The E of the GILZ primers was 
calculated as 2.08 while the E of the GAPDH primers was 1.89. These values indicate a high degree 
of E for both primers as they are close to 2, which is the theoretical maximum for E (71). These 
efficiencies were calculated from the slope of the standard curves: 
 
The efficiencies were applied to subsequent CT values in order to quantify the relative expression ratio 
of the target gene (GILZ) relative to that of the reference gene (GAPDH) using the Pfaffl (71) 
mathematical model: 
 
 
Standard Curve   CT = -3.623*log(conc) + 25.595  
R Value 0.99981 
Standard Curve  CT = -3.140*log(conc) + 28.544  
R Value 0.99855 
 
A
C
B
D
Figure 6.18. Melting and standard curves of GILZ and GAPDH. RT-PCR was carried out as 
described in materials and methods using primers for GILZ and GAPDH cDNA. Melting curves for (A) 
GILZ and (B) GAPDH. Standard curves of (C) GILZ and (D) GAPDH. Amplification efficacy was 
generated using Rotor-Gene 6000 Series Software 1.7 (Corbett) to determine primer efficiency. 
 
 
(Etarget) 
(Ereference) 
∆CPtarget(control – sample) 
∆CPreference(control – sample) 
Relative 
expression
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= 
E = 10[-1/slope] 
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6.4.1 Ligand independent transactivation of GILZ 
 
Our results indicate that ligand independent transactivation of the endogenous GILZ gene increases 
significantly as GR concentrations increase (Fig.6.19A). Unlike the ligand independent transactivation 
of the multiple GRE containing promoter reporter (Fig.6.12A), the medium concentration of GRdim 
displays significantly reduced ligand independent induction compared to the medium GRwt 
concentration. However, these results are more in line with the single GRE promoter reporter studies 
(Fig.6.12B) that also showed significantly less ligand uninduced transactivation via GRdim at the 
medium GR concentration.  Ligand independent induction also seems to plateau at the GRwt levels 
which display positive cooperative ligand binding with no significant difference between medium and 
high GRwt concentrations (Fig.6.19A). This is in sharp contrast to the promoter reporter studies with 
the multiple GRE containing promoter construct where ligand uninduced transactivation sharply and 
significantly increased between medium and high GRwt concentrations (Fig.6.12A). The level of ligand 
independent transactivation of the endogenous GILZ gene is far less than that seen through the 
multiple GRE containing promoter reporter. The maximal ligand independent induction of the GILZ 
gene displayed by the high GRwt concentration is only 2.5-fold greater than where no GR was 
transfected. This is in sharp contrast to the 571-fold increase in ligand independent transactivation of 
the multiple GRE containing promoter reporter at the high GRwt concentration (Fig.6.12A). 
Furthermore, the difference between ligand uninduced transactivation between the low and medium 
GRwt concentrations is also greatly reduced in the endogenous assay with only a 1.4-fold difference 
for the GILZ gene versus a 4.7-fold difference for the multiple GRE and a 9.4-fold difference for the 
single GRE containing construct.  
 
The literature suggests that the GILZ promoter is a weak inducer of transcription with activity roughly 
10-fold lower than that of the single GRE containing TAT promoter (7). In line with the ‘hit and run’ 
theory of transcription, Meijsing et al. (7) demonstrate higher levels of transcription through promoters 
that bind the GR weakly. Although the GILZ promoter has a relatively low affinity for the GR it is still 
considerably higher than that of the TAT promoter (7). The fact that one of our reporter promoter 
constructs contains two TAT GRE’s may further enhance its capacity for transactivation relative to that 
seen for the endogenous GILZ gene.  
 
A further difference may lie at the level of quantification or transcription in each of these systems. 
Where as the concentration of the stable protein luciferase produced over a 24 hour period is 
measured in the promoter reporter assay the transactivation of the endogenous GILZ gene is 
quantified as the level of mRNA produced after 8 hours of stimulation. Recent research has shown 
that following stimulation, the level of mRNA produced by GR responsive genes may either peak 
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rapidly and remain constant for a 24 hour period, peak rapidly and decrease quickly or increase slowly 
over a 24 hour period (72), which suggests that mRNA does not necessarily accumulate in the way 
that the luciferase protein does. Our own time studies to optimise for the maximal level of GILZ mRNA 
transcription following DEX stimulation ranged from 2 to 24 hours and revealed that the 8 hour time 
point was optimal in our system (data not shown). The time period of 24 hour induction for the 
promoter reporter allows for a greater build up of transactivation product, namely luciferase. On the 
whole, measurements of endogenous transactivation which rely on mRNA detection are known to 
display lower fold induction and maximal response than promoter reporters containing multiple GREs 
(33, 36). Our findings are thus in line with those reported in the literature.  
 
6.4.2 Efficacy of GILZ  transactivation 
 
6.4.2.1 Maximal induction 
 
Maximum induction by DEX of the GILZ gene (Fig.6.19B) normalizes DEX induced GILZ induction to 
the GILZ levels of the uninduced no GR transfected population. This is comparable to the maximal 
induction of promoter reporter transactivation (Fig.6.13A, Fig.6.15A) as induction is not normalized to 
the specific levels of ligand independent transactivation, but rather represents the total ligand induced 
as well as ligand uninduced transcription. Stimulation of the GRwt results in a significant GR 
concentration dependent increase in GILZ expression, which is similar to what is demonstrated by the 
GRwt in the single and multiple GRE containing promoter reporter construct assays (Fig.6.13A, 
Fig6.15A).  
 
Interestingly, there is a 1.4-fold increase in GILZ maximal induction through the endogenous GR in 
COS-1 cells, indicated as the cells where no GR has been transfected (Fig.6.19B) and suggests the 
presence of low levels of endogenous GR in COS-1 cells. Maximal DEX induction of GILZ mRNA 
production by the GRdim was not significantly different from that of the corresponding GRwt 
concentration. This is in sharp contrast to the significantly heightened response displayed by GRdim in 
the multiple GRE containing promoter reporter assay (Fig.6.13A) and the significantly decreased 
response seen with the single GRE promoter reporter assay (Fig6.15A). Furthermore, the low and 
medium GRdim maximal DEX induced GILZ inductions are not significantly different from one another. 
Increasing GRdim concentration from low to medium GR levels results in a 1.3-fold increase in 
maximal induction of the endogenous GILZ gene, while the same increase in GRdim concentration 
results in a 5.5-fold increase in maximal induction of the multiple GRE containing promoter reporter 
(Fig.6.13A). This highlights the decreased transactivation efficacy displayed by GRdim in the 
endogenous assay and is supported by results from a recent paper which studied the GC, 
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prednisolone’s ability to induce endogenous gene transcription in a GRdim expressing mouse model 
that revealed that while 347 genes were upregulated in GRwt expressing mice only 29 were 
upregulated in the GRdim mice (73). 
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Figure 6.19. Real time PCR quantification of endogenous GILZ gene expression. RT-PCR was 
carried out as described in the materials and methods on cells induced for 8 hours with either EtOH or 
10-6M DEX. GILZ expression was calculated relative to GAPDH for each condition. (A) Uninduced 
GILZ expression was calculated from EtOH induced GILZ expression at the indicated levels of 
transfected GR normalized to EtOH induced GILZ expression where no GR was transfected. (B) 
Maximum GILZ expression where 10-6M DEX at each GR condition was normalized to EtOH induced 
GILZ expression where no GR was transfected. (C) Fold induction induced by 10-6M DEX relative to 
EtOH for each transfection condition. Statistical analysis was carried out using ANOVA followed by 
Newman-Keuls multiple comparison post test, were conditions with different letters are statistically 
different from one another (P<0.01).  Results represent a minimum of two independent experiments 
performed in quadruplicate (±SEM). 
 
6.4.2.2 Fold induction 
 
When results are converted to fold induction (Fig.6.19C) by normalizing the maximal induction to the 
specific ligand independent induction at each GR concentration (Fig.6.19A) we see minimal increases 
in fold induction at the low and medium GRwt and GRdim concentrations. Only the high concentration 
of GRwt results in significantly raised fold induction when compared to that of the no GR transfected 
population. Fold induction of both the multiple and single GRE containing promoter reporters displayed 
the inverse, namely significant decreases in fold induction as GRwt concentrations increased 
(Fig.6.13B, Fig.6.15B). These disparate results reflect the 22.2-fold and 9.4-fold increases in ligand 
Stellenbosch University  https://scholar.sun.ac.za
 167
independent transactivation of the multiple and single GRE containing promoter reporters, 
respectively, when moving from low to maximal GRwt concentrations (Fig.6.12A,B) as compared to 
the 1.5-fold increase in ligand independent transactivation of the GILZ gene when moving from the low 
to the high GRwt concentration (Fig.6.19A). The GRdim demonstrated a significant increase in fold 
induction as its concentration increased in the multiple GRE containing promoter reporter assay 
(Fig6.13B), a similar trend emerges for GRdim driven GILZ transactivation, however, the increase in 
levels was not significant.  
 
The 3.6-fold induction we see at the high GRwt concentration is comparable to previous work using 
the same primers. Avenant et al. (36) achieved 4.5-fold induction of GILZ in COS-1 cells transiently 
transfected with high levels of GR and stimulated with a saturating DEX concentration. Fold induction 
of the endogenous GILZ gene has been shown to increase from 3.6 to 6 in U2OS cells transfected 
with increasing amounts of GRwt (74), which again reflects the significant shift we demonstrate from 
1.8-fold induction at the low GRwt concentration to 3.6-fold induction at the high GRwt concentration.  
 
6.4.3 Summary of endogenous GILZ transactivation 
 
Meijsing et al. (7) demonstrated that a D-loop dimerization impaired GR mutant, similar to the one we 
have used, can activate the GILZ promoter at roughly 80 percent of the GRwt levels in a promoter 
reporter assay, while Rogatsky et al. (74) show GRdim induction of the endogenous GILZ in U2OS 
cells to be only 20 percent of the GRwt induction. At our low GR concentration we demonstrate that 
the GRdim is capable of 110 percent of the maximal induction achieved by the GRwt (Fig.6.19B), 
which falls to 86 percent of the maximal induction achieved by the GRwt at the medium GR 
concentration (Fig.6.19B). This decrease in maximal induction demonstrated by the GRdim relative to 
the GRwt may reflect positive cooperative ligand binding to the GRwt at the medium GR 
concentration. However, once corrected for the increased ligand independent induction seen through 
the GRwt, the GRdim displays better fold induction than the GRwt at both the low and medium GR 
concentrations (Fig.6.19C). It would be of great interest to us to place the GRdim gene in the same 
vector as the GRwt in order to test the behaviour of the GRdim at GR levels similar to that of the high 
GRwt. As yet we can not conclusively conclude whether the difference we see in maximal induction 
between the medium concentration of GRwt and GRdim is due to positive cooperative ligand binding 
or as a result of the enhanced ligand independent transactivation displayed by the GRwt in general. 
To definitively establish the effect of cooperative ligand binding on maximal induction it would be 
useful to compare the maximal induction of high GRdim to high GRwt to ascertain whether positive 
cooperative ligand binding causes an increase in transactivation of the endogenous GILZ gene.  
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To conclude, we have demonstrated that increased GRwt concentrations result in increased ligand 
independent transactivation of the endogenous GILZ gene and an increase in maximal induction. 
Ligand independent transactivation is significantly higher at the levels of GRwt, which display positive 
cooperative ligand binding, while they remain statistically similar to the low GRwt concentration, which 
displays non-cooperative ligand binding, at both low and medium GRdim concentrations. Increasing 
GRwt concentrations results in a significant increase in maximal DEX induction at each GRwt 
population, while maximal DEX induction at the low and medium GRdim concentrations are not 
significantly different from one another. Furthermore, the medium GRwt concentration displays a trend 
towards greater maximal induction than the medium concentration of GRdim. Only the high 
concentration of GRwt, which also shows the greatest extent of ligand independent dimerization 
(Chapter 4) and largest Hill slope (Chapter 3), displays significantly different fold induction relative to 
COS-1 cells where no GR has been transfected. As the medium GRdim and medium GRwt have 
similar levels of fold induction we can not conclude that positive cooperative ligand binding is 
responsible for the increased fold induction at the high GRwt concentration, as the medium GRwt 
concentration also binds ligand in a positive cooperative fashion. As reflected by the greatly reduced 
ligand independent induction, maximal induction, and fold induction it is clear that the endogenous 
GILZ transactivation assay is far less sensitive to the shift in positive cooperative ligand binding than 
the promoter reporter assay. In the future we would like to investigate the response of the endogenous 
GILZ gene to subsaturating concentrations of DEX at varying GR concentrations in order to determine 
whether the increase in potency we see through our promoter reporter assay  (Fig.6.9A) is also seen 
with an endogenous gene. 
 
We offer a summary of all results and a discussion of their relevance when viewed as a whole, in the 
following chapter. 
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Introduction 
 
In this, the final Chapter, we aim to distil the relevance of our diverse findings into a succinct whole. 
The role of (7.1) dimerization as a method for generating functional diversity will be addressed 
followed by a (7.2) brief overview of our own results and their (7.3) implications at a molecular, cellular 
and physiological level (7.4). Finally, strategies for future studies will be presented.    
 
7.1 Dimerization generates functional diversity 
 
The interactions between proteins form part of nearly all biological processes. These protein-protein 
interactions may be stable or dynamic. The covalent dimerization of the two subunits which make up 
the anti-body molecule (1) and the interaction between the subunits of haemoglobin (2) are examples 
of highly stable protein-protein interactions. We will focus our attention on the dynamic interactions, 
specifically dimerization, which may be defined as the interaction between two related subunits (3, 4). 
 
Dynamic dimerization, refers to the transitory, non-covalent, association of two identical or closely 
related proteins in response to a particular signal. More often than not dimerization results in an active 
complex whose formation initiates a signalling process, examples of which include cytokine receptors 
(5, 6), Bcl-2 proteins (7) and the NR family (8, 9). An obvious consequence of dimerization is the fact 
that it brings the two subunits into close proximity with one another. In the case of cytokine receptors, 
their dimerization allows the interaction of kinases, which are bound to each of the cytokine receptors 
(10). A further manner through which dimerization enhances signalling reaction rates is by the creation 
of favourable orientations. An example of which is the insulin receptor that despite relatively high 
concentrations in the cell membrane requires ligand induced dimerization in order to initiate signalling 
(11). 
 
Many proteins, which are capable of homodimerization, are also capable of forming heterodimers with 
related proteins (12). The formation of heteromeric complexes allows for a further level of differential 
regulation as many heterodimers behave differently than the homodimers of their constitutive subunits 
(13). For example, while homodimerization of the Bax protein promotes apoptotic cell death following 
apoptotic stimulation, the disruption of Bax-Bax dimerization by the over expression of Bcl-2 has been 
shown to prevent apoptosis due to the formation of Bax-Bcl-2 heterodimers (14). Similar behaviour 
has been reported for the GR where over expression of the largely inactive (15) dominant negative 
GRβ isoform results in significantly reduced transcription through the active GRα (16) brought about 
by heterodimerization between the two GR isoforms (17). Furthermore, an increase in the ratio of 
GRβ/GRα expression has been linked to GC resistance in a number of diseases (18, 19). 
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Heterodimerization of the GR with MR or AR may result in heterodimer specific transactivation via 
HREs (13, 20), while GR heterodimerization with the MR leads to impaired transactivation via GREs 
(21).  
 
Dynamic dimerization is especially prevalent in transcription factors where the formation of a dimer 
creates twice the number of potential protein-DNA interactions and has been shown to stabilize DNA 
binding (22). This is reflected in the greater binding affinity that GR dimers display for DNA as 
compared to GR monomers (23). The fact that GREs consist of two hexameric half-sites, which are 
each recognized by one GR DBD, is in itself suggestive of the role which dimerization plays in the 
recognition of and binding to DNA.  Considering the 24-fold greater DNA binding affinity shown by the 
GR dimer than the GR monomer (24) we hypothesize that the ‘cooperative’ binding of GR to DNA is 
brought about not through the sequential binding of two GR monomers and their subsequent 
dimerization as suggested by Ong et al. (25) but rather through the sequential association of each GR 
subunit in the GR dimer. The advantage of closer proximity and favourable orientation elicited by GR 
dimerization may account for the increase in DNA binding affinity displayed by GR dimers. 
 
The process of dimerization itself may be sufficient to activate a cell surface receptor related to the 
epidermal growth factor receptor (26, 27). Although primarily ligand activated, studies in this receptor 
have shown that dimerization induced by antibodies or resulting from naturally occurring mutations 
results in signalling independent of ligand (26, 27). Another influence of ligand independent 
dimerization involves its effect on ligand binding affinity and has been documented in SRs. FRET 
studies of a truncated ERα LBD mutant, which retains the ability to bind ligand, have demonstrated 
that the ERα LBD exists as a homodimer independently of ligand binding and that the Kd of 
dimerization of the truncated ERα LBD was 1nM in the absence of ligand and 0.33nM in the presence 
of 10-6M estradiol (28). As the Kd implies ligand independent dimerization of the ERα LBD is 
dependent on its concentration, the higher its concentration the greater the level of ligand independent 
dimerization. An increase in ER concentration has also been linked to a shift from non-cooperative to 
positive cooperative ligand binding (29), which in turn has been shown to be dependent on the 
capacity of the ER to dimerize (29). Since positive cooperative ligand binding, which is defined by a 
Hill slope >1, implies ligand binding to more than one binding site, these results strongly suggest that 
ligand independent dimerization at high concentrations of ER facilitates positive cooperative ligand 
binding. Evidence that ligand independent dimerization of the GR may facilitate cooperative ligand 
binding was presented by Cho et al. (30) who demonstrated that positive cooperative ligand binding to 
the GR at high but not at low concentrations of receptor, in vitro was dependent on GR dimerization. 
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Considering the ubiquity of dynamic dimerization as a tool for enhancing the functional diversity of 
proteins and SRs in particular, could it be that ligand independent dimerization of the GR at high 
concentrations is a mechanism employed physiologically to impart hypersensitivity to cells expressing 
high GR levels? 
 
7.2 Overview of results 
 
Following the extensive results Chapters 3, 4, 5 and 6 we feel it is advantageous to present an 
overview of our findings. The most prominent of which are summarized in Tables 7.1 and 7.2. The 
results discussed below refer to those presented in either of these Tables, unless otherwise indicated. 
 
In Chapter 3 we defined the low, medium and high GR concentration ranges employed in subsequent 
assays. In so doing we have made it possible to directly compare the influence of these three receptor 
concentrations on various aspects of GR behaviour. As far as we have been able to ascertain, through 
exhaustive literature review, this is the first time that a systematic exploration of the influences of GR 
concentration has been conducted. Where possible we have duplicated our experiments with low and 
medium concentrations of the D-loop mutant, GRdim, which has a reduced capacity to dimerize. In so 
doing we have been able to confirm the influence of GR dimerization in many of our assays. 
Furthermore, CpdA, a GR ligand shown to abrogate GR dimerization (Addendum B, (31)), has been 
used to further confirm effects due to GR dimerization. 
 
7.2.1 Chapter 3: Ligand binding affinity increases and cooperative ligand binding occurs at 
medium and high GRwt concentrations (Table.7.1) 
 
Our saturation binding studies revealed that ligand binding to the GRwt changed from non-cooperative 
at the low GRwt concentration to positive cooperative at the medium and high GR concentrations as 
demonstrated by the significant increase in Hill slope at these GR levels. The low GRdim 
concentration was similar to the low GRwt concentration and displayed non-cooperative ligand 
binding. Revealingly the medium GRdim concentration also displayed non-cooperative ligand binding, 
which is not statistically different from either the low GRwt or low GRdim concentrations, despite the 
fact that this concentration of GRdim is statistically similar to the medium GRwt concentration. The 
increase in ligand binding affinity reflected by positive cooperative ligand binding was mirrored by a 
significant decrease in the Kd at the medium and high GRwt concentrations. Once again, at the same 
medium concentration of GR that resulted in an increase in ligand binding affinity through the GRwt, 
the Kd of the medium GRdim concentration remained statistically comparable to the low GRwt 
concentration. These results demonstrate that an increase in GR concentration resulted in an increase 
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in cooperative ligand binding and ligand binding affinity as displayed at the medium and high GRwt 
concentrations. Furthermore, the behaviour of the GRdim at the medium receptor concentration 
confirmed the necessity of GR dimerization for the GR concentration induced cooperative ligand 
binding and increase in ligand binding affinity. 
 
7.2.2 Chapter 4: Ligand independent dimerization occurs at GR concentrations that display 
positive cooperative ligand binding (Table.7.1) 
 
In order for ligand binding affinity of the GRwt to be altered its conformation would have to change. 
Since the Hill slopes generated at the medium and high GRwt concentrations approach 2 it is 
suggestive of a shift from predominant ligand binding to the GR monomer at low GRwt concentrations 
to predominant ligand binding to the GRwt dimer at medium and high GRwt concentrations. Based on 
these findings as well as those of Cho et al. (30) we predicted that the conformational change required 
to alter ligand binding affinity was the increased level of ligand independent dimerization of the GR at 
heightened receptor concentrations. 
 
To test this hypothesis we employed both a live cell as well as an in vitro assay as described in 
Chapter 4. The Co-IP assay was used to visualize the levels of dimerization between a Flag-GRwt and 
either GFP-GRwt or GFP-GRdim at the low, medium and high GR concentrations. When quantified 
relative to the maximal dimerization elicited by the administration of DEX at the low, medium or high 
GRwt concentrations within each of these receptor concentration populations a clear pattern emerged, 
namely, significantly increased levels of ligand independent dimerization at the medium and high 
GRwt concentrations. These GRwt levels display equal levels of dimerization independent of potent 
agonist stimulation. The administration of the dimerization abrogating, dissociative GC, CpdA, 
significantly decreased the level of ligand independent dimerization of both medium and high GRwt 
concentrations, without significantly altering the dimerization level of low GRwt or any of the GRdim 
concentrations (Fig.4.3B). Although the level of ligand independent GRdim dimerization also increases 
as the receptor level does, the results are not significantly different from the low GRwt population and 
may reflect the fact that binding between the GRwt and GRdim is being measured and not between 
the GRdim and GRdim, exclusively. One may conclude that the GRdim although not completely 
incapable of dimerization, certainly displays a reduced capacity to dimerize particularly at the low 
GRdim concentration, where even the administration of DEX did not significantly influence the level of 
dimerization (Fig.4.3B).  
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Table 7.1. Summary of results from Chapters 3, 4 and 5. The effects of GR concentration and the influence of dimerization have been 
compared in a number of assays. Grey shaded blocks represent results achieved using tagged GRwt or GRdim but who’s concentration 
remains statistically comparable to the non-tagged receptors and falls within the designated concentration range, either low, medium or 
high. Statistical analysis was through ANOVA followed by Dunnett's post test against the lowest respective GRwt concentration (*P<0.05, 
**P<0.01, ***P<0.001).  
aassuming 20% transfection efficiency 
bbold numbers indicate GR concentrations where cooperative ligand binding has been demonstrated 
Results Chapters Figure GRwt concentration GRdim concentration Low Medium High Low Medium High 
Chapter 3: Cooperative ligand binding 
       
• fmol GR per mg proteina 3.6B, 6.1B 
335 763*** 1420*** 328 721*** - 
- 949*** 1462***    
• Hill slopeb 3.8B 1.08 1.57** 1.72*** 1.00 0.88 - 
- 0.78 1.44**    
• Kd (nM) 3.8B 49.1 23.9* 16.8* 52.3 33.2 - 
 - 28.4 10.9*    
Chapter 4:  
      
Ligand independent dimerization  
      
• Co-IP (% dimerization) 4.3B 43% 107%* 102%* 36% 60% 66% 
• FRET (% dimerization) 4.7 37% 60%* 63%* - - - 
Ligand induced dimerization 
       
• Co-IP (% dimerization) 4.3B 100% 100% 100% 37%* 80% 90% 
• FRET (fold induction) 4.8C 2.63 1.79*** 1.36*** - - - 
Chapter 5: Nuclear localization and distribution  
      
Nuclear import rate (t½ in min)        
• Live cell (10-6M DEX) 5.2B - 7.5 3.9** - 20.9*** 7.5 
• Immunofluorescence (10-6M DEX) 5.4D 3.2 3.2 - 5.1* 3.0 - 
• Immunofluorescence (10-9M DEX) 5.11 18.8 9.4*     
Nuclear localization extent (% nuclear) 
  
 
    
• Immunofluorescence (10-6M DEX) 5.4C 94% 96% - 76%** 77%* - 
Nuclear distribution 
   
 
   
• % CV 5.5C - 18% 18% - 15%** 18% 
Nuclear export (t½ in hours)        
• Live cell (10-9M DEX) 5.8B - 3.6 4.0 - 2.3* 2.7 
• Immunofluorescence (10-6M DEX) 5.10B 13.3 21.4** - 10.9 15.8 - 
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We next analysed the dimerization of low, medium and high concentrations of GRwt through a live cell 
FRET assay where the levels of ligand independent and dependent YFP-GR and CFP-GR association 
were visualized in real time. Mathematical modelling of our FRET results revealed a significant 
increase in ligand independent dimerization at the medium and high GR concentrations. When 
dimerization was induced by the addition of DEX, the fold induction of FRET was significantly lower at 
both of these GR levels when compared to the low GR concentration. The reduced capacity for ligand 
dependent dimerization of the medium and high GR concentrations is due to the high levels of ligand 
independent dimerization, which diminishes the fold induction of dimerization following DEX 
stimulation.  
 
Our in vitro and live cell analysis of GR dimerization in Co-IP and FRET experiments, respectively, 
both strongly support our hypothesis that cooperative ligand binding at the medium and high GRwt 
concentrations is facilitated by ligand independent dimerization of the GR. 
 
7.2.3 Chapter 5: Nuclear import, export and distribution are influenced by GR dimerization 
(Table.7.1) 
 
Live cell nuclear import studies revealed that the t½ of GFP-GR nuclear import decreased as receptor 
concentration increased. However, this trend occurred through both the GFP-GRwt and the GFP-
GRdim, implying that cooperative ligand binding was not responsible. The rate of nuclear import was 
influenced by the ability to dimerize as the GFP-GRdim displayed significantly slower rates of nuclear 
import than the GFP-GRwt. Immunofluorescent analysis showed no difference in the import rate of low 
and medium GRwt concentrations at saturating DEX concentrations. Tellingly, there was a significant 
difference in the nuclear import rate of the low and medium GRwt concentrations at subsaturating 
DEX levels which may reflect the increased affinity and shift to cooperative ligand binding at this GRwt 
level. At saturating DEX levels the low GRdim condition had a significantly reduced import rate 
compared to the GRwt, which implies an effect of dimerization. The extent of nuclear import at 
saturating DEX concentrations as revealed by the immunofluorescent analysis was not affected by GR 
concentration. However, GR dimerization is clearly required in order to achieve complete nuclear 
localization. In support of this, GRwt showed similarly reduced levels of maximal nuclear localization 
following stimulation with dimerization abrogating CpdA (Fig.5.4C). We have speculated that the 
reduced nuclear import rates seen through the live cell nuclear import assay as opposed to the 
immunofluorescent assay was as a result of the fact that the immunofluorescent technique quantified 
what is in effect 60 percent nuclear localization. However, another possibility does exist, namely that 
the nuclear mobility of the GFP tagged receptor may be reduced due to its large protein tag. 
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The use of CpdA was instrumental in deciphering our nuclear distribution results. While GFP-GR 
concentration did not influence this parameter, the medium GRdim concentration displayed 
significantly more random distribution following DEX stimulation than the medium GFP-GRwt 
concentration. However, the high GFP-GRdim displayed non-random distribution similar to the GFP-
GRwt. Induction with CpdA resulted in random nuclear distribution at all GFP-GR levels and through 
both constructs, suggesting that the ability to dimerize does in fact influence the pattern of nuclear 
distribution. We hypothesize that in this assay the high GFP-GRdim was capable of wild type 
behaviour due to the significant level of DEX induced dimerization it displayed in the Co-IP assay 
(Fig.4.3B). 
 
The live cell nuclear export of GFP-GR following the washout of subsaturating DEX concentrations 
revealed no significant GR concentration dependent differences through either the GFP-GRwt or GFP-
GRdim. However, there was a significant increase in export rate through the GFP-GRdim at both 
medium and high receptor levels when compared to the same concentrations of GFP-GRwt 
(Fig.5.8B). As the rate of nuclear import reflects both import as well as export, the decreased rate of 
nuclear import displayed by the GFP-GRdim may reflect the increased export rate. However, this 
observation must come with the disclaimer that subsaturating concentrations of ligand (export) are 
being compared with saturating concentrations of ligand (import). Finally, although the 
immunofluorescent study of nuclear export following the washout of saturating DEX concentrations 
displayed a trend towards decreased export rates through the GRdim they were not significant. There 
was, however, a significant decrease in the rate of nuclear export through the medium GRwt 
concentration, an effect which is not seen following the washout of saturating CpdA concentrations 
(Fig5.10B) and is therefore dimerization dependent. The tendency towards ligand independent 
dimerization at the medium GRwt concentration may facilitate nuclear retention because of ligand 
independent association of the GR dimer to DNA or tethering proteins in the nucleus.   
 
Taken as a whole increased GR concentration resulted in reduced nuclear import times, most 
probably due to the laws of mass action, while dimerization is required for optimal nuclear import 
levels and rate. In addition, dimerization influences nuclear localization allowing for non-random 
association and thus suggests that GR dimerization is required for the majority of GR interactions with 
DNA. Nuclear export occurs faster through the GRdim and appears to be sensitive to cooperative 
ligand binding but only following the washout of saturating concentrations of ligand. 
 
7.2.4 Chapter 6: Transactivation and transrepression of genes is influenced by positive 
cooperative ligand binding to the GR (Table.7.2) 
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Table 7.2. Summary of results from Chapter 6. Transactivation and transrepression results have been normalized to the respective low 
GRwt value in all conditions except the biocharacter shifts of CpdA, MPA and RU486 were the GRdim values have been normalized to the 
low GRdim value.  Statistical analysis was through ANOVA followed by Dunnett's post test against the low GRwt concentration (*P<0.05, 
**P<0.01, ***P<0.001) except for the GRdim biocharacter shift results of CpdA, MPA and RU486 which have been compared using two 
tailed unpaired t tests of low against medium GRdim concentration (†P<0.05). 
 
abold numbers indicate GR concentrations where cooperative ligand binding has been demonstrated
 
Figure 
GRwt 
concentration GRdim concentration 
Low Medium High Low Medium 
Repression of NFĸB promoter reporter 
      
 Ligand independent fold inductiona 6.3B 1 0.9 0.9 1.0 1.1 
 Potency (DEX) 6.5A 1 0.5 0.2* 1.3 2.5 
 Efficacy (DEX) 6.5B 1 1.2 1.9*** 0.9 1.1 
 Biocharacter shift: CpdA 6.5C 1 0.7** 0.2*** 1 0.4† 
Activation of 2 x GRE promoter reporter 
  
  
  
 Ligand independent activation 6.12A 1 4.7* 22.2*** 1.9 6.0*** 
 Potency (DEX) 6.9A 1 417*** 1250*** 0.8 1.0 
 Efficacy (DEX) 6.13A 1 3.7 12.3*** 5.2** 28.4*** 
 Biocharacter shift: MPA 6.16A 1 1.5 1.8*** 1 1.1 
 Biocharacter shift: RU486 6.16A 1 1.7 1.8* 1 1.1 
Activation of 1 x GRE promoter reporter 
  
  
  
 Ligand independent activation 6.12B 1 9.4*** - 0.4 4.2*** 
 Efficacy (DEX) 6.15A 1 5.0*** - None None 
Activation of endogenous GILZ 
  
  
  
 Ligand independent activation 6.19A 1 1.4* 1.5* 0.8 0.9 
 Efficacy (DEX maximal induction) 6.19B 1 1.6* 2.3*** 1.1 1.4 
 Efficacy (DEX fold induction) 6.19C 1 1.3 2.0* 1.2 1.3 
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Neither GR concentration nor dimerization significantly influenced ligand independent 
transrepression of the NFĸB containing promoter reporter construct. However, the multiple GRE (2 
x GRE) promoter reporter displayed ligand independent transcription, which is GR concentration 
dependent, increasing significantly as GR concentration did. As this behaviour was shown by both 
the GRwt as well as the GRdim, it suggests that cooperative ligand binding does not play a role. 
Ligand independent activation of the single GRE (1 x GRE) containing promoter reporter also 
displayed a significant GR concentration dependent increase.  
 
Furthermore, there was a significant difference in the ligand independent transactivation shown by 
GRwt and GRdim, suggesting an influence of dimerization on ligand independent transactivation 
through this construct. Ligand independent transactivation of the endogenous GILZ gene displayed 
a significant increase at the medium and high GRwt concentrations, where cooperative ligand 
binding occurs, but not at similar concentrations of GRdim. Clearly the ligand independent 
transactivation of genes is sensitive to GR concentration. However, the effects of dimerization and 
cooperative ligand binding are more complex. While the multiple GRE containing construct did not 
discriminate between GRwt and GRdim, the single GRE favoured activation by GRwt and the 
endogenous GILZ gene was only sensitive to ligand independent transactivation at GR 
concentrations which displayed positive cooperative ligand binding. 
 
Intriguingly, transrepression showed a significant decrease in potency as GRwt concentration 
increased, while the potency of the GRdim at low and medium concentrations remained statistically 
unchanged. Thus cooperative ligand binding influences the potency of transrepression. We 
hypothesize that the decrease in potency observed at GRwt concentrations favouring cooperative 
ligand binging suggests that transrepression of NFĸB favours activated GR monomer over the 
activated dimer. The increased tendency towards dimerization at the medium and high GRwt levels 
restrict GR monomer availability while the increased ligand binding affinity (Fig.3.8B) of preformed 
dimers results in greatly reduced numbers of activated monomers at subsaturating ligand 
concentrations. This in turn results in decreased potency due to decreased activated monomer 
concentrations. The potency of DEX transactivation via the multiple GRE containing promoter 
construct showed that there was a significant increase in potency at the medium and high GRwt 
concentrations, which displayed positive cooperative ligand binding. The potencies of both GRdim 
concentrations and the low GRwt concentration were, however, not significantly different. As the 
potency of the high GRwt concentration was 1250-fold greater than that of the low GRwt 
concentration, we can not simply ascribe this to the 3-fold increase in ligand binding affinity 
(Fig.3.8B). Positive cooperative ligand binding at this level of GRwt means that a 10-fold increase 
in ligand concentration shifts receptor occupancy from 10 percent to 90 percent and this may also 
be a contributing factor. As the potency change is ligand specific (Fig.6.9B), varying from 417-fold 
for DEX to 53-fold for F and 2.5-fold for RU486 at the medium GRwt concentration, we hypothesize 
Stellenbosch University  https://scholar.sun.ac.za
 184
that a further ligand dependent conformational change to the receptor is required to explain the 
potency shift of DEX through the multiple GRE promoter reporter. However, other mechanisms 
such as the association of FKBP52 (32) or Ubc9 (30) with the GR may be involved in the higher 
than predicted shift in transactivation potency. Whether or not these are directly related to 
cooperative ligand binding, remains to be explored. 
 
Efficacy of the NFĸB promoter containing construct was not influenced by dimerization, displaying 
similar levels of maximal repression through GRwt and GRdim at both the low and medium GR 
concentrations. It was, however, affected by GR concentration, rising significantly at the high GRwt 
concentration. We noted a high degree of promoter specific behaviour concerning efficacy through 
our various transactivation assays. The efficacy of DEX induction of the multiple GRE containing 
construct was affected by GR concentration and dimerization, displaying enhanced efficacy 
through the GRdim compared to the GRwt. We ascribe this to the ‘hit and run’ theory of 
transactivation where the weaker DNA binding of the GRdim results in more rounds of transcription 
initiation in the same time frame as the high affinity DNA bound GRwt. Recent results from Visser 
et al. (33) suggest another possible reason for this behaviour. They demonstrate significant DEX 
induced degradation of the GRwt over a 24 hour period, while incubation with CpdA resulted in a 
significant upregulation of GRwt levels. In unpublished data from our lab, a similar trend emerges, 
where incubation of the GRdim with DEX results in significant upregulation of GRdim levels. These 
results suggest that the loss of GR dimerization through the GRdim mutant or dimerization 
abrogating, CpdA, may protect the GR from degradation and even lead to its upregulation. If this 
were the case, it would help to explain the 5.2-fold and 7.7-fold higher efficacy we see through the 
GRdim at the low and medium GR concentrations, respectively. The maximal DEX induced 
efficacy of the single GRE containing construct and endogenous GILZ gene displayed similar 
behaviour in terms of GRwt response. As GRwt concentrations increased so too did their efficacy. 
However, they diverge in terms of their dimerization dependent behaviour. While the single GRE 
containing construct displayed no ligand dependent transactivation, there is a non-significant trend 
towards an increase in the DEX induced efficacy of the transactivation of the GILZ via the GRdim 
as receptor levels increase. As the levels of maximal efficacy of GILZ transactivation by DEX 
through the GRdim and GRwt were similar, it suggests that cooperative ligand binding does not 
play a role in this parameter. The fold induction of the GILZ gene seems to support this theory, 
displaying a similar level of efficacy through the medium GRwt concentration as through the 
medium GRdim concentration. However, it is important to note that this parameter is influenced by 
the high degree of ligand independent activation shown by the medium and high GRwt 
concentrations. The fact that the single GRE displayed significant receptor concentration 
dependent ligand independent transactivation through the GRdim but no ligand dependent 
transactivation is worthy of consideration. Could this imply that GRdim is capable of ligand 
independent dimerization and transactivation, but not of ligand dependent dimerization? 
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The biocharacter of CpdA, relative to DEX, in the transrepression assay displayed a shift from full 
agonist to weak agonist behaviour as both GRwt and GRdim concentrations increased. This was 
quantified as a significant reduction in the percentage repression relative to DEX. As this tendency 
was shown through both the GRwt and GRdim it is unlikely that cooperative ligand binding was 
responsible. Intriguingly, competitive ligand binding experiments demonstrated a significantly 
reduced ability of CpdA to displace [3H]-DEX at the medium and high GRwt levels (Fig.6.6D). 
However, although it is important to note that this result reflects CpdA’s ability to displace [3H]-DEX 
and is therefore influenced by both the binding characteristics of DEX and its own binding capacity 
it is suggestive of a receptor concentration dependent influence on CpdA’s ability to bind GR. 
 
The biocharacter of MPA and RU486 induced transactivation of the multiple GRE containing 
construct displayed a shift towards enhanced agonist behaviour relative to that of DEX as GRwt 
concentrations increased. MPA shifted from partial to supra agonist, while RU486 shifted from 
weak to partial agonist behaviour. As the GRdim displayed no such shift for either ligand, we 
conclude that dimerization was necessary for the shift in biocharacter. Furthermore, although the 
medium GRwt concentration did not demonstrate a significant difference from that of the low GRwt 
concentration, there was a clear increase in agonist behaviour at this level which plateau at the 
high GRwt level for both ligands. This suggests that a shift towards cooperative ligand binding is 
responsible for the biocharacter changes of MPA and RU486. 
 
7.3 Implications of positive cooperative ligand binding and enhanced ligand binding affinity 
at high GR concentrations 
 
7.3.1 Molecular 
 
The relevance of potein-protein interactions has been studied for years in G-protein coupled 
receptors.  Models such as the two-state receptor activation model have been proposed to explain 
the behaviour of these receptors (34), which are activated by ligand binding but require binding of 
G-proteins in order to become productive. The association of G-proteins to G-protein coupled 
receptors results in a receptor with high ligand binding affinity while the uncoupled receptor has a 
low ligand binding affinity (35). This behaviour is similar to that which we have demonstrated at 
medium and high GR concentrations, where ligand independent dimerization of the GR results in 
increased ligand binding affinity and positive cooperative ligand binding (Fig.3.8B). Intriguingly, the 
ligand independent association of G-proteins to G-protein coupled receptors causes a degree of 
ligand independent signalling, termed constitutive activity (36, 37). This is very much in line with 
our own results that demonstrate a high degree of ligand independent transactivation at GR levels 
which are known to display ligand independent dimerization (Fig.6.19A, Fig.6.12A). 
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We propose a model based on the two-state receptor activation model (38) which accounts for the 
existence of cooperative ligand binding and explains the energetics involved in the two alternate 
pathways of GR activation (Fig.7.1).  
 
 
Figure 7.1 Non-cooperative versus cooperative ligand binding model. The red arrows denote 
non-cooperative ligand binding at low GR concentrations. (A) Non-cooperative ligand binding to 
GR monomers following by (B) ligand dependent dimerization. The black arrows denote 
cooperative ligand binding at high GR concentrations. (C) Ligand independent dimerization of the 
GR, followed by (D) cooperative ligand binding. 
 
As hypothesized in Chapter 1, we propose that the formation of an activated ligand-bound GR 
dimer may occur in one of two ways (Fig1.11A,B, Fig.7.1). Firstly, via the canonical process of non-
cooperative ligand binding to the GR monomer followed by dimerization of two activated GR 
monomers (Fig.7.1. (A) and (B)). Secondly, by positive cooperative binding of two ligands to the 
two binding sites of the ligand independently dimerized GR (Fig.7.1. (C) and (D)). As demonstrated 
by the GR concentration dependent increase in ligand independent GR dimerization (Fig4.3B, 
Fig.4.7), the GR exists in equilibrium between monomeric and dimeric form where increasing the 
GR concentration results in an increase in ligand independent dimerization. As the GR may exist 
as either a monomer or a dimer and is capable of binding ligand through both conformations, this 
implies that both pathways of activated GR dimer creation may occur concurrently. As these two 
pathways share the same substrate (unbound GR and ligand) and convert them to the same 
product (ligand bound GR dimers) they must share the same total Gibbs free energy (Fig7.1). 
(D)  
Cooperative binding 
of ligand to GR dimer 
at ↑ [GR] 
           (C)  
Dimerization of GR 
in absence of ligand 
at ↑ [GR] 
(A) 
Non-cooperative binding 
of ligand to GR monomer 
at ↓ [GR] 
GR GR 
 
GR 
R 
GR 
R
GR 
R 
GR 
R 
GR 
R 
GR 
R 
Gibbs free energy (∆G): ∆GA + ∆GB = ∆GC + ∆GD 
Thus KdA x KdB = KdC x KdD 
If KdD < KdA then KdC > KdB 
                        (B) 
 Ligand induced dimerization 
of ligand bound GR 
at ↓ [GR] 
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Therefore the Gibbs free energy of reactions A plus B must equal that of reactions C plus D. If one 
pathway required less energy for the conversion of substrate to product that pathway would come 
to dominate the entire reaction process. Another way of comparing the energetics of the two 
reaction pathways is through the Kd, the product of each pathway’s constituent reaction’s Kds must 
be equal in order for the Gibbs free energy requirement of both pathways to remain the same 
(Fig.7.1). Our results have shown that the Kd of reaction D, namely ligand binding to the preformed 
GR dimer, is lower than that of ligand binding to the GR monomer, represented by reaction A 
(Fig.7.1). Thus, in order for the Gibbs free energy to remain equal between the two pathways the 
Kd of reaction C must be higher than that of reaction B (Fig.7.1). Ligand independent GR 
dimerization is therefore less energetically favourable than ligand dependent dimerization and will 
only occur at high concentrations of substrate i.e. GR. Another way of viewing this paradigm is as a 
means to prime the GR for ligand binding. The fact that the GR dimer is preformed, allows for a 
protein-protein interaction, which not only forms two ligand binding sites which facilitate 
cooperative ligand binding, but also increases the GR’s affinity for ligand.   
 
7.3.2 Cellular 
 
In a recent review article by Simons (39), he comments on the fact that maximal response 
(efficacy) of transcription through either transactivation of transrepression can not be correlated 
with EC50 (potency). This is a telling observation as many studies on the response to GCs only look 
at one subsaturating concentration of ligand (40-42) and do not explore the potency through dose 
response assays. The growing number of factors, which have been shown to influence the potency 
of the GC response, including GR concentration (43), highlight the importance of analysing both 
potency and efficacy. 
 
Having established the molecular consequences of an increase in GR concentration, namely, 
ligand independent dimerization, which facilitates cooperative ligand binding and an increase in 
ligand binding affinity, we looked at the effects of these on the mechanism of GR action at a 
cellular level. While an increase in GR concentration in the live cell import assay resulted in faster 
import of the GR, this was unrelated to cooperative ligand binding as a similar trend was observed 
with GRdim (Fig.5.2B). Tellingly, while no GR concentration dependent difference in the rate of GR 
import was detected at saturating ligand concentrations in the immunofluorescent import assay, a 
3-fold difference was detected between low and medium GR concentrations at subsaturating 
ligand concentrations (Fig.5.3). Thus, the influence of the increased affinity for ligand of the 
medium GR concentration could only be observed at subsaturating ligand concentrations. The 
capacity to dimerize increased the rate of nuclear import (Fig.5.2B, Fig5.4D) and its extent in a 
population of cells (Fig.5.4C), facilitated non-random nuclear distribution (Fig.5.5C), and prolonged 
nuclear export following the washout of a subsaturating ligand concentration (Fig.5.8B). 
Stellenbosch University  https://scholar.sun.ac.za
 188
Furthermore, the increased ligand binding affinity and capacity for ligand independent dimerization 
of the medium GR concentration most probably contributed to its significantly prolonged nuclear 
export, following the washout of a saturating DEX concentration (Fig.5.10B). Thus it appears as if 
GR concentration and the ability to dimerize, but not cooperative ligand binding to the GR, affects 
nuclear import, export and distribution. 
 
However, cooperative ligand binding can be directly correlated with a large and significant increase 
in the potency of DEX transactivation of the multiple GRE containing promoter construct (Fig.6.9A). 
Furthermore, our results suggest that cooperative ligand binding decreased the potency of 
transrepression through a promoter reporter construct containing 3 x NFĸB promoter elements 
(Fig.6.5A). While both the single and multiple GRE containing promoter constructs displayed ligand 
independent transactivation, which increased as GR concentration did, only the ligand independent 
transactivation of the endogenous GILZ gene can be ascribed specifically to ligand independent 
dimerization of the GR at medium and high concentrations and thus cooperative ligand binding. 
 
In general, the efficacy of transcription increased as GR concentration does. This is an observation 
which has been documented for most transcription factors (44-46) and was also seen in the 
present study. There was, however, considerable promoter construct specific variation in response 
to GR dimerization in our study. While efficacy through the multiple GRE containing construct is 
decreased by GR dimerization (Fig.6.13A), the single GRE containing construct displayed no 
ligand dependent induction through the GRdim (Fig6.15A), and only the endogenous GILZ gene 
showed a significant correlation between cooperative ligand binding and an increase in DEX 
induced efficacy when maximal induction is considered (Fig.6.19B). 
 
The biocharacter of the dissociative GC, CpdA, shifts from a full agonist to a weak agonist in 
transrepression of a NFĸB containing promoter construct as GR concentration increases (Fig6.5C). 
This behaviour is not influenced by GR dimerization. On the other hand, cooperative ligand binding 
influences the biocharacter shift from partial to full agonist behaviour of MPA (Fig.6.16A), as well 
as the shift from weak to partial agonist behaviour of RU486 (Fig.6.16A) in transactivation of a 
multiple GRE containing promoter reporter construct. 
 
It is clear that GR concentration and the ability to dimerize have far ranging effects on GC 
response. This study has attempted to tease apart the cause of these influences and find that 
cooperative ligand binding and an increased ligand binding affinity, although not particularly 
influential at saturating ligand concentrations, are especially prominent at subsaturating ligand 
concentrations. This one may expect considering the enhanced sensitivity to ligand binding that 
ligand independent dimerization facilitates at high GR concentrations. The medium and high GR 
levels, which display cooperative ligand binding, result in considerable and significant ligand 
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independent GILZ induction. The constitutive activity which ligand independent dimerization elicits 
from this endogenous gene is telling as it implies constant low levels of GR activation in cells 
exposed to no GC at all. Finally, the high levels of GR concentration dependent, but ligand 
independent, transcription of the GRE containing promoter constructs serves as a reminder that 
the highly processed data presented for these assays in many articles may actually result in 
promising findings being over looked.  
 
7.3.3 Physiological 
 
Although we have not conducted any physiological studies, it is informative to address the 
ramifications of our cellular observations particularly in light of the observed trends towards GC 
hypersensitivity at high physiological GR levels (47),(48),(49) and GR resistance at low 
physiological GR levels (50),(51). Our results stress the numerous influences which GR 
concentration has on the response to GCs and offer an insight into how increased GR 
concentrations may result in greater response (efficacy) and sensitivity (potency) to GCs.  
 
An interesting observation from our study is the decrease in the potency of DEX through the NFĸB 
containing promoter construct as GR concentrations increase to levels that display cooperative 
ligand binding, as apposed to the greatly increased potency of DEX through the multiple GRE 
containing promoter reporter construct under the same conditions. This would imply a reduced 
capacity for the anti-inflammatory response and a greater likelihood of side effects in tissues 
expressing high GR concentrations and exposed to subsaturating concentrations of GCs. It may be 
that patients who experience greater GC induced side effects also express higher levels of GR in 
the affected tissues. 
 
Tissues which express GR concentrations within or above the range of our medium GR 
concentration may furthermore display faster nuclear import of the GR at lower concentrations of 
GC as well as prolonged nuclear retention following GC withdrawal or no withdrawal at all, 
considering the ultradian secretion of endogenous GCs. These tissues may have an increased 
potency for transactivation and a reduced potency for transrepression. In addition, they may 
display ligand independent activation of GRE containing promoters by the preformed GR dimer. 
This hypersensitivity to GCs due to ligand independent dimerization of the GR at high GR 
concentrations may be an important factor in determining the interindividual, tissue-specific and 
healthy versus diseased state, differences in GC response. 
 
The majority of human tissue biopsies (Table 1.1 and 1.2) display GR concentrations below that of 
the medium GR concentration of 763 fmol GR/mg protein or 298000 GR/cell tested in this study. 
They therefore fall outside the range of GR concentration for which positive cooperative ligand 
Stellenbosch University  https://scholar.sun.ac.za
 190
binding has been demonstrated and would retain the capacity to respond to variations in the 
concentration of endogenous or pharmacologically administered GCs. Only a few healthy tissues, 
such as skin, and some diseased tissue, like lung cancer tissue and Kaposi’s sarcoma in AIDS 
patients, would be constantly signalling due to their high GR concentrations at physiological GC 
concentrations. 
 
7.4 Future research 
 
As the association of GCs to GR is the first step in the GR mediated response to GCs (Fig.1.6), the 
influences of increased ligand binding affinity and cooperative ligand binding are potentially myriad. 
Having shown that GR concentration and the ability to dimerize directly influences ligand 
independent dimerization, ligand binding affinity, nuclear import, distribution and localization as 
well as transrepression and transactivation through GC responsive promoters, we are spoilt for 
choice in terms of future studies. We have mentioned a number of potential follow up studies within 
the results chapters and offer the most promising here.   
 
7.4.1 GR dimerization 
 
The construction of a Flag-GRdim or a CFP-GRdim/YFP-GRdim pair would allow us to definitively 
elucidate the dimerization capacity of the D-loop dimerization impaired GRdim mutant in Co-IP or 
FRET studies, respectively.  
 
Furthermore, it would be of great interest to us to place the GRdim gene in the same vector as the 
GRwt in order to test the behaviour of the GRdim at similar levels to that of the high GRwt. As yet 
we can not predict whether the difference we see in maximal induction of the endogenous GILZ 
gene between the medium concentration of GRwt and GRdim is due to positive cooperative ligand 
binding or as a result of the enhanced ligand independent transactivation displayed by the GRwt. 
The behaviour of the high GRdim concentration would be an acid test as to whether positive 
cooperative ligand binding is influential in this system. 
 
The ability to induce dimerization of the GR has a prominent affect on the actions of CpdA and 
DEX, especially on their capacity to induce transactivation. Could the ability to induce GR 
dimerization be used as a determinant for transactivative function? By testing the ability to induce 
dimerization of a variety of GCs through either FRET or Co-IP assays and their ability to induce 
transactivation, we would be able to correlate these parameters. 
 
Our hypothesis for enhanced efficacy of the multiple GRE containing construct through the GRdim 
rests on its decreased affinity for GREs. This theory could be tested by analysing the DNA 
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occupancy of the GRdim compared to that of the GRwt using DEX and CpdA stimulation, using the 
CHIP assay. Furthermore, ligand independent DNA association at high GRwt levels would confirm 
the capacity for ligand independent GR behaviour.  
 
Vanderbilt et. al. (52) established that GR is the primary regulatory factor of GC response by 
demonstrating a directly proportional relationship between GR concentration and the RNA 
expression of GRE containing genes following DEX induction. However, recent research has 
highlighted the importance of GRE structure in GC response (53) Evaluation of a range of GRE’s, 
that differ at times only by one nucleotide, has indicated that their GC responses vary considerably, 
that GRwt and GRdim have unique transactivation profiles and that GR binding affinity to the GREs 
does not correspond to the degree of transcription facilitated (53). It would be of interest to 
examine the influence that GR concentration, the capacity to dimerize as well as ligand 
independent dimerization have on the ligand dependent as well as ligand independent 
transactivation of a variety of GREs. 
 
7.4.2 Cooperative ligand binding and increased ligand binding affinity 
 
The comodulators, FKBP51 and FKBP52, are known to influence the localization of the GR (32, 
54) as well as its ligand binding affinity (32). FKBP52 association with the GR, via Hsp90, 
increases the ligand binding affinity of GR as well as stimulating its nuclear import (32), while 
FKBP51 has the opposite affect on GR action (55-57). It would be of interest to determine whether 
these comodulators bind preferentially to the GRwt and GRdim through Co-IP assays.  
Investigating the influence of CpdA or DEX stimulation on the association of either FKBP51 or 
FKBP52 to the GR would also be advantageous. 
 
The potent synthetic agonist, DEX, and the potent endogenous agonist, F, display greater 
increases in potency through the multiple GRE containing promoter at the medium GR level than 
the partial agonists, MPA and RU486. To clarify this issue it would be of interest to test whether all 
of these test compounds bind to the medium and high GR concentrations in a positive cooperative 
fashion. 
 
7.4.3 CpdA 
 
Co-incubation of [3H]-estradiol with the antagonist clomiphene abrogates the positive cooperative 
ligand binding displayed by the ER (58). Considering CpdA’s capacity to abrogate dimerization, it 
would be interesting to show whether it could prevent cooperative ligand binding of the GR, 
especially in light of its reduced capacity to displace DEX from the GR at high concentrations. 
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The fact that we have displayed CpdA’s ability to abrogate ligand independent dimerization at the 
medium and high GR concentrations to levels seen at the low GR concentration (Fig.4.3B) is a 
difficult point to resolve considering the reduced capacity to induce transrepression and displace 
[3H]-DEX in competitive binding assays. Future competitive binding studies of CpdA’s ability to 
displace [3H]-DEX at the low and medium concentration of GRdim may help us to unravel this 
conundrum.  Furthermore, we could confirm CpdA’s ability to compete with DEX for binding 
through the dimerization elicited by co-incubation of CpdA and DEX in the FRET or Co-IP assays. 
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A.1. S. Robertson, A. Louw and J. Hapgood (2006), Does receptor concentration affect 
Glucocorticoid action? AstraZeneca medical research day, Cape Town, South Africa 
 
The glucocorticoid receptor (GR) is a ligand-activated transcription factor that is a member of the 
nuclear receptor family and the target of anti-inflammatory drugs. Upon ligand-binding the GR 
translocates to the nucleus and the degree of GR nuclear localization is a critical factor in 
determining the level of GR function. In addition, several reports suggest that GR concentration 
may modulate the bioactivity of ligands. We propose that exploring the link between GR 
concentration and ligand-binding parameters, ligand bioactivity and nuclear translocation kinetics 
will lead to a greater understanding of ligand specificity and the role of GR concentration. COS-1 
cells containing very little endogenous GR were transiently transfected with high, medium and low 
levels of Green Fluorescent Protein-GR (GFP-GR) and exposed to a battery of test compounds 
that include GR agonists, partial agonists, partial antagonists and a selective GR agonist (SEGRA). 
Whole cell saturation binding indicates cooperative binding at high GR concentrations (Hill slope > 
1) and in accordance, a shift to higher affinity. These findings are mirrored by transactivation 
studies which demonstrate the impact of GR concentration on bioactivity. We show that increased 
GR concentration leads to a significant increase in ligand potency (EC50) and efficacy (fold 
induction). In addition, the bio-character of some compounds change with increased GR 
concentration. MPA, for example, displays partial agonist activity at lower GR concentrations that 
shift to supra-agonist activity at high GR concentrations. Fluorescence microscopy reveals that 
nuclear import of the GR is influenced by the type of ligand, with full agonists displaying the highest 
rate of import. In addition, increased GR concentration increases the rate of nuclear import. By 
studying the behaviour of ligands at varying GR concentrations we have shed light on the 
mechanistic implications of GR-concentration for GR-mediated gene regulation. In addition, our 
findings may have physiological implications in glucocorticoid resistance or chronic stress. 
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A.2. S. Robertson, A. Louw and J. Hapgood (2008), Does cooperative ligand binding affect 
glucocorticoid action?, South African society for biochemistry and molecular biology 
(SASBMB), Grahamstown, South Africa 
 
We examine the implications of cooperative ligand binding for GR-mediated gene regulation by 
exploring the link between glucocorticoid receptor (GR) concentration and ligand-binding 
parameters, ligand bio-activity and bio-character, and nuclear translocation kinetics. 
 
COS-1 cells, without endogenous GR, transiently transfected with high, medium and low levels of 
GR were exposed to a battery of GR ligands. We demonstrate in saturation binding studies that 
cooperative ligand-binding (Hill slope > 1) with a concurrent significant increase in affinity occurs at 
high GR concentrations. At GR concentrations that result in cooperative ligand-binding we 
demonstrate a significant shift in transactivation potency (EC50) and efficacy (fold induction) as 
measured with promoter reporter assays, a significant decrease in the half time for nuclear 
localization, as measured by live-cell fluorescent microscopy, and a significant shift in 
transactivation bio-character for some compounds, such as RU486. 
 
Positive cooperativity has the potential to shift the GR response from a gradual increase in 
response to increased ligand concentration to a mechanism that resembles a molecular switch. 
These findings may have physiological implications in that differential gene expression could result 
in different levels of gene product with the same concentration of steroid.  
 
Keywords: Glucocorticoid receptor, cooperative ligand binding, steroid ligands 
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A.3. S. Robertson, A. Louw and J. Hapgood (2009), Cooperative ligand binding affects 
glucocorticoid action, Experimental biology group (EBG), Stellenbosch, South Africa 
 
Won best student speaker of 2009 for this presentation. 
 
It has recently been shown that cooperative ligand-binding to the glucocorticoid receptor (GR) 
occurs at high, but not low GR concentrations and that increased GR concentrations cause a bio-
character switch in ligands in both transrepression and transactivation systems. No investigation 
has, however, specifically examined the implications of cooperative ligand binding for GR-mediated 
gene regulation. We have explored the link between GR concentration and ligand-binding 
parameters, ligand bio-activity and bio-character, and nuclear translocation kinetics in an attempt 
to evaluate the implications of cooperative ligand binding. 
 
COS-1 cells, containing very little endogenous GR, were transiently transfected with high, medium 
and low levels of Green Fluorescent Protein-GR (GFP-GR) and exposed to a battery of test 
compounds that include GR agonists, partial agonists, partial antagonists and a selective GR 
agonist (SEGRA). We demonstrate in whole cell saturation binding studies that cooperative ligand-
binding (Hill slope > 1) with a concurrent significant (P < 0.05) increase in affinity occurs at high GR 
concentrations. Promoter reporter studies show a significant (P < 0.05) shift in transactivation 
potency (EC50) and efficacy (fold induction) at GR concentrations that elicit cooperative ligand-
binding. In addition, a significant (P < 0.05) shift in transactivation bio-character is demonstrated for 
some compounds, such as RU486, at GR concentrations that show cooperative ligand-binding. 
Finally, at GR concentrations that result in cooperative ligand-binding a significant (P < 0.01) 
decrease in the half time for nuclear localization, as measured by live-cell fluorescent microscopy, 
is observed.   
 
Cooperative ligand-binding presupposes the presence of more than one binding site and as this is 
only observed at high GR concentrations we hypothesize that binding to GR dimers must be 
involved and present a model describing our theory. Positive cooperativity in ligand-binding and 
thus by implication increased levels of GR has the potential to shift the GR response from a 
gradual increase in response to increased ligand concentration to a mechanism that resembles a 
molecular switch. These findings may thus have physiological implications in that differential gene 
expression may result in different levels of gene product with the same concentration of steroid.  
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ABROGATION OF GLUCOCOTICOID RECEPTOR DIMERIZATION CORRELATES WITH 
DISSOCIATED GLUCOCORTICOID BEHAVIOUR OF COMPOUND A 
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